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BACKGROUND
The estimated date of delivery (EDD) or ‘due date’ is a mathematically calculated date and is set on 
266 days from the date of conception or 280 days from the onset of the last menstrual period in a 
normal 28-day menstrual cycle. (1-3) When pregnancy is achieved through in vitro fertilisation, the 
date of fertilisation is certain, and thus so is the EDD. In the case of a spontaneous conception, the 
exact date of fertilisation is unknown as the duration of the follicular stage in the menstrual period 
varies. (4, 5) Since 2010, an early ultrasound is performed to measure the crown rump length (CRL) 
that can subsequently be used to reliably determine the EDD.(6) Measurement of the CRL is preferably 
performed between 10.0 weeks and 12.6 weeks of gestation. (6) Using sonographically confirmed 
gestational ages, the overall mean gestational age at birth is 273 days (39.0 weeks) with a standard 
deviation (SD) of 14 days and a median gestational age at birth of 276 days (39.3 weeks). (5) Only 4% of 
all births occur at the exact EDD (40.0 weeks). Nearly half (47%) of women with a singleton pregnancy 
give birth after the EDD. (7) The onset of labour is a multifactorial process involving, amongst others, 
the oestrogen/ progesterone balance and inflammatory processes. However, the exact trigger, and 
therefore timing of birth, remains unknown. (8) Gestational age at deliveries can be categorised in 
groups. Deliveries from 37.0 weeks to 41.6 weeks are considered ‘term deliveries’ and can be further 
subdivided to 37.0-38.6 weeks or ‘early term’, 39.0 to 40.6 weeks or ‘full term’ or 41.0 to 41.6 weeks or 
‘late-term’ deliveries. Deliveries beyond 42.0 weeks of gestational age are called ‘post-term deliveries’. 
Implementation of early pregnancy dating by sonography has led to more reliable determination of 
the EDD and led to a significant decrease in the incidence of post-term (>42.0) pregnancies (5.4% in 
2001 to 1.4% in 2017). (9-11) 
In the Netherlands, all pregnancy, birth and neonatal outcomes are recorded and stored in the 
Perined Database. (7) In 2016, 27,330 (16.7%) singleton late-term pregnancies and 2,274 (1.4%) post-
term pregnancies were recorded in this database. The major risk factors for a post-term birth include 
previous post-term delivery, nulliparity, obesity, advanced maternal age and ethnicity (non-Hispanic 
white women). Post-term birth is associated with an increased risk of perinatal death, macrosomia, 
instrumental delivery (caesarean section  or operative vaginal delivery, perineal trauma, shoulder 
dystocia and postpartum haemorrhage. (12) It is therefore recommended to offer induction of labour 
to women presenting with post-term pregnancies. (12) The exact mechanism by which post-term birth 
leas to a poorer pregnancy outcome is not completely understood. Most post-term pregnancies occur 
physiologically as a consequence of the natural variation in pregnancy duration. The so called ‘biological 
post-term pregnancy’ with decreased placental function can also occur before the ‘mathematical’ post-
term pregnancy’ of 42.0 weeks has occurred. (13) Because there is no test to assess the placental function 
properly, it is hard to predict which women are at risk for an adverse pregnancy outcome. Possible risk 
factors could be a gestational age beyond 41 weeks, maternal age ≥35 years, or non-white ethnicity. (14-
16) Management of pregnancies and these possible risk factors widely vary between countries. (17-19) 
It is difficult to generate general recommendation from studies identifying these risk factors, as the risks 
are calculated on population level and can be hard to translate to the individual patient. 
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Obstetric care in the Netherlands is provided by both midwifery-led care (primary care) consisting 
mainly of independent midwifes and by obstetrician-led care (secondary care), consisting of clinically 
working midwifes, residents and obstetricians. (19-21) Midwifery-led care is represented by the 
‘Koninklijke Nederlandse Organisatie van Verloskundigen‘ (KNOV), obstetrician-led care is represented 
by the ‘Nederlandse Vereniging voor Obstetrie en Gynaecologie´ (NVOG). All pregnant women are 
categorised into certain risk categories using an extensive, consensus based document called the 
‘Verloskundigen Indicatie Lijst’ (VIL). (22) Women with a or a risk of developing a high risk pregnancy, 
delivery or puerperium, receive their pre- peri- and postnatal care in obstetrician-led care. Women 
with uncomplicated, low-risk pregnancy receive their obstetric care in midwifery-led care unless they 
choose to receive care in obstetrician-led care. Women in both midwifery-led care and obstetrician-
led care can have a spontaneous onset of labour. If there is an indication to induce labour, this takes 
place in obstetrician-led care. In 2016, 146,727 (86.8%) of all women, started care in midwifery-led 
care. 86,822 (51.5%) started labour in midwifery-led care, while 50,572 (30.0%) also delivered in 
midwifery-led care. (7) 
Late-term pregnancies are considered to be low risk, which means that women primarily receive 
their obstetrical care in midwifery-led care or in obstetrician-led care on maternal request. The 
KNOV factsheet on late-term pregnancies recommend to set up local agreements on: counselling, 
consultation and antenatal monitoring between 41.0 to 41.6 weeks, sweeping the membranes starting 
from 41.0 weeks, planning an induction at 42.0 weeks and amniotomy in midwifery-led care the day 
before start induction in obstetrician-led care. (23) The NVOG guideline on post-term pregnancies 
state that women should be informed on: the risks of remaining pregnant after 42.0 weeks, the 
limitations of antenatal foetal testing and membrane sweeping starting from 38.0 weeks to reduce the 
risk on post-term pregnancy. When there is a request for an induction ≥41.0 weeks, labour could be 
induced after information on this process. This guideline also advises to make a local protocol with the 
associated midwifery-led care practices. 
The interpretation of the national- and international literature on late-term and post-term pregnancy 
is interpreted differently by both midwifery-led care and obstetrician-led care. (16) Therefore, in the 
Netherlands, there are multiple ways of practice possible for low risk women reaching 41.0 weeks of 
gestation. Some obstetric caregivers consider late-term pregnancy as a high-risk situation where labour 
should be induced. Others consider late-term pregnancy as a physiological phenomenon, which allows 
women to await spontaneous onset of labour and to induce labour only in specific circumstances including 
reduced foetal movement, suspected foetal growth restriction, maternal hypertension or maternal request. 
All obstetric caregivers strive to provide the best practice for each individual patient. Unfortunately, 
to date no clear evidence exists on what should be considered best practice in low risk women in 
late-term pregnancy. Women who choose to await spontaneous onset of labour, may have a small 
and increasing risk on adverse perinatal and maternal outcomes.(12) The advantage of awaiting 
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spontaneous labour is that pregnant women can experience the natural process of onset of labour 
and even give birth at home guided by their midwife from the midwifery-led care. It is thought that 
giving birth an unknown environment guided by a previously unknown obstetric caregiver could 
adversely influence their experience on childbirth. Women who opt for induction of labour and thus 
give birth in obstetrician-led care, could face higher risks of perinatal and maternal complications and 
interventions. (24) Recent trials and systematic reviews, however, did not show an increased risk of 
caesarean sections. (14, 16, 17, 25-27)
SETTING
This thesis is the first part of a total of three PhD-theses which describe the data generated in 
the INDEX project. The INDEX project contains multiple researches on INDuction of labour or 
Expectant management in obstetrical low-risk late- term pregnancies. The INDEX team consists of 
a multidisciplinary group representing obstetric caregivers in the Netherlands on all care levels, 
performing multiple studies on late- and post-term pregnancy.
AIM AND OUTLINE
This thesis aims to identify and address potential risks of late- and post-term pregnancy. After 
identification of possible risk factors of late-term and post-term pregnancy, the thesis aims to provice 
guidance to the obstetric caregivers to implement in daily practice in women with late- and post-term 
pregnancies in the Netherlands.
The effects of a recurrent post-term birth and the effects of maternal age on adverse pregnancy 
outcomes in late- and post-term pregnancy using retrospective cohort data from the Perined Database 
are described in chapters 2 and 3.
Timing, most relevant condition of death and substandard factors in late- and post-term pregnancies, 
as assigned by the perinatal audit, were analysed and described in chapter 4.
The results of a survey on current practice in late- term and post-term pregnancies in midwifery-led 
care and obstetrician-led care in the Netherlands are shown in chapter 5.
Chapter 6 contains the outline of the INDEX trial: Induction of labour at 41 weeks versus expectant 
management until 42 weeks. In chapter 7, the results of the INDEX trial are presented.
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CHAPTER 2
Recurrence rate and outcome of post-term pregnancy, 
a national cohort study
J.C. Kortekaas, B.M. Kazemier, A.C.J. Ravelli, K. de Boer, J. van Dillen, B.W.J. Mol, E.R. de Miranda
European Journal of Obstetrics & Gynecology and Reproductive Biology 193 (2015) 70–74
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ABSTRACT
Objective
To assess the recurrence rate of post-term delivery (gestational age at or beyond 42.0 weeks or 294 
days) and to describe maternal and perinatal outcomes after previous post-term delivery.
Study design
From the longitudinal linked Netherlands Perinatal Registry database, we selected all singleton 
primiparous women who delivered between 37.0 and 42.6 weeks with a subsequent singleton 
pregnancy from 1999-2007. We excluded congenital abnormalities. We compared the recurrence 
rate of post-term delivery and risk of antenatal foetal death in women with and without a post-term 
delivery in their first pregnancy. We compared perinatal outcome (composite of perinatal mortality, 
Apgar score <7 and birth injury) and adverse maternal outcome (composite of maternal death, 
abruptio placentae, PPH>1000 ml and blood transfusions) between women with a recurrent and a de 
novo post-term second pregnancy. 
Results
Our study population consisted of 233,327 women of whom 17,874 (7.7%) delivered post-term in 
the first pregnancy. In the second pregnancy, 2,678 (15%) women had a recurrent post-term delivery 
compared to 8,698 (4%) women with a de novo post-term delivery (odds ratio (OR) 4.2 95% confidence 
interval (CI) 4.0 to 4.4). Subgroup analysis in recurrent and de novo post-term delivery showed no 
differences in composite perinatal and composite maternal outcome (OR1.0; CI 0.7 to 1.5, p=0.90 and 
OR1.1, CI 0.9 to 1.4, p=0.16), adjusted for foetal position and mode of delivery).
Conclusions
Women with a post-term delivery in the first pregnancy have a higher risk of recurrent post-term 
delivery. Our data suggest that there is no difference in the composite adverse perinatal outcome 
between recurrent and de novo post-term delivery. 
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INTRODUCTION 
Post-term pregnancy is defined as a pregnancy with a gestational age of >42.0 weeks (>294 days) after 
the first day of the last menstrual period, which occurs in 1.5-10% of all pregnancies, depending on 
the population characteristics, methods of determining gestational age and the proportion of women 
with induced labour before 42 weeks. (1-4) Term pregnancies are pregnancies with a gestational age 
of > 37.0-41.6 weeks. Late-term pregnancies are defined as pregnancies with a gestational age of 
>41.0-41.6 weeks [Figure 1]. (5)
Figure 1 Definitions of term (early, full and late-term) and post-term pregnancy
Post-term pregnancies contribute to increased adverse maternal or perinatal outcomes in comparison 
to term deliveries (37-41.6 weeks). Maternal adverse outcomes e.g. labour dystocia (9-12% versus 
2-7% at term) and severe perineal injury related to macrosomia (3.3% versus 2.6% at term) are 
increased in post-term deliveries. (6) Furthermore, there is an increased risk of adverse perinatal 
outcomes such as foetal death. (6-10)
Factors known to influence length of pregnancy are paternal genetics, maternal height, obesity and 
male foetal gender. (11-15) Previous studies showed a high recurrence risk of post-term delivery. (7, 
16-19) The risk of adverse maternal or perinatal outcomes in a second, recurrent or de novo, post-
term delivery is unknown. However, knowledge about possible differences in outcomes with de novo 
or recurrent of post-term delivery could be incorporated in the clinical management of subsequent 
pregnancies. Risk stratification could be made and could lead to individualisation of the management 
of post-term pregnancies, specifically in the timing of induction of labour. The objective of this study 
was to assess the recurrent risk of post-term delivery and the adverse maternal and perinatal outcome 
in recurrent and de novo post-term delivery.
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MATERIALS
We performed a national cohort study using the perinatal database from the Netherlands Perinatal 
Registry (PRN) between 1999 and 2007.(20) The PRN registry consists of population-based data and 
contains information on pregnancies, deliveries and readmissions until 28 days after birth. It consists 
of a validated linkage of three different registries: primary midwifery care registry, secondary obstetric 
care registry and neonatology registry of hospital admissions of neonates, with an overall coverage 
of approximately 96% of all deliveries in the Netherlands. (21, 22) The Registry contains details of 
all pregnancies > 22 weeks’ gestation and a birth weight of > 500 grams and is used primarily for 
an annual assessment of the quality indicators of obstetric care. A longitudinal probabilistic linkage 
procedure was performed to create a cohort with complete data on first and second deliveries of the 
same mother. (20) Since the data in the perinatal registry are anonymous, no ethical approval was 
needed. The PRN gave their approval for the use of the data for the purpose of this study (approval 
no 11.44.).
From our cohort with two subsequent pregnancies, we selected all singleton nulliparous women 
who delivered between 37.0 and 42.6 weeks and had a second singleton pregnancy and delivery in 
the Netherlands between 1 January 1999 and 31 December 2007 between 37.0 and 42.6 weeks. We 
excluded women with neonates born with congenital abnormalities. (22) Pregnancy dating was either 
performed by first trimester ultrasound and/or known (regular) last menstruation. All women were 
categorized by gestational age at first pregnancy; term group (37.0 till 41.6 weeks) and post-term 
group (42.0 till 42.6 weeks). We included both spontaneous and induced onset of labour because 
labour induction at 42 weeks for post-term pregnancy is regular policy in the Netherlands during the 
years of the study.
We studied the recurrence rate of post-term delivery in women with and without a post-term delivery 
(>42.0 weeks, >294 days) in their first pregnancy and their risk on antenatal foetal death. In addition, 
we analysed a subset of the cohort consisting of only women with a post-term delivery in their second 
pregnancy. Besides recurrent risk we also analysed adverse perinatal and maternal outcomes. Perinatal 
outcomes were; antepartum death, neonatal death, Apgar score <7 and birth injury of the neonate 
(composite score of intracerebral bleeding, cephalic haematoma, facial nerve paresis, brachial plexus 
lesion, fracture of clavicle, humerus or femur and other injury) and a composite perinatal outcome 
consisting of the before mentioned items. Maternal outcomes analysed in this group are maternal 
death, placental abruption, postpartum haemorrhage (PPH) >1000ml or blood transfusion, as well as 
a composite maternal outcome consisting of the items mentioned before. 
We compared baseline characteristics between women with a first term and a first post-term delivery 
using Chi-square tests and independent t-test when appropriate. Risk of recurrence was expressed 
using Odds ratios and adjusted for ethnicity and maternal age. In addition, the recurrent risk was also 
calculated for spontaneous onset of labour and non-spontaneous onset of labour. 
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Time to spontaneous delivery in second pregnancy, stratified by gestational age at first delivery, was 
expressed using a Kaplan Meier/ survival curve. Induced pregnancies were censored at the time of induction. 
Multivariate logistic regression was used to assess the association between de novo and recurrent post-
term delivery and perinatal and maternal outcomes. We adjusted for induction of labour, non-cephalic 
presentation, small for gestational age (SGA, birth weight below the fifth percentile) and socio-economic 
status (SES). Low SES was determined on postal code. Fisher exact test was used to compare antenatal 
death rates in second late-term (41.0-41.6 weeks) and post-term (>42.0-42.6 weeks) pregnancy, stratified 
by gestational age at first delivery. We used the post-term delivery group in first pregnancy as a reference 
group. Due to the rare occurrence of antepartum deaths, we combined the 41 and 42 weeks of gestational 
age at second delivery to increase the power of the analysis on antepartum death rates in second postdate 
pregnancy. Both % and ‰ are used, when appropriate. All analyses were completed using SAS 9.2. 
RESULTS
In the longitudinal linked PRN database, 272,551 women had a subsequent ongoing pregnancy in 
the study period. We excluded 7,480 women with a multiple pregnancy, 4,572 with a congenital 
abnormality of the foetus and 27,172 who delivered before 37.0 or after 42.6 weeks, leaving 233,327 
patients in the total cohort, who delivered twice between 37.0 weeks and 42.6 weeks in the study 
period. In total 97,129 deliveries were induced or had a primary caesarean section performed, and 
136,198 deliveries had a recurrent spontaneous onset of labour.
Table 1 baseline characteristics of the cohort (n=233,327) stratified by gestational age of first delivery
Term (37.0-41.6) Post-term (42.0-42.6) p-value
Maternal characteristics N=215,453 N=17,874  
Maternal age, mean (SD) 28.6 (4.1) 28.8 (4.3) <0.0001
Low SES * % 21.6 22.8 0.0002
Non-Caucasian % 10.8 11.2 0.18
Induction of labour % 38.9 79.2 <0.0001
 
Neonatal characteristics    
Male % 50.3 52.6 <0.0001
Birthweight, mean (SD) 3431 (475) 3750 (462) <0.0001
* Low social economic status is determined on postal code
Baseline characteristics of the singleton primiparous women who delivered between 37.0 and 42.6 
weeks are shown in Table 1. The rate of women who had a post-term delivery in their first pregnancy 
was 7.7% (17,874/233,327) (Table 2). The risk of recurrent post-term delivery in these women was 
15.0% (2,678/17,874) compared to 4.0% (8,698/215,453) for women with a term delivery. The 
adjusted OR (aOR) of the recurrent post-term risk was 4.2 (95%CI 4.0 to 4.4), p<0.0001).
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Table 2 The recurrence risk of post-term birth
First delivery Second delivery
n = 233,327
 
Post-term: 42.0-42.6 
n = 11,376 (%)
Term: 37.0-41.6  
n = 221,951 (%) OR (95% CI) aOR* (95% CI)
Post-term: 42.0-42.6 2,678 (23.5) 15,196 (6.8) 4.19 (4.0 to 4.4) 4.2 (4.0 to4.40)
Term: 37.0-41.6 8,698 (76.5) 206,755 (93.1)
*aOR= adjusted odds ratio
When stratified by mode of delivery, 2.8% of the women with spontaneous onset of labour in both 
pregnancies (3,847/136,198) delivered post-term > 42.0 weeks, 14.6% of these women (561/3,847) 
had a recurrent spontaneous onset of post-term labour in comparison to 3.4% (4,642/136,198) who 
had a de novo post-term delivery (aOR 4.7 (95%CI 4.0 to 5.5, p<0.0001)).
Figure 2 displays the Kaplan Meier curve of the proportion of women remaining pregnant after 37 
weeks in the second pregnancy, stratified by gestational age of the first pregnancy. The higher the 
gestational age in the first pregnancy, the higher the gestational age in the second pregnancy (log rank 
testing for equality p<0.0001). 
Figure 2 Kaplan Meier curve on time to delivery in second pregnancy
Log rank testing for equality p<0.0001
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Table 3 represents the antepartum death rates in the subsequent 46,960 late-term pregnancies (41.0-
41.6) and 11,376 post-term pregnancies (42.0-42.6) stratified by gestational age in the first pregnancy. 
In the late-term pregnancy group the overall risk of antenatal foetal death was 0.87‰ (41/46,960). 
In the post-term pregnancy group, the overall risk of antenatal foetal death was 0.62‰ (7/11,376). 
In the group with spontaneous onset of labour, antenatal death occurred in 1.05 ‰ (27/25,697) 
when second delivery was in the 41.0-41.6 week and in 0.58‰ (3/5,203) in the 42.0-42.6 week. In 
the most ‘extreme’ group (gestational age of 42.0-42.6 weeks) at first delivery and gestational age 
of 42.0-42.6 weeks at second delivery (week 42- week 42) no antepartum deaths occurred. In the 
total group, women with an early term first pregnancy (37.0 weeks) had a significantly higher rate of 
antepartum death compared to women with a first delivery at a gestational age of 42 weeks (3.1‰ 
vs 0.7‰ (reference), p=0.04) or a first delivery from 41 weeks onwards (41.42 weeks, 2.6‰ versus 
0.5‰ (reference), p=0.02). In the combined late-term and post-term second pregnancies, the rate of 
antepartum death decreases with increasing gestational age of the first pregnancy. In the late-term 
and post-term groups separately, this did not reach statistical significance. In the subset of women 
with only spontaneous onset of labour, there were no significant differences between the gestational 
age groups.
To assess the perinatal outcomes of the recurrent and the novo post-term births we excluded 221,951 
women with a second term delivery, leaving a total of 11,376 women with a second post-term delivery. 
Table 4 shows the individual maternal and perinatal outcomes in the subset of these 11,376 women 
with a second post-term delivery. Composite maternal outcome (5.5% vs 1.2%, p=0.16) and composite 
perinatal outcome (1.2% vs 1.3%, p=0.90) did not differ between recurrent and de novo post-term 
delivery. There were no maternal deaths in this specific cohort.
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Table 4 Maternal and perinatal outcomes in women with a second post-term pregnancy stratified by gestational 
age at first delivery
 First delivery
 
Post-term 
N=2678
Term 
N=8698
Maternal outcomes N ‰ N ‰ OR 95%CI aOR* 95%CI
Maternal death 0 0.0 0 0.0 xxx xxx xxx xxx
Abruptio placentae 1 0.0 2 0.0 $
HPP>1000 ml 169 6.3 475 5.5 1.2 1.0 to 1.4** 1.1 0.9 to 1.4
Blood transfusion during labour or puerperium 2 0.1 22 0.3 0.3 0.1 to 1.3 0.3 0.1 to 1.3
Composite maternal outcome 170 6.3 477 5.5 1.2 1.0 to 1.4*** 1.1 0.9 to 1.4
 
Perinatal outcomes N ‰ N ‰     
Antepartum death 0 0.0 7 0.1 xxx xxx xxx xxx
Neonatal death 4 0.1 10 0.1 1.3 0.4 to 4.2 1.3 0.4 to 4.0
Birth trauma 7 0.3 26 0.3 0.9 0.4 to 2.0 0.8 0.4 to 1.9
Apgar score <7 25 0.9 78 0.9 1.0 0.7 to 1.6 1.0 0.6 to 1.6
Composite neonatal outcome 34 1.3 104 1.2 1.1 0.7 to 1.6 1.0 0.7 to 1.5
OR= Odds Ratio
aOR= adjusted Odds Ratio
CI= confidence interval
* adjusted for induction, non-cephalic presentation, SGA P5, SES in second pregnancy
** p=0.096
*** p=0.098
$ no calculation possible due to low numbers 
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COMMENT
Gestational age of the first delivery is correlated with gestational age of delivery in the second 
pregnancy and there is a recurrent risk of post-term pregnancy. The increased risk of antepartum 
death when the first delivery occurred at 37weeks and the second at 41-42 weeks disappeared when 
stratified by type of labour onset. Composite adverse maternal and adverse perinatal outcome do not 
differ between recurrent and de novo post-term delivery. 
We were able to do our analysis in a longitudinal cohort of 233,327 pregnant term and post-term 
women and their first and second child. Although our data showed a small but statistically significant 
difference between age and SES in term and post-term delivery in first pregnancy, this difference can 
be considered as clinically irrelevant for this study. In our analyses, we decided to include women with 
induction of labour, resulting in a ‘non-natural’ gestational age of delivery. By including only the women 
who delivered spontaneously, we would miss all women induced at or beyond 42 weeks leading to 
selection bias. The Dutch obstetric guideline for the management of post-term pregnancy indicates 
induction of labour beyond 42.0 weeks, unless there is a contra-indication for expectant management 
until 42 weeks or unless the mother request earlier induction at 41 weeks. (23) In addition, most 
deliveries of an antepartum death are induced in the Netherlands. By excluding all inductions, we 
would have underestimated the risk of antepartum death. 
Early pregnancy dating (10-14 weeks) is advised for reliable determination of gestational age and 
subsequently, of post-term pregnancy. Prior to 2007, there was no uniform pregnancy dating policy in 
the Netherlands although ultrasound increasingly replaced the last menstrual period for dating since 
its introduction in the 1980’s. (24) During the study period, dating was based on crown-rump-length 
and head circumference measurements, depending on the gestational age at time of dating. However, 
there is no data on individual pregnancy dating. This could have contributed to an increase in our 
estimated risk on post-term pregnancy. (25)
Current practice in the Netherlands is to induce labour in uncomplicated pregnancies at 42.0 weeks or 
at mothers’ request from 41.0 weeks. This results in a lower percentage of post-term pregnancies in 
the spontaneous onset group in comparison to all labour in first (2.8% vs 7.7%) and recurrent (14.6% 
vs 15.0%) delivery. Because of the regular policy to induce labour at 42 weeks, we decided to analyse 
both spontaneous onset of labour and induced labour.
The exact time or date of antenatal death is commonly unknown. Theoretically, this could have occurred 
more than one week before the delivery. As a result, this would increase the risk on antenatal death 
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in our cohort of term deliveries (37-42 weeks) in a more advanced week than the actual antenatal 
death. This could have contributed to an increase of antenatal deaths in the advanced gestational 
ages, implicating that we could have overestimated the risk in those specific groups.
Our data confirmed that women with a previous post-term delivery are at increased risk of recurrent 
post-term delivery (15.0% recurrent versus 4.0% de novo post-term delivery), a finding that has been 
reported before. (7, 16, 17)
The information provided by this study can be used in the counselling procedure of women with a 
previous post-term pregnancy with regards to the risk of recurrent post-term delivery and composite 
adverse maternal and perinatal outcome. Women with de novo post-term pregnancy in a second 
pregnancy can be informed about the same incidence of adverse perinatal and maternal outcomes in 
comparison to women with a recurrent post-term pregnancy. Women who delivered at 37 weeks in 
first pregnancy and are late-term in the current pregnancy, possibly benefit from earlier induction of 
labour at 41 weeks.
Due to the rare occurrence of antepartum foetal death (Table 3) in late-term and post-term pregnancy, 
we can’t advise clinicians on the optimal time for induction of labour. Current research on optimal 
timing of delivery highlights that the risk of delivery and the risk of non-delivery must be taken in 
account when determining the time of delivery. It is mentioned that the optimal time of delivery 
should be individualized by healthcare providers in each patient. (26)
CONCLUSION
Women with a post-term delivery in their first pregnancy have a higher risk of recurrent post-term 
delivery. In general, gestational age in first pregnancy appears to be associated with gestational age 
at delivery in second pregnancy. Our data suggest that there is no difference in maternal or perinatal 
outcome between recurrent and de novo post-term delivery. 
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ABSTRACT
Introduction
There is an increase in women delivering ≥35 years of age. We analysed the effects of advanced 
maternal age on pregnancy outcomes in late- and post-term pregnancies.
Material and Methods
A national cohort study was performed on obstetrical low-risk women using data from the Netherlands 
Perinatal Registry from 1999-2010. We included women >18 years of age with a singleton pregnancy 
at term. Women with a pregnancy complicated by congenital anomalies, hypertensive disorders or 
diabetes mellitus were excluded. Composite adverse perinatal outcome was defined as stillbirth, 
neonatal death, meconium aspiration syndrome, 5-minute Apgar Score <7, neonatal intensive care 
unit admittance and sepsis. Composite adverse maternal outcome was defined as maternal death, 
placental abruption and postpartum haemorrhage of >1000ml.
Results
We stratified the women in three age groups: 18-34 (n=1 321 366 (reference)); 35-39 (n=286 717) and 
≥40 (n=40 909). Composite adverse perinatal outcome occurred in 1.6% in women aged 18-34, 1.7% 
in women aged 35-39 (Relative Risk 1.06; 95% Confidence Interval 1.03 to 1.08) and 2.2% in women 
aged ≥40 (Relative Risk 1.38; Confidence Interval 1.29 to 1.47), with 5-minute Apgar Score < 7 as the 
most contributing factor. Composite adverse maternal outcome occurred in 4.6% in women aged 18-
34 (ref), 5.0% in women aged 35-39 (Relative Risk 1.08; Confidence Interval 1.06 to 1.10) and 5.2% in 
women aged ≥40 (Relative Risk 1.14; Confidence Interval 1.09 to 1.19), with postpartum haemorrhage 
> 1000ml as the most contributing factor. In all age categories, the risk on adverse pregnancy outcomes 
was higher for nulliparous than for multiparous women. The risk on adverse outcomes increased in 
both nulliparous and parous women with advancing gestational age. The effect of gestational age on 
adverse pregnancy outcomes is larger than the effect of maternal age. 
Conclusions
The risk on adverse pregnancy outcome increases with advancing maternal age. Women aged ≥40, 
have an increased risk on adverse perinatal and maternal outcome when pregnancy goes beyond 
41 weeks. The influence of gestational age on adverse pregnancy outcomes is larger than that of 
maternal age. 
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 33
Advanced maternal age and pregnancy outcomes
33
3
INTRODUCTION 
Advanced maternal age (AMA) is mostly defined as a pregnancy in women at or beyond 35 or at or 
beyond 40 years of age at their pregnancy or delivery.(1-6) In the Netherlands, there has been an 
increase in women ≥35 years giving birth from 5.6% during the 1970s up until 21.4% in 2010, with 
increasing age at first child from 24.3 years in 1970 to 29.4 years in 2010.(7) In 2010, of all women 
who delivered in the Netherlands 18.2% were aged 35-39 years, 3.2% were 40-44 years and 0.1% >45 
years.(8) 
AMA is associated with adverse perinatal outcomes, such as foetal death and adverse maternal 
outcomes, like emergency operative deliveries. (3-6, 9-13) In some countries, it is advised in guidelines 
to induce women with an advanced maternal age in order to prevent adverse pregnancy outcomes. 
(14, 15) Women with AMA have an increased risk on a late- term (41.0-41.6) and post-term (≥42.0) 
pregnancy.(16) Post-term pregnancy at any age is associated with adverse perinatal and maternal 
outcome, though the absolute risk on foetal death remains low.(17, 18) In the Netherlands and 
Scandinavian countries, debate is going on about whether to induce labour at 41.0 weeks or allow 
pregnancy to continue until 42.0 weeks in low risk women. (19-21) However, little is known of the 
influence of maternal age on perinatal and maternal outcomes in each gestational week. To get more 
insight in possible associations, we analysed the effects of both maternal age and gestational age on 
adverse pregnancy outcomes using data from the Dutch Perinatal Registry (Perined) to determine the 
effects of AMA on adverse perinatal and maternal outcomes in term-, late- and post-term pregnancies.
MATERIAL AND METHODS
Database
A national retrospective cohort study was performed using births, registered between 1999 and 2010 in 
Perined. It contains information of all pregnancies, deliveries, neonatal admissions and resubmissions 
until 28 days after birth in the Netherlands, with a coverage of 96%. Since this study used anonymous 
data collected by Perined, no ethical approval was needed under Dutch law and regulations.(22) This 
study was approved by Perined under approval number 16.16.
Inclusion and exclusion
We selected women with a singleton birth, no known foetal congenital anomalies, ≥37 weeks of 
gestation and a foetus in cephalic position. Women <18 of age, women with hypertensive disorder 
or diabetes mellitus were excluded from analysis. Thereby, we created a cohort mimicking obstetrical 
low-risk women with a high probability of reaching 41.0 weeks of gestation without medical or 
obstetrical interventions. 
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In general, pregnancy dating in the Netherlands is performed by first trimester ultrasound, or if 
ultrasound is not performed, by known last menstruation. (23) BMI and smoking were not reliably 
reported and could therefore not be included in the analyses. All women were stratified into three 
maternal age categories: 18-34, 35-39 and ≥40 years. (1) We defined age category 18-34 years as the 
reference group and both 35-39 and ≥40 years as AMA. Within these age groups, women were also 
stratified by gestational age by week of gestation. We defined pregnancies with a gestational age of 
37.0-40.6 as the reference group, 41.0-41.6 as late-term and 42.0-42.6 as post-term pregnancy. 
OUTCOME MEASURES
We studied the incidence of adverse perinatal and adverse maternal outcomes. Composite adverse 
perinatal outcome consisted of stillbirth, neonatal death (up to 28 days), meconium aspiration 
syndrome (MAS), 5-minute Apgar score<7 (AS5’<7), Neonatal Intensive Care Unit (NICU) admittance 
for at least 24 hours and sepsis. Composite adverse maternal outcomes (consisted of maternal death, 
placental abruption and postpartum haemorrhage of >1000mL. Though a case (woman or neonate) 
could suffer from more than one adverse event, it is counted as one event in the composite adverse 
perinatal outcome or composite adverse maternal outcome. Mode of delivery was categorized as 1. 
spontaneous, 2. operative vaginal delivery due to foetal distress, operative vaginal delivery due to 
arrest of labour or operative vaginal delivery due to a combination of foetal distress and arrest of 
labour and 3. caesarean section, either elective caesarean section or emergency caesarean section 
based on foetal distress, arrest of labour or a combination. We analysed all modes of delivery 
separately in each age group. 
Statistics
All outcomes were stratified for the three maternal age groups. Live birth was used as the denominator 
to assess the variables neonatal death, MAS, AS5’<7, NICU admission and sepsis. In all other variables, 
‘birth’ was used as denominator in order to calculate proportions. Comparisons on mode of delivery 
were made by stating the denominator as ‘the sum of the opposite mode of deliveries’. We stated age 
18-34 as a reference group and compared proportions in age group 35-39 and ≥40 with proportions in 
the reference group on each variable with Chi-square testing. Relative Risks (RR) and 95% Confidence 
Intervals (CI) are provided. Tests were performed two-sided and, because of multiple testing, a p-value 
of <0.001 was considered statistically significant. Data analyses were conducted with SPSS (IBM SPSS 
Statistics 23).
RESULTS
In the Perined database 1 810 372 women had a term, singleton birth in cephalic position without 
known congenital anomalies from January the 1st 1999 through December the 31st 2010. We excluded 
139 958 (7.7%) women with a hypertensive disorder, 14 809 (0.8%) women with diabetes mellitus and 
6 613 women <18 years of age (0.4%), leaving 1 648 992 births in the total cohort as shown in figure 1. 
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Baseline characteristi cs and mode of delivery are shown in table 1. Women with AMA were more oft en 
multi parous, pregnant aft er arti fi cial reproducti ve techniques, had more labour inducti ons and less 
spontaneous vaginal delivery in comparison to women without AMA. The rate of caesarean secti on 
increased from 8.8% in women aged 18-34, to 12.3% in women aged 35-39 (RR1.35; CI1.34 to 1.36), 
to 16.3% in women aged ≥ 40 (RR1.98 (CI1.93 to 2.03), mainly due to an increase in electi ve caesarean 
secti on (2.5% to 5.2% to 7.1%). There was an increase in caesarean secti on due to foetal distress (1.3% 
to 1.6% to 2.5% in age 18-34; 35-39 and ≥ 40 respecti vely) or arrest of labour (3.9% to 4.0% to 4.6%).
Figure 1 Flowchart cohort
Cohort 1999-2010, term, singleton births in cephalic position without known congenital anomalies : 
n=1,810,372
Total included: n=1,648,992
Excluded: 
High blood pressure: n=139,958
Diabetes Mellitus: n=14,809
<18 years of age: n=6,613
Age 18-34: n=1,321,336
Age 35-39: n=286,717
Age ≥40: n=40,909
Perined Database: all birth outcomes ≥ 22 weeks of gestation
37.0-37.6: n=68,095
38.0-38.6: n=174,002
39.0-39.6: n=327,518
40.0-40.6: n=412,785
41.0-41.6: n=269,398
42.0-42.6: n=69,568
37.0-37.6: n=14,573
38.0-38.6: n=40,691
39.0-39.6: n=71,208
40.0-40.6: n=87,165
41.0-41.6: n=58,252
42.0-42.6: n=14,828
37.0-37.6: n=2,383
38.0-38.6: n=6,435
39.0-39.6: n=10,102
40.0-40.6: n=11,654
41.0-41.6: n=8,063
42.0-42.6: n=2,272
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Table 1 Baseline characteristics and mode of delivery
 Maternal Age
 18-34 (ref) 35-39 >40
n (%) n (%) n (%)
  1,321,366 80.1% 286,717 17.4% RR 95% CI 40,909 2.5% RR 95% CI
Maternal Characteristics           
Nulliparous 632,797 47.9% 69,999 24.4% 0.42 0.41 to 0.42# 9,390 23.0% 0.33 0.33 to 0.34$
Low SES 346,327 26.2% 57,786 20.2% 0.75 0.75 to 0.76# 10,305 25.2% 0.95 0.93 to 0.97$
White ethnicity 1,055,459 79.7% 241,439 84.2% 1.28 1.27 to 1.29# 31,505 77.0% 0.85 0.83 to 0.87$
Spontaneous & Unknown 
conception
1,297,184 98.2% 275,747 96.2% 0.56 0.55 to 0.57# 38,488 94.1% 0.32 0.3 to 0.33$
Gestational Age at Delivery           
37.0 to 37.6 68,095 5.2% 14,573 5.1% 0.99 0.97 to 1.00 2,383 5.8% 1.13 1.09 to 1.18$
38.0 to 38.6 174,002 13.2% 40,691 14.2% 1.07 1.06 to 1.08# 6,435 15.7% 1.22 1.19 to 1.26$
39.0 to 39.6 327,518 24.8% 71,208 24.8% 1.00 0.995 to 1.01 10,102 24.7% 1.00 0.97 to 1.02
40.0 to 40.6 412,785 31.2% 87,165 30.4% 0.97 0.96 to 0.98# 11,654 28.5% 0.88 0.86 to 0.90$
41.0 to 41.6 269,398 20.4% 58,252 20.3% 1.00 0.99 to 1.01 8,063 19.7% 0.96 0.94 to 0.98$
42.0 to 42.6 69,568 5.3% 14,828 5.2% 0.99 0.97 to 0.999 2,272 5.6% 1.06 1.01 to 1.10
Onset of Labour           
Induction of Labour 160,442 12.1% 39,335 13.7% 1.21 1.11 to 1.13# 6,819 16.7% 1.43 1.39 to 1.47$
Mode of delivery           
Spontaneous 1,055,271 79.9% 226,451 79.0% 0.96 0.95 to 0.97# 30,515 74.6% 0.75 0.73 to 0.76$
Operative Vaginal Delivery 150,232 11.4% 25,125 8.8% 0.79 0.78 to 0.79# 3,707 9.1% 0.78 0.76 to 0.81$
Foetal Distress 39,464 3.0% 7,396 2.6% 0.88 0.86 to 0.90# 1,191 2.9% 0.98 0.92 to 1.03
Arrest of Labour 92,212 7.0% 14,403 5.0% 0.75 0.73 to 0.76# 1,994 4.9% 0.69 0.66 to 0.72$
Foetal Distress and Arrest of Labour 15,602 1.2% 2,827 1.0% 0.86 0.83 to 0.89# 439 1.1% 0.91 0.83 to 0.999
Caesarean Section 115,863 8.8% 35,141 12.3% 1.35 1.34 to 1.36# 6,687 16.3% 1.98 1.93 to 2.03$
Elective 32,730 2.5% 14,941 5.2% 1.80 1.78 to 1.82# 2,902 7.1% 2.84 2.74 to 2.95$
Foetal Distress 16,778 1.3% 4,583 1.6% 1.21 1.18 to 1.24# 1,034 2.5% 1.96 1.84 to 2.08$
Arrest of Labour 51,408 3.9% 11,412 4.0% 1.02 1.00 to 1.04 1,889 4.6% 1.19 1.14 to 1.24$
Foetal Distress and Arrest of Labour 9,340 0.7% 2,421 0.8% 1.16 1.12 to 1.20# 480 1.2% 1.64 1.50 to 1.79$
Neonatal Characteristics           
Male 674,001 51.0% 146,583 51.1% 1.00 0.997 to 1.01 20,731 50.7% 0.99 0.97 to 1.01
Birthweight           
≥4000 gram 219,662 16.6% 57,370 20.0% 1.20 1.19 to 1.21# 7,627 18.6% 1.14 1.12 to 1.17$
≥4500 gram 36,244 2.7% 10,600 3.7% 1.28 1.26 to 1.30# 1,382 3.4% 1.23 1.67 to 1.30$
# p-value <0.001 between 18-35 and 35-39
$ p-value <0.001 between 18-35 and ≥40
* Separate items do not add to total % in mode of delivery, due to missing numbers
CI: confidence intervals
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Adverse perinatal and maternal outcomes are shown in table 2. Composite adverse perinatal outcome 
was found in 1.6% in women aged 18-34 years, in comparison to 1.7% in women aged 35-39 years 
(RR 1.06; 95% CI 1.03 to 1.08, p<0.001) and 2.2% in women aged ≥40 years (RR 1.38; CI 1.29 to 1.47, 
p<0.001). 5-minute Apgar Score< 7 was the main contributor to this composite outcome. Composite 
adverse maternal outcome was found in 4.6% in women aged 18-34, in comparison to 5.0% in women 
aged 34-39 (RR 1.08; CI 1.06 to 1.10, p<0.001) and 5.2% in women aged ≥40 (RR 1.14; 95% CI 1.09 to 
1.19, p<0.001). Postpartum haemorrhage was the main contributor to this composite outcome. 
Table 2 Composite Adverse Perinatal and Maternal outcomes
 Maternal Age
 18-34 (ref) 35-39 >40
n % n % RR 95% CI n % RR 95% CI
Composite Adverse Perinatal Outcome 20,629 1.6% 4,778 1.7% 1.06 1.03 to 1.08# 884 2.2% 1.38 1.29 to 1.47$
Stillbirth 2,211 0.17% 619 0.22% 1.22 1.15 to 1.32# 122 0.30% 1.74 1.47 to 2.07$
Neonatal death* 684 0.05% 154 0.05% 1.03 0.70 to 1.19 22 0.05% 1.04 0.69 to 1.57
Meconium Aspiration Syndrome* 1,168 0.09% 291 0.10% 1.12 1.01 to 1.24 62 0.15% 1.69 1.32 to 2.15$
5-minute Apgar Score<7* 12,229 0.93% 2,748 0.96% 1.03 0.997 to 1.07 531 1.30% 1.40 1.28 to 1.52$
Neonatal Intensive Care Unit* 4,362 0.33% 1,125 0.39% 1.15 1.09 to 1.21# 199 0.49% 1.46 1.27 to1.67$
Sepsis* 6,172 0.47% 1,429 0.50% 1.06 1.01 to1.107 252 0.62% 1.30 1.16 to 1.48$
Composite Adverse Maternal Outcome 60,196 4.6% 14,261 5.0% 1.08 1.06 to 1.10# 2,123 5.2% 1.14 1.09 to 1.19$
Maternal Death 38 0.003% 12 0.004% 1.35 0.62 to 2.20 0 0.000% nc
Placental Abruption 261 0.020% 68 0.024% 1.16 0.94 to 1.43 14 0.034% 1.70 1.02 to 2.63
Postpartum Haemorrhage >1000ml 59,972 4.5% 14,204 5.0% 1.08 1.06 to 1.09# 2,113 5.2% 1.14 1.09 to 1.19$
* Live birth
# p-value <0.001 between 18-35 and 35-39 
$ p-value <0.001 between 18-35 and ≥40
CI: confidence intervals
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Table 3 shows the influence of AMA stratified by gestational age, parity and onset of labour on the 
composite adverse perinatal- and maternal outcome in each age category. The incidence of both 
composite adverse perinatal – and maternal outcome increased in women with AMA, irrespective of 
gestational age, parity or onset of labour, though the absolute risk difference is small and did not always 
reach statistical significance. Women with a higher gestational age and nulliparous women are more 
at risk for composite adverse perinatal- or maternal outcome, irrespectively of maternal age. Women 
with a spontaneous onset of labour have a lower risk for composite adverse perinatal- or maternal 
outcome in comparison to all other ‘onset of labour’, except for women ≥40 having an elective CS. The 
effect of increasing gestational age is larger than the effect of increasing AMA on the risk of composite 
adverse perinatal outcome or composite adverse maternal outcome. For example: the risk difference 
between a gestational age of 42.0- 42.6 weeks and 37.0-40.6 weeks on a composite adverse perinatal 
outcome within women aged 18-34 years is 0.9%, within women aged 35-39 years is 0.9% and within 
women aged ≥40 years 0.7%. These risk differences between gestational ages are larger than the 
risk differences between the maternal age groups on composite adverse perinatal outcomes. The risk 
difference between women aged 18-34 and ≥40 is 0.6% in women with a gestational age of 37.0-40.6, 
0.8% in women with a gestational age of 41.0-41.6 and 0.4% in women with a gestational age of 42.0-
42.6. Induction of labour was associated with an increased risk for composite adverse perinatal- and 
maternal outcome. The effects of induction of labour in comparison to a spontaneous onset of labour 
are larger than the effects of AMA. 
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Table 3 Influence of advanced maternal age on adverse outcome stratified by gestational age, parity and onset of labour.
 Maternal Age
 18-34 (ref) 35-39 >40
n % n % RR 95% CI n % RR 95% CI
Composite Adverse Perinatal Outcome 20,629 1.6% 4,778 1.7% 1.06 1.03 to 1.08# 884 2.2% 1.38 1.29 to 1.47$
 Gestational Age           
37.0-40.6 14,234 1.4% 3,334 1.6% 1.06 1.03 to 1.10# 616 2.0% 1.38 1.28 to 1.49$
41.0-41.6 4,828 1.8% 1,069 1.8% 1.02 0.97 to 1.08 206 2.6% 1.42 1.24 to 1.63$
42.0-42.6 1,567 2.3% 375 2.5% 1.10 1.01 to 1.21 62 2.7% 1.21 0.94 to 1.55
 Parity            
Nulliparous 12,907 2.0% 1,980 2.8% 1.35 1.29 to 1.40# 335 3.6% 1.76 1.58 to 1.96$
Multiparous 7,722 1.1% 2,798 1.3% 1.11 1.08 to 1.15# 549 1.7% 1.53 1.41 to 1.66$
Onset of labour  
SOL 15,424 1.4% 3,366 1.4% 1.05 1.01 to 1.08 592 1.9% 1.37 1.26 to 1.48$
IOL 4,581 2.9% 1,165 3.0% 1.03 0.98 to 1.09 247 3.6% 1.26 1.12 to 1.43$
elective SC 624 2.1% 247 1.8% 0.91 0.82 to 1.01 45 1.8% 0.85 0.64 to 1.13
Composite Adverse Maternal Outcome 60,196 4.6% 14,261 5.0% 1.08 1.06 to 1.10# 2,123 5.2% 1.14 1.09 to 1.19$
 Gestational Age           
37.0-40.6 40,576 4.1% 9,886 4.6% 1.10 1.08 to 1.12# 1,471 4.8% 1.17 1.11 to 1.23$
41.0-41.6 15,027 5.6% 3,323 5.7% 1.02 0.99 to 1.05 485 6.0% 1.08 0.99 to 1.18
42.0-42.6 4,593 6.6% 1,052 7.1% 1.07 1.01 to 1.13 167 7.4% 1.12 0.96 to 1.31
 Parity            
Nulliparous 33,418 5.3% 4,808 6.9% 1.28 1.25 to 1.32# 661 7.0% 1.35 1.25 to 1.46$
Multiparous 26,778 3.9% 9,453 4.4% 1.09 1.08 to 1.11# 1,462 4.6% 1.19 1.13 to 1.25$
 Onset of labour            
SOL 49,235 4.4% 10,952 4.7% 1.07 1.05 to 1.08# 1,537 4.9% 1.12 1.07 to 1.18$
IOL 9,629 6.0% 2,659 6.8% 1.11 1.07 to 1.15# 452 6.6% 1.11 1.01 to 1.22
elective SC 1,332 4.5% 650 4.9% 1.05 0.99 to 1.12 134 5.3% 1.17 0.99 to 1.38
# p-value <0.001 between 18-35 and 35-39
$ p-value <0.001 between 18-35 and ≥40
CI: confidence intervals
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DISCUSSION
Implications of findings
In our cohort, we found an increase of both composite adverse perinatal – and maternal outcome in 
both advancing maternal age and in increasing gestational age. However, the effect of gestational age 
on composite adverse perinatal- and maternal outcome is larger than the effect of AMA. In general, 
the absolute risk on a serious event remains low and the differences between the different age groups 
are small. 
Internationally, there is no pre-defined reference group of maternal age, no official definition of 
‘advanced maternal age’, nor an ‘age interval’ between groups which makes a clear comparison to the 
literature difficult (1-4, 11, 24-27). Most studies and guidelines use a reference group ≥18 or ≥20 years 
of age, or define AMA at ≥35 years or ≥40 years and use a 5-year age interval between groups in sub 
analyses. In order to make our study more comparable to existing literature, we chose to evaluate the 
risks in women aged 18-34; 35-39 and ≥40 years.
Of all women in our cohort, 19.9% had a maternal age of 35 years or older, which is higher in 
comparison to the WHO multi-country survey on maternal and new-born health in women from 29 
countries in Africa, Asia, Latin America and Middle East (12.3%) (4), but more comparable to studies 
in high income countries. (3, 25) Our results can be applicable to low risk women with white ethnicity 
in high income countries with similar baseline characteristics. We did not find age ≥40 as a risk factor 
for late term pregnancy ≥41.0 weeks, as has been described in a retrospective cohort study from 
1995-1999 in 199,162 term women showing an OR of 1.07 (confidence interval 1.02-1.12). (16) This 
difference can be due to a higher rate of induction of labour in women with AMA in our cohort, which 
decreases the number of women who can reach a higher gestational age or the fact that we studied a 
predefined low-risk like population
We showed an increase in risk on caesarean section overall and on all components separately in women 
with AMA. In two population-based cohorts (in the UK and the United States), containing 214,296 and 
78,880 women, the proportions of caesarean section increased, in both elective and overall caesarean 
section as well as in multi- and nulliparous women. We found a much lower absolute incidence on 
elective caesarean section, which is possibly due to the absolute lower rate of caesarean section in 
the Netherlands (around 12.5% in 2000 and 16.8% in 2010). (3, 8, 28) Despite the lower incidence in 
our cohort, women ≥40 years of age received an elective caesarean section more often than woman 
aged 18-35, possibly indicating a lower threshold to perform a caesarean section in women with AMA. 
In our cohort, AMA is associated with an increase in emergency caesarean section (defined as both 
foetal distress and/or arrest of labour) in both nulli- and multiparous women, which is in concordance 
in several other studies. (2, 12, 29-32) Induction of labour in women with AMA showed no significant 
increase of caesarean section rates in more recent studies(24, 26).
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The components of the composite adverse perinatal -and maternal outcome are considered to be 
clinically relevant and reliably entered in the database, though the content of this composite outcomes 
can be discussed. Composite adverse perinatal outcome was significantly more often present in women 
with AMA, with 5-minute Apgar Score <7 as the most contributing factor. After approval of our study, 
the ACOG Committee published an update of their Committee opinion on the use and interpretation of 
the Apgar score in which a 5-minute Apgar Score <4 is considered as a non-specific sign of illness which 
“may be one of the first indications of encephalopathy”. The ACOG recommend to use this lower cut 
off in outcome studies instead of 5-minute Apgar score <7.(33) We did not have data of the 5-minute 
Apgar Score <4, though this had most probably led to a decrease in the absolute risk of the composite 
adverse perinatal outcome. Sepsis is the second most contributing factor to the composite adverse 
perinatal outcome, although maternal age is not a known risk factor for sepsis. One other study using 
a population-based cohort in Denmark containing 369,516 women, addressed the composite adverse 
perinatal outcome by combining chromosomal abnormalities, congenital malformation, miscarriage, 
stillbirth and birth before 34 weeks of gestation. They found an increase in this composite outcome 
in women aged 35-39 (7.0%) and ≥40 (10.8%) in comparison to women aged 20-34 (5.5%). (25) In our 
cohort, stillbirth is seen more often in women with AMA, with an absolute risk between 0.2% and 
0.3%, which is comparable to other studies in high income countries in women with a white ethnicity. 
(3, 6, 34, 35) In a retrospective cohort study in the USA, including 37,504,230 women, there was an 
increase in rates of stillbirth from age ≥35.(11) In a systematic review and meta-analysis in women 
aged ≥35, an increased risk of stillbirth was seen in comparison to the reference group (OR 1.75 95%CI 
1.62-1.89).(36) Most stillbirths in advanced maternal age are explained by congenital abnormalities. 
(37) Stillbirths in our study should not be attributable to congenital abnormalities, since we excluded 
all neonates with a congenital anomaly. However, misclassification of congenital anomalies cannot 
be ruled out. (38) We found no difference in neonatal death, which has been described by others, 
possibly due to the low incidence of neonatal death in our cohort. (36) 
Composite adverse maternal outcome was seen significantly more in women with AMA, with 
postpartum haemorrhage >1000ml as the most contributing factor. Uterine atony accounts in most 
cases of PPH. (39) We were not able to differentiate between the multiple aetiologies for postpartum 
haemorrhage in our study based on the Perined data. We found no increase in maternal death, which 
is a rare outcome in high-income countries, whereas in both low- and high-income countries, an 
increase in maternal death is described with AMA. (4, 34) Adverse maternal outcomes like placental 
abruption have been studied before and have been associated with AMA. (36, 40) In our study, we did 
not find a relation between AMA and placental abruption, probably due to the low incidence of this 
outcome. 
The RCOG opinion paper on induction of labour at term in older mothers raises an argument for offering 
induction of labour at 39–40 weeks of gestation to women ≥ 40 years of age because of an increased 
risk on e.g. stillbirth. This practice would reduce both perinatal and maternal adverse outcomes, but 
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they raise awareness on the effect of induction of labour in women of advanced maternal age.(41) In 
addition, the 35/39-trial found that, among nulliparous women aged ≥35 years, induction of labour 
at 39 weeks of gestation had no significant effect on rate of caesarean section nor other adverse 
perinatal and maternal outcomes, as compared with expectant management. (26) In our cohort study, 
we showed that the risks on adverse perinatal- or maternal events increase in late- and post-term 
pregnancies, irrespectively of maternal age, though women aged ≥40 carried the highest risk on an 
adverse outcome. This implies that they probably would benefit from labour induction before 41.0 
weeks of gestation. Our findings could be helpful in the process of shared decision-making weighing 
different management strategies in low risk women with advanced maternal age and/ or increasing 
gestational age.
Strength and limitations
The Perined database consists of all types of maternal and perinatal characteristics on pregnancy 
outcomes. (8) We used perinatal and maternal birth outcomes to create a composite adverse 
perinatal -and maternal outcome which represents a clinically relevant adverse outcome. We could 
not use data on perinatal high care admission, cephalic hematoma, umbilical cord pH, plexus brachialis 
lesions, shoulder dystocia and maternal Obstetric Anal Sphincter Injuries because these items are not 
registered systematically (free entry field) in the database or are known for underreporting. We were 
also not able to define the indications to induce labour and therefore we could not assess possible 
associations between induction of labour and composite adverse perinatal outcomes. Risk factors for 
adverse perinatal and maternal outcome such as smoking and BMI were not entered in the Perined 
registration before 2011. We used data from a historical cohort from 1999-2010, because after 2010 
the coding in the Perined registration system changed. Therefore, the newer database could not yet 
be combined with our data. Data should also be interpreted in the light of changing policy in term 
and late-term pregnancy in the Netherlands into more frequent induction of labour at 41.0 weeks of 
gestation. (19,42, 43)
We are aware of the limitations and pitfalls of using national register-based data. (38, 44) One of the 
major pitfalls, besides the historical cohort as mentioned earlier, is the representation of our cohort 
for the Dutch and high-income countries. These findings may therefore not apply to other maternity 
care settings. 
The strength of our study is that we could use a large nationwide cohort, which still contained data on 
pregnancies ≥42.0 weeks. Therefore, our study could determine the influence of gestational age and 
maternal age on composite adverse perinatal -and maternal outcome. 
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CONCLUSION
In low-risk women the risk on adverse pregnancy outcomes increases with advancing maternal age 
the influence of gestational age on the occurrence of adverse outcomes is larger than the influence of 
maternal age. Women aged ≥40, have an increased risk on adverse perinatal and maternal outcome 
when pregnancy goes beyond 41 weeks, though the absolute risk on perinatal death is low. Our 
conclusions can help clinicians to inform women of AMA to guide clinical decision making. 
ACKNOWLEDGEMENT
We thank Perined for using the Perined database. We thank all health care professionals for entering 
the data in the Perined database.
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 44
Chapter 3
44
REFERENCES
1. Royal College of Obstetricians and Gynaecologists. Induction of labour at term in older mothers. 2013;Scientific 
impact paper no. 34.
2. Schimmel MS, Bromiker R, Hammerman C, Chertman L, Ioscovich A, Granovsky-Grisaru S, et al. The effects 
of maternal age and parity on maternal and neonatal outcome. Archives of gynecology and obstetrics. 
2015;291(4):793-8.
3. Kenny LC, Lavender T, McNamee R, O’Neill SM, Mills T, Khashan AS. Advanced maternal age and adverse 
pregnancy outcome: evidence from a large contemporary cohort. PloS one. 2013;8(2):e56583.
4. Laopaiboon M, Lumbiganon P, Intarut N, Mori R, Ganchimeg T, Vogel JP, et al. Advanced maternal age 
and pregnancy outcomes: a multicountry assessment. BJOG : an international journal of obstetrics and 
gynaecology. 2014;121 Suppl 1:49-56.
5. Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, Gibbons K, et al. Major risk factors for stillbirth in 
high-income countries: a systematic review and meta-analysis. Lancet. 2011;377(9774):1331-40.
6. Haavaldsen C, Sarfraz AA, Samuelsen SO, Eskild A. The impact of maternal age on fetal death: does length of 
gestation matter? American journal of obstetrics and gynecology. 2010;203(6):554 e1-8.
7. Centraal Bureau voor de Statistiek (CBS)/ Statistics Netherlands.
8. Perined. Perinatal Birth Registration the Netherlands. 2010.
9. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population 
based register linkage study. Bmj. 2000;320(7251):1708-12.
10. Page JM, Snowden JM, Cheng YW, Doss AE, Rosenstein MG, Caughey AB. The risk of stillbirth and infant death 
by each additional week of expectant management stratified by maternal age. American journal of obstetrics 
and gynecology. 2013;209(4):375 e1-7.
11. Balayla J, Azoulay L, Assayag J, Benjamin A, Abenhaim HA. Effect of maternal age on the risk of stillbirth: a 
population-based cohort study on 37 million births in the United States. American journal of perinatology. 
2011;28(8):643-50.
12. Herstad L, Klungsoyr K, Skjaerven R, Tanbo T, Forsen L, Abyholm T, et al. Maternal age and emergency 
operative deliveries at term: a population-based registry study among low-risk primiparous women. BJOG : 
an international journal of obstetrics and gynaecology. 2015;122(12):1642-51.
13. Dunn L, Kumar S, Beckmann M. Maternal age is a risk factor for caesarean section following induction of 
labour. Aust N Z J Obstet Gynaecol. 2017;57(4):426-31.
14. Norsk gynekologisk forening. Overtidig svangerskap/ Pregnancies above term. 2014.
15. Danish Society of Obstetrics and Gynaecology. Overtidig svangerskap/ Pregnancies post due date. 2011.
16. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who is at risk for prolonged and postterm pregnancy? 
American journal of obstetrics and gynecology. 2009;200(6):683 e1-5.
17. Practice bulletin no. 146: management of late-term and postterm pregnancies. Obstet Gynecol. 2014;124(2 Pt 
1):390-6.
18. Middleton P, Shepherd E, Crowther CA. Induction of labour for improving birth outcomes for women at or 
beyond term. The Cochrane database of systematic reviews. 2018;5:CD004945.
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 45
Advanced maternal age and pregnancy outcomes
45
3
19. Dutch Society of Obstetrics and Gynaecology (NVOG). Serotiniteit/ ‘post-term pregnancy’. 2007.
20. Kortekaas JC, Bruinsma A, Keulen JK, van Dillen J, Oudijk MA, Zwart JJ, et al. Effects of induction of labour 
versus expectant management in women with impending post-term pregnancies: the 41 week - 42 week 
dilemma. BMC Pregnancy Childbirth. 2014;14:350.
21. Elden H, Hagberg H, Wessberg A, Sengpiel V, Herbst A, Bullarbo M, et al. Study protocol of SWEPIS a Swedish 
multicentre register based randomised controlled trial to compare induction of labour at 41 completed 
gestational weeks versus expectant management and induction at 42 completed gestational weeks. BMC 
Pregnancy Childbirth. 2016;16:49.
22. Centrale Commissie Mensgebonden Onderzoek (CCMO) in Dutch, Central Committee on Research Involving 
Human Subjects. Vragenlijstonderzoek (Dutch)/ Questionnaire Research  [Available from: https://english.
ccmo.nl/investigators/types-of-research/other-types-of-research/questionnaire-research.
23. Dutch Society of Obstetrics and Gynaecology (NVOG). Datering van zwangerschap/ pregnancy dating. 2018.
24. Walker KF, Malin G, Wilson P, Thornton JG. Induction of labour versus expectant management at term by 
subgroups of maternal age: an individual patient data meta-analysis. Eur J Obstet Gynecol Reprod Biol. 
2016;197:1-5.
25. Frederiksen LE, Ernst A, Brix N, Braskhoj Lauridsen LL, Roos L, Ramlau-Hansen CH, et al. Risk of Adverse 
Pregnancy Outcomes at Advanced Maternal Age. Obstet Gynecol. 2018;131(3):457-63.
26. Walker KF, Bugg GJ, Macpherson M, McCormick C, Grace N, Wildsmith C, et al. Randomized Trial of Labor 
Induction in Women 35 Years of Age or Older. The New England journal of medicine. 2016;374(9):813-22.
27. Saccone G, Berghella V. Induction of labor at full term in uncomplicated singleton gestations: a systematic 
review and metaanalysis of randomized controlled trials. American journal of obstetrics and gynecology. 
2015;213(5):629-36.
28. Richards MK, Flanagan MR, Littman AJ, Burke AK, Callegari LS. Primary cesarean section and adverse delivery 
outcomes among women of very advanced maternal age. Journal of perinatology : official journal of the 
California Perinatal Association. 2016;36(4):272-7.
29. Greenberg MB, Cheng YW, Sullivan M, Norton ME, Hopkins LM, Caughey AB. Does length of labor vary by 
maternal age? American journal of obstetrics and gynecology. 2007;197(4):428 e1-7.
30. Treacy A, Robson M, O’Herlihy C. Dystocia increases with advancing maternal age. American journal of 
obstetrics and gynecology. 2006;195(3):760-3.
31. Main DM, Main EK, Moore DH, 2nd. The relationship between maternal age and uterine dysfunction: 
a continuous effect throughout reproductive life. American journal of obstetrics and gynecology. 
2000;182(6):1312-20.
32. Muto H, Ishii K, Nakano T, Hayashi S, Okamoto Y, Mitsuda N. Rate of intrapartum cesarean section and related 
factors in older nulliparous women at term. J Obstet Gynaecol Res. 2018;44(2):217-22.
33. Committee on Obstetric Practice American Academy of Pediatrics - Committee on F, Newborn. Committee 
Opinion No. 644: The Apgar Score. Obstet Gynecol. 2015;126(4):e52-5.
34. Klemetti R, Gissler M, Sainio S, Hemminki E. At what age does the risk for adverse maternal and infant 
outcomes increase? Nationwide register-based study on first births in Finland in 2005-2014. Acta Obstet 
Gynecol Scand. 2016;95(12):1368-75.
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 46
Chapter 3
46
35. Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United 
States. American journal of obstetrics and gynecology. 2006;195(3):764-70.
36. Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: A 
systematic review and meta-analysis. PloS one. 2017;12(10):e0186287.
37. Walker KF, Bradshaw L, Bugg GJ, Thornton JG. Causes of antepartum stillbirth in women of advanced maternal 
age. Eur J Obstet Gynecol Reprod Biol. 2016;197:86-90.
38. de Jonge A, Wouters M, Klinkert J, Brandenbarg J, Zwart JJ, Van Dillen J, et al. Pitfalls in the use of register-
based data for comparing adverse maternal and perinatal outcomes in different birth settings. BJOG : an 
international journal of obstetrics and gynaecology. 2017;124(10):1477-80.
39. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, 
nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368-73.
40. McCall SJ, Nair M, Knight M. Factors associated with maternal mortality at advanced maternal age: a population-
based case-control study. BJOG : an international journal of obstetrics and gynaecology. 2017;124(8):1225-33.
41.  Royal College of Obstetricians and Gynaecologists (RCOG). Induction of Labour at Term in Older Mothers.2013.
42. The Royal Dutch Organisation of Midwives (Dutch: Koninklijke Nederlandse Organisatie van Verloskundigen). 
Factsheet serotiniteit/ Factsheet postterm pregnancy. 2015.
43. The european perinatal heath report 2015 (PERISTAT). 2015.
44.  Meray N, Reitsma JB, Ravelli AC, Bonsel GJ. Probabilistic record linkage is a valid and transparent tool to 
combine databases without a patient identification number. J Clin Epidemiol. 2007;60(9):883-91.
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 47
Advanced maternal age and pregnancy outcomes
47
3
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 48
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 49
CHAPTER 4
Perinatal Death beyond 41 Weeks Pregnancy: 
An Evaluation of Causes and Substandard Care Factors 
as Identified in Perinatal Audit in the Netherlands
J.C. Kortekaas, A.C. Scheuer, E.R. de Miranda, A.E. van Dijk, J.K.J. Keulen, A. Bruinsma, B.W.J. Mol,
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ABSTRACT
Background
Late- and post-term pregnancy are associated with adverse perinatal outcomes, like perinatal death. 
We evaluated causes of death and substandard care factors (SSFs) in term and post-term perinatal 
death.
Methods
We used data from the Perinatal Audit Registry System of the Netherlands (PARS). Women with a term 
perinatal
death registered in PARS were stratified by gestational age into early−/full-term (37.0–40.6 weeks) and 
late−/post-term (≥41.0 weeks) death. Cause of death and SSFs ≥41 weeks were scored and classified 
by the local perinatal audit teams.
Results
During 2010–2012, 947/479,097 (0.21%) term deaths occurred, from which 707 cases (75%) were 
registered and could be used for analyses. Five hundred ninety-eight early−/full-term and 109 late−/
post-term audited deaths were registered in the PARS database. Of all audited cases of perinatal 
death in the PARS database, 55.2% in the early-/ full-term group occurred antepartum compared to 
42.2% in the late−/post-term group, while intrapartum death occurred in 7.2% in the early−/full-term 
group compared to 19.3% in the late−/post-term group in the audited cases from the PARS database. 
According to the local perinatal audit, the most relevant causes of perinatal death ≥41 weeks were 
antepartum asphyxia (7.3%), intrapartum asphyxia (9.2%), neonatal asphyxia (10.1%) and placental 
insufficiency
(10.1%). In the group with perinatal death ≥41 weeks there was ≥1SSF identified in 68.8%. The most 
frequent SSFs concerned inadequate cardiotocography (CTG) evaluation and/or classification (10.1%), 
incomplete registration or documentation in medical files (4.6%) or inadequate action on decreased 
foetal movements (4.6%).
Conclusions
In the Netherlands Perinatal Audit Registry, stillbirth occurred relatively less often antepartum and 
more often intrapartum in pregnancies ≥41 weeks compared to pregnancies at 37.0–40.6 weeks in 
the audited cases from the PARS database. Foetal, intrapartum and neonatal asphyxia were identified 
more frequently as cause of death in pregnancies ≥41 weeks. The most identified SSFs related to 
death in pregnancies ≥41 weeks concerned inadequate CTG monitoring (evaluation, classification, 
registration or documentation) and inadequate action on decreased foetal movements.
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BACKGROUND
The incidence of post-term pregnancies (≥42.0 weeks) in European countries varies from 0.5% 
(Austria/ Belgium) to 9% (Denmark/ Sweden), depending on accurate pregnancy dating and clinical 
management protocols. (1-5) Ongoing pregnancy from 41 weeks onwards is associated with an 
increased risk of perinatal death and morbidity although the absolute risk of perinatal death is low. 
(2, 6-8) In the Perinatal Registry Netherlands (PRN), 534,058 births were registered between 2010 and 
2012; 380,252 singletons were born between 37.0-40.6 weeks and 98,845 were born ≥41.0 weeks 
of gestation. The overall perinatal mortality rate in term and post-term singleton births per ongoing 
pregnancy in the gestational age interval was 0.20% (947/479,097). In the early-/full-term pregnancy 
(37.0-40.6) a perinatal mortality rate of 0.21% (787/380,252) was found and 0.16% (160/98,845) in 
pregnancies ≥41.0 weeks. (9)
Controversy about the clinical management of an uncomplicated pregnancy reaching 41 weeks 
concerns the question whether labour should be induced at 41.0 weeks or if expectant management 
until 42.0 weeks could be allowed considering the prevention of adverse perinatal outcomes such 
as perinatal death. (1, 4, 6, 10, 11) In the Netherlands, this question has been identified by Dutch 
midwives and gynaecologists as the main dilemma in obstetrical policy in the term period resulting in 
the INDEX trial: a randomised clinical trial in which effects and costs of both induction of labour at 41.0 
weeks and expectant management until 42.0 weeks are studied. (12) 
The aim of this perinatal audit study was to gain more insight into perinatal death in early-/full- (37.0-
40.6 weeks) and late-/post-term (≥41.0 weeks) pregnancies by analysing the causes of death. A second 
goal of this study was to describe substandard care factors (SSFs) of all audited perinatal deaths at or 
beyond 41 weeks of gestation. 
MATERIAL AND METHODS
A quantitative descriptive study was conducted on data from the Perinatal Audit Registry System 
(PARS) from 2010-2012. No ethical approval was needed according to the Dutch Central Committee of 
Human Research, because it concerns a study with anonymous data. 
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Aim, design and setting of the study
All birth outcomes, including death, in pregnancies with a delivery of ≥22.0 weeks of gestation are 
anonymously entered in the Perinatal Registry Netherlands (PRN). A nationwide perinatal mortality 
audit was introduced in the Netherlands in 2010 by the foundation Perinatal Audit in the Netherlands 
(PAN). (9, 13) Perined, a merger of PAN and the PRN, manages three web-based databases with 
anonymous (information not traceable to individual patients) registration on case level: the PRN, 
the Perinatal Audit Registry of the Netherlands (PRN-audit) and PARS. Cases of perinatal death are 
registered in the PRN audit. After registration, an anonymous narrative of each case is automatically 
constructed for use in the local perinatal audit. The aim to audit all cases of perinatal death was 
not always fulfilled. Based on content, some cases are selected by the local team to evaluate in the 
local perinatal audit. For example, cases can be chosen based on impact of the case on the obstetric 
caregivers involved, to stimulate modifications in local obstetric care to prevent future cases or 
because cases contain a rare event which can be informative to any obstetric caregiver. Cases are 
then evaluated by a multidisciplinary team, consisting of gynaecologists, midwives, paediatricians, 
general practitioners, and nurses, using the format of the local perinatal audit. In the local perinatal 
audit, the quality of perinatal care, the cause of the perinatal deaths, and the presence of SSFs are 
identified and systematically and critically analysed. (14-16) Time of death is determined by using the 
Wigglesworth/Hey classification. (17, 18) Cause of death is determined by using the modified relevant 
condition of death (ReCoDe). The modified ReCoDe was created by PAN and contains the ReCoDe of 
Gardosi added with the neonatal classification of Chan and maternal risk factors. (19, 20) On each 
case, more than one clinical condition can be chosen as cause of death and in each case one item with 
the ‘most important relation to death’ is chosen. A detailed handbook for definition and classification 
was distributed to each local perinatal audit team (21). The results of the audit process are registered 
in PARS by a trained representative of each local perinatal audit team. (17-19, 22, 23) Data used for this 
study originated from the registered cases of perinatal death in PARS. Details about the organisation 
and training of care providers participating in the Perinatal Audit is described by Eskes. (23)
Characteristics of participants 
Based on the Wigglesworth/Hey classification (WHEN) all perinatal deaths of ≥37 weeks in the PARS 
registry could be selected. A comparison could be made between early-/full-term pregnancy (37.0-
40.6 weeks of pregnancy) and late-/post-term pregnancy (≥41 weeks). Unfortunately, discrimination 
between the late-term and post-term group was not possible in the PARS registry, only a group ≥41 
weeks could be selected. 
Description of processes, interventions and comparisons
A handbook for definition and classification of perinatal death was distributed to each local perinatal 
audit team. Stillbirth is defined as all antepartum and intrapartum stillbirth combined. Neonatal death 
is specified as all deaths after livebirth until 28 days and is divided in early (day 0-6) and late (day 
7-27). Foetal asphyxia is defined as pathological changes caused by lack of oxygen, resulting in hypoxia 
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and hypercapnia. Intrapartum asphyxia is defined as evidence of severe hypoxemia after the onset of 
labour, in the presence of contractions. (24) To determine foetal well-being before or during labour, 
foetal cardiac rhythm is monitored either by doptone (low risk pregnancies in midwifery-led care) or 
by cardiotocography (CTG, high risk pregnancies in obstetrician-led care). Severe CTG abnormalities 
are used in the modified ReCoDe as a proxy for foetal hypoxia. (21)
The main outcomes of a local perinatal audit concerns SSFs and recommendations. In each discussed 
case, all possible SSFs are collected by the local perinatal audit team, entered in PARS and used to 
change practice in order to prevent future SSFs of the same type. At the next local perinatal audit, the 
SSFs from the previous audit are presented to all present obstetric caregivers. The aim of this process 
is to improve the quality of care. For each perinatal death, multiple SSFs could be entered in free 
description fields. An SSF was defined as “a care management problem involving care that deviated 
from the safe limits of practice as laid down in guidelines, standards, protocols or normal practice”. (23, 
25, 26) The category ‘guidelines’ is used to describe deviations from care as laid down in documents on 
practice/ management by obstetric caregivers. The category ‘usual care’ is used for what is considered 
as standard acts of care by professional caregivers. The subclassifications of ‘usual care’ for this study 
were based on examples from Eskes et al. and from a national report on term perinatal mortality audit. 
(9, 23) The probability that the SSF was related to the cause of death was subdivided into: very likely, 
likely, possible, indeterminable, unlikely, none, and no consensus. The cases in the groups very likely, 
likely and possible were analysed to examine the SSF’s relation to the cause of death. In line with the 
INDEXstudy, we selected data of the SSFs in perinatal deaths beyond 41 weeks of gestation. For this 
reason, we did not make a comparison with SSFs in the early-/full-term pregnancy period.
Statistics 
Descriptive statistics were used to describe differences between early-/full-term and the late-/post-
term group and to describe SSFs in perinatal deaths in pregnancies of 41 weeks and beyond. No 
statistical analyses were performed, due to the rare occurrence of the outcome, the content of data 
and the design of the study.
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Figure 1 Flowchart of selection of cases of perinatal death ≥37 weeks between 2010-2012
Perinatal Registry Netherlands: all  birth outcomes ≥ 22 weeks of gestation
Cohort 2010-2012, singleton pregnancy
37.0-40.6 weeks (early-/full-term pregnancy): n=380,252
41.0-41.6 weeks (late-term pregnancy): n=89,812
≥42.0 weeks (post-term pregnancy): n=9,033
787 perinatal deaths (0.21%)
139 perinatal deaths (0.15%)
21 perinatal deaths (0.23%)
Total term- and post-term deliveries: n= 479,097 
947 perinatal deaths (0.21%) 
925 audited cases of perinatal death (98%)
Automatically constructed, anonymous narrative for use in local perinatal 
audit 
707 cases registered (75%)
PRN-audit
PARS
PRN
P
E
R
I
N
E
D
22 cases not registered in PRN-audit
218 cases not registered in PARS
Local Perinatal Audit-team
- Selection of cases based on content
- Evaluation care
- Cause of death
- Presence of SSF
- Reporting in PARS
≥37.0-40.6: n=598/787 (76%)
≥41.0: n=109/160 (68%)
RESULTS 
Between 2010-2012, 947 perinatal deaths in pregnancies of ≥37.0 were registered in the PARS 
database. From these registered deaths, 925 (98%) were audited and 707 (75%) were registered in 
PARS, from which 8 with an ‘unknown’ timing of death. (9, 27-29) No extra information could be 
obtained from the 218 (24%) perinatal deaths that were not registered in PARS (figure 1). Based on the 
Wigglesworth/Hey classification (WHEN), it was possible to stratify 598/787 (76%) registered perinatal 
deaths to the early-/full-term group (37.0-40.6) and 109/153 (71%) to the late-/post-term group 
(≥41.0) (figure 1). Stratified by moment of death we could identify 440 stillbirths and 259 neonatal 
deaths (table 1). Antepartum stillbirth was registered in 55.2% in the early-/full-term group and in 
42.2% in the late-/post-term group. Intrapartum stillbirth was registered 7.2% in the early-/full-term 
group and in 19.3% the late-/post-term group.
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Table 1 Term stillbirth and neonatal death stratified by gestational age registered in the Dutch Perinatal Audit system. 
 Stillbirth (n=440) Neonatal death (n=259) Missing Total
Gestational age (wk) Antepartum Intrapartum Early (day 0-6) Late (day 7-27)    
≥ 37.0-40.6 (n, %) 330 55.2% 43 7.2% 166 27.8% 51 8.5% 8 1.3% 598
≥ 41.0 (n, %) 46 42.2% 21 19.3% 31 28.4% 11 10.1%   109
Total (n, %) 376 53.2% 64 9.1% 197 27.9% 62 8.8% 8 1.1% 707
See figure 1 for national cases of term perinatal death between 2010-2012
In table 2, the most common classification of perinatal death (Modified ReCoDe) is shown, as 
determined by the local perinatal audit, stratified by gestational age and subdivided by congenital 
anomalies. Foetal congenital anomalies were found in 15% in the early-/full-term group and in 4% in 
the late-/post-term group. In foetus/ neonates without congenital anomalies, foetal asphyxia occurred 
in 19% of the early-/full-term group in comparison to 33% in the late-/post-term group. Intrapartum 
asphyxia occurred in 16% in the early-/full-term group and 34% in the late-/post-term group (table 
2). Acute infections, neonatal asphyxia and BMI ≥25 kg/m2 are less often classified as reason of death 
in the early-/full-term group in comparison to the late-/post-term group. In 16 cases, both foetal 
asphyxia and intrapartum asphyxia were selected by the local perinatal audit in the same case. 
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Table 2 Most common classification of perinatal death (Modified ReCoDe) stratified by gestational age.
  
37.0-40.6 
weeks (ref)
≥ 41 weeks
Classification Subclassification N % N %
Overall 598  109  
Foetal/ antepartum Congenital anomaly 89 15% 4 4%
Neonatal Congenital anomaly 104 17% 8 7%
Without congenital anomalies 441  97  
Foetal/ antepartum Infection: acute 13 3% 8 8%
 Asphyxia* 82 19% 32 33%
Neonatal Asphyxia 63 14% 20 21%
Maternal Risk factor: overweight (BMI ≥ 25) 100 23% 33 34%
Intrapartum Asphyxia* 70 16% 33 34%
*16 cases of perinatal death are registered in both foetal asphyxia and in intrapartum asphyxia
For each case ≥1 condition could be entered
Figure 2 Most relevant condition of death in 109 cases of perinatal death in late-/ post-term pregnancy with an 
incidence of >1%.
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The most frequent, most relevant condition causing death in the full late-/post-term group according 
to the local perinatal audit was foetal asphyxia in 7.3% (8/109), intrapartum asphyxia in 9.2% (10/109), 
neonatal asphyxia in 10.1% (11/109) and placental insufficiency in 10.1% (11/109) (Figure 2).
A total of 178 SSFs were identified in 109 cases of perinatal death in pregnancies of 41 weeks and 
beyond. In 75 cases (68.8%), at least one or more SSFs could be identified (Table 3). There were 
no differences in number of cases with SSFs across 2010-2012. In 63/109 (57.8%) cases, SSFs were 
identified as a very likely, likely and possible relation to the cause of death. The most frequent reported 
SSFs in this group concerned ‘CTG evaluation and classification’ in 11/109 (10.1%), ‘CTG registration 
or documentation’ in 5/109 (4.6%) and ‘inadequate management in reduced foetal movements’ in 
5/109 (4.6%). 
Table 3 Number and content of substandard care factors (SSF) per perinatal death case ≥41 weeks as identified by 
the local perinatal audit.
    n %
Cases of perinatal death 109  
 ≥ 1 SSF 75 68.8%
  1 SSF 29 38.7%
  2 SSF 14 18.7%
  3 SSF 17 22.7%
  ≥ 4 SSF (max 8) 15 20.0%
 No SSF 27 24.8%
 Missing / insufficient data 7 6.4%
SSF with possible/ likely/ very likely relation to death* 63 57.8%
 Guideline- oriented SSF   
  Cardiotocography evaluation or classification 11 10.1%
  Cardiotocography registration or documentation 5 4.6%
  Guideline obesity 3 2.8%
 Usual Care- oriented SSF   
  Midwifery guidelines 4 3.7%
  Documentation in the medical records 3 2.8%
  Decreased foetal movements 5 4.6%
  Patient factor 3 2.8%
Total number SSF 178  
*Unknown/ unclear cases are not presented.
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DISCUSSION 
Main findings
Perinatal death in term- and post-term pregnancy is rare. In our study, stillbirth occurred less often 
antepartum and more often intrapartum in pregnancies ≥41.0 weeks in comparison to pregnancies at 
37.0-40.6 weeks. Asphyxia was seen more frequently as the most relevant condition causing death in 
pregnancies ≥41.0 weeks. Substandard factors with a likely relation to death in pregnancies ≥41.0 weeks 
concerned inadequate CTG monitoring (evaluation, classification, registration or documentation) in 
14.7% (16/109) and ‘reduced foetal movements in 4.6%.
Validity of the results
This nationwide study shows an audited cohort regarding the perinatal mortality in the Netherlands. 
Of the late-/post-term perinatal deaths, 68% (109/160) were registered in PARS, which is comparable 
to the 76% (598/787) of the early-/full-term registered perinatal deaths. (27-29) It was described 
in the study of Eskes et al. that —although not all term cases of perinatal death are audited—
characteristics of the audited cases like parity, maternal age, and gestational age, are comparable with 
all term perinatal deaths in the national registration of the Netherlands Perinatal Registry (PRN). (23) 
We assume that this statement also applies on our cohort, since we have used the same source of 
data, though comparisons with other studies should be made keeping this selection of cases in mind. 
Audit teams auditing perinatal care is becoming more and more part of common care, with the aim 
to reduce perinatal mortality and improve the quality of care at all levels of the health system. (30-33) 
Efforts to prevent perinatal and maternal deaths will improve perinatal and maternal outcomes, which 
are markers of the quality of care in pregnancy and childbirth, also in high-income countries. (34, 35)
Eskes et al. assessed the implementation and the results of the Perinatal Audit in 2010-2012 of 
pregnancies ≥37 weeks in the Netherlands using PARS data. They showed that total stillbirth in the 
early-/full-term period was comparable to the late-/post-term period, without making the sub-
classification in ante- and intrapartum stillbirth like shown in our study. (23) 
There are different ways to describe perinatal and maternal death (36). Perined uses Wigglesworth/
Hey and the modified ReCoDe to determine timing and cause of death (24). Internationally, the ICD-
PM is often used to describe deaths during the perinatal period and is based on the coding rules of 
the ICD-10 (International Statistical Classification of Diseases and Related Health Problems) and allows 
comparisons of perinatal death between settings). (37, 38) The ICD-PM first codes the timing of death 
(antepartum, intrapartum or neonatal) and is comparable to the Wigglesworth/Hey. Secondly, ICD-
PM assigns the main cause of perinatal death, which is comparable to the modified ReCoDe we used. 
Lastly, ICD-PM assigns the main maternal condition at the time of perinatal death, which is also part 
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of the classification by Perined. Although both classification systems are broadly comparable, Perined 
should be advised to introduce ICD-PM for future studies and to be able to compare with international 
data. 
When using term singleton deliveries registered in the PRN, the proportion of perinatal death is lowest 
(0.15%) in the late-term pregnancy period (41.0-41.6), 0.21% in the early-/full term period and 0.23% 
in the post-term pregnancy period. In the PRN data, the proportion of foetal death (0.14% vs 0.11%) 
and neonatal death (0.07% vs 0.06%) is slightly higher in the early-/full-term group in comparison 
to the late- and post-term group. When using the selected cases of perinatal deaths from the PARS 
database, the proportion of stillbirth exceeds the proportion of neonatal mortality in both the early-/
full-term group and the late-/post-term group. The systematic review of Gulmezoglu on induction of 
labour in women at or beyond term, showed no differences in timing of induction regarding perinatal 
death. (6) Our results are in concordance with the observations of Mandujano et al., who analysed 
more than 8 million pregnancies in 2003-2005 in the US, showing that at 37-38 weeks of gestation the 
number of neonatal deaths is lower than the level of stillbirths. (39) Our results are in contrast with 
the results of Rosenstein et al., who analysed nearly 4 million pregnancies in 1997-2006 in the state 
of California, showing that the proportion of infant death (defined as number of children who died 
in the first year of live) exceeds the proportion of stillbirths in the term period in all ethnicities. (40) 
This difference could be due to a pregnancy dating based on last menstrual period instead of early 
ultrasound and we were only able to analyse data on perinatal death during the first month instead of 
the first year. In a Swedish cohort study from 1982-1991, the stillbirth rate was highest for primiparas 
at 38 completed weeks (0.27%), lowest at 40 weeks (0.12%), and 0.23% in the post-term period. (8) All 
mentioned studies concern other methods of pregnancy dating and other timeframes than our study 
which makes a clear comparison difficult. 
In our Perinatal Audit study, foetal and intrapartum asphyxia was identified more in the late-/post-
term death group than in the early-/full-term group in the present study. In 16 cases, both foetal and 
intrapartum asphyxia was selected in the ReCoDe. In some cases, it could be hard to differentiate 
whether the pathological process of asphyxia started before or during labour. If antepartum 
asphyxia occurred, this process would most probably continue throughout labour, which could have 
contributed to the double selection in ReCoDe. Hereby, we could have both over- and underestimated 
the proportion of foetal and intrapartum asphyxia. The placental function is presumably the most 
important factor contributing to asphyxia in general and to asphyxia in foetal growth restriction. (41, 
42) Regarding intrapartum asphyxia, Berglund et al. reported a threefold increased risk for asphyxia in 
post-term deliveries compared to term deliveries. (43) In post-term pregnancy, labour is induced and 
monitored by CTG evaluation, which is the most important SSF in our audit reports. When labour is 
induced, there is a risk of hyperstimulation which, if not recognised, could contribute to asphyxia. In 
late-/post-term pregnancy, one of the most important risk factors associated with increased perinatal 
mortality is foetal growth restriction. (44, 45) However, in the present study foetal growth restriction 
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was classified as most important reason of death in 1.8% and classified as ‘relevant ‘in 6.4%. This 
difference in incidence could be due to the way data was entered: Asphyxia is considered a more 
contributing factor to perinatal death than growth restriction resulting in a higher registration of this 
risk factor. Also, at suspected growth restriction, most women are induced at 40 weeks, resulting in a 
lower overall incidence. (45)
There is no uniform international standardisation of SSFs categories and definitions, making it difficult 
to compare the results of studies with each other and with our present study. The possibility to 
compare with other studies would help us to learn from SSFs demonstrated by others, keeping in 
mind the level of development of obstetric care in each country. In the EuroNatal study, 1,619 cases 
of perinatal death ≥28 weeks were analysed in an external audit. SSFs with a possible or probable 
relation to death were found in 46% of the cases. (15) In 63/109 (57.8%) of the cases in this study an 
SSF with a very likely, likely or possible relation to death was found. According to the EuroNatal results, 
the most important SSF was undetected foetal growth restriction and in 10% it was seen as a cause 
that might have or was likely to have contributed to death. (15) 
In our study, the main reason for an SSF with a relation to death, were inadequate CTG evaluation or 
classification in 11/109 (10.1%) and registration or documentation in 5/109 (4.6%). Berglund et al. 
performed a case-control study in which neonates with and without an Apgar score of <7 at 5 minutes 
were compared regarding substandard care during labour. The main finding of substandard care was 
“misinterpretation of CTG, not acting on an abnormal CTG in a timely fashion and incautious use of 
oxytocin”. (46) In an earlier study of Berglund et al., staff did not act timely on pathological CTGs in 71% 
of the pregnancies. (47) In a study by Batlle et al., in which the quality of intrapartum care regarding 
birth asphyxia was assessed, two of the main shortcomings were related to misinterpretation of CTG 
and a delayed response time to CTG anomalies. (48) Auditing cases of perinatal death/ asphyxia 
often classifies a CTG as non-reassuring in retrospect, while it is known that there is a poor inter-
observer agreement on classification and management on non-reassuring CTGs. (49) These studies, as 
well as the present study, show the importance of adequate execution of CTG monitoring to reduce 
substandard care and to improve birth outcome.
Strengths and limitations 
The perinatal audit was not primarily set up for scientific purposes, but as an instrument to monitor 
and improve the quality of perinatal healthcare. Because PARS is set up as an anonymous database it 
was not possible to link the data to the national perinatal registry or check the source files, resulting 
in missing maternal and perinatal information on case level. Especially the impossibility to distinguish 
between late-term and post-term pregnancy, parity, level of care during pregnancy and delivery, onset 
of labour (spontaneous onset or labour induction) and mode of delivery are major limitations of the 
current PARS registry. This makes it difficult to draw conclusions on the level of obstetric management 
and is the main reason we did not perform statistical analyses. (9, 13, 23) Another limitation is that only 
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75% of all cases are audited and entered in PARS. Cases with a clear cause of death are sometimes not 
audited, which results in a selected group of perinatal deaths registered in PARS and could contribute 
to an over-/ underestimation in timing of perinatal death, causes of perinatal death and SSFs. Though 
auditing cases of maternal/ perinatal/ adverse events is getting more and more ‘standard care’, it is 
still not obligatory to perform an audit, or to enter audited cases in the PARS database. This reflection 
on management of care could be a quality requirement to ensure high standards in obstetric care in 
the Netherlands.
A limitation of the SSF classification system is that this is not standardized, which makes it more difficult 
to compare our results to other countries. The main outcome regarding inadequate CTG monitoring 
could not be differentiated into monitoring prior or during delivery. 
Recommendations 
There is an urgent need for a uniform international classification system of SSFs. The Groningen system 
has a moderate to good inter-rater agreement on well-defined (sub)categories, with clear guidelines 
and examples, which can be used to standardise the SSFs in the PARS database together with the 
studies of Eskes. (50) In addition, the PARS database should also make some basic characteristics and 
obstetric characteristics (e.g. spontaneous onset of labour/ induction) obligatory to fill in and use 
the ICD-PM classification in order to make the database more suitable for future evaluation. Finally, 
in pregnancies ≥41 weeks, care providers should be aware of the risk of intrapartum asphyxia and 
in those pregnancies where CTG is indicated, attention should be paid to adequate CTG registration, 
evaluation and classification.
CONCLUSIONS
Pregnancies with a gestational age at or beyond 41 weeks, from which 75% registered in the Dutch 
Perinatal Audit system, showed less antepartum stillbirth and more intrapartum stillbirth than 
pregnancies of 37.0-40.6 weeks. More foetal, intrapartum, and neonatal asphyxia were identified as 
causes of death in pregnancies beyond 41 weeks compared to pregnancies of 37.0-40.6 weeks. The 
most identified SSFs with a relation to death in pregnancies beyond 41 weeks concerned inadequate 
CTG monitoring (evaluation, classification, registration or documentation) and ‘inadequate action on 
decreased foetal movements’.
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ABSTRACT
Background: 
Since there is no consensus regarding the optimal management in late-term pregnancies (≥41.0 
weeks), we explored the variety of management strategies in late-term pregnancy in the Netherlands 
to identify the magnitude of this variety and the attitude towards late-term pregnancy.
Methods:
Two nationwide surveys amongst all midwifery practices (midwifery-led care) and all hospitals with an 
obstetric unit (obstetrician-led care) were performed with questions on timing, frequency and content 
of consultations/surveillance in late-term pregnancy and on timing of induction. Propositions about 
late-term pregnancy were assessed using Likert scale questions. 
Results:
The response rate was 40% (203/511) in midwifery-led care and 92% (80/87) in obstetrician-led 
care. All obstetric units made regional protocols with their collaborating midwifery practices about 
management in late-term pregnancy. Most midwifery-led care practices (93%) refer low-risk women at 
least once for consultation in obstetrician-led care in late-term pregnancy. The content of consultations 
varies among hospitals. Membrane sweeping is performed more in midwifery-led care compared 
to obstetrician-led care (90% vs 31%, p<0.001). Consultation at 41 weeks should be standard care 
according to 47% of midwifery-led care practices and 83% of obstetrician-led care units (p<0.001). 
Induction of labour at 41.0 weeks is offered less often to women in midwifery-led care in comparison 
to obstetrician-led care (3% vs 21%, p<0.001).
Conclusions: 
Substantial practice variation exists within and between midwifery- and obstetrician-led care in the 
Netherlands regarding timing, frequency and content of antenatal monitoring in late-term pregnancy 
and timing of labour induction. An evidence based interdisciplinary guideline will contribute to a 
higher level of uniformity in the management in late- term pregnancies.
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BACKGROUND
Maternity care in the Netherlands is provided by independent/ community midwives (midwifery-led 
care) and clinically working midwives and obstetricians (obstetrician-led care). (1-4) Healthy women 
with an uncomplicated pregnancy and childbirth receive midwifery-led care. When complications 
arise or when an increased risk on adverse perinatal and or maternal outcomes during pregnancy or 
childbirth occur, women in midwifery-led care will be referred to obstetrician-led care for consultation/ 
surveillance and/ or for take over if necessary. The risk selection is performed by midwives in 
midwifery-led care in order to provide the most appropriate care for mother and foetus. (5) This risk 
selection is based on the ‘Obstetrical Indication List’ (VIL) and agreements of regional collaborations. 
The Obstetrical Indication List is a national Dutch evidence and/ or consensus based document which 
contains nationwide agreements between midwives, gynaecologists and paediatricians on the required 
level of care for women with specific conditions or risk of complications. (6) Regional collaborations 
between midwifery-led care and obstetrician-led care are formalized in a ‘Maternity Care Network’ 
(MCN, in Dutch VSV), a regional partnership between an obstetric unit and all collaborating midwifery 
practices, in which local protocols are made based on national and international guidelines. Local 
protocols and agreements may differ between MCNs. 
In the Netherlands in 2013, 167,159 women with an ongoing vital pregnancy ≥22 weeks were 
registered, 142,782 (85.4%) of them started pregnancy in midwifery-led care. 164,257 (98.3%) women 
had a singleton pregnancy, from which 152,323 (92.7%) gave birth at term. From this singleton term 
gestation group, 79,622 (52.3%) started labour in midwifery-led care and 45,335 (29.8%) gave birth in 
midwifery-led care, from which 26,175 (17.2%) at home. (7)
Post-term pregnancy is defined as a pregnancy with a gestational age ≥42.0 weeks. Late-term 
pregnancy refers to a pregnancy between 41.0-41.6 weeks. (8) In the Netherlands in 2013, 2,199 
women (1.3%) gave birth post-term and 27,460 (16.7%) late-term, with an absolute risk of perinatal 
death of 0.23% in post-term pregnancies and 0.16% in late-term pregnancies. (7) There is no national 
guideline regarding management in uncomplicated late-term pregnancy. Obstetrical low risk women 
remain under the responsibility of midwifery-led care until 42.0 weeks. Between 41 and 42 weeks 
they can receive their antenatal checks in midwifery-led care or they are referred for consultations 
in obstetrician-led care. Internationally, women reaching late-term or post-term pregnancy are 
induced in order to reduce the risk on adverse perinatal or maternal outcomes. (9-14) However, there 
is no consensus regarding the optimal timing of induction of labour nor about the frequency and 
content of consultation(s) in late-term pregnancies. There is no clear evidence regarding performance 
of an ultrasound, determining amniotic fluid or assessing foetal growth in late-term pregnancy.(9) 
International guidelines and literature suggest that both an induction of labour during week 41 and 
expectant management until 42 weeks with or without any antenatal consultation(s)/surveillance 
could be considered. (9, 12-16)
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According to the ‘Obstetrical Indication List’, patients should be referred >294 days of gestation 
(>42.0 weeks). (6) The Royal Dutch Organisation of Midwives (KNOV) representing midwifery-led care, 
recommends local interdisciplinary agreements regarding management in late-term pregnancy with 
the option of an antenatal consultation in obstetrician-led care between 41.0-41.6 weeks, to sweep 
membranes at 41.0 weeks and to refer to obstetrician-led care to plan an induction at 42.0 weeks. 
(17, 18) The Dutch Society for Obstetrics and Gynaecology (NVOG), representing obstetrician-led care, 
gives no details about the frequency and content of antenatal consultations at 41.0-41.6 weeks, but 
states that an induction of labour can be considered between 41.0-41.6 weeks on the patients request 
or at 42.0/42.1 and that this should be in accordance with local interdisciplinary agreements made in 
the MCN. (15) Due to the lack of evidence on how to monitor late-term pregnancy and the variety in 
local protocols there is wide practice variation in the management of late-term pregnancies.
In order to gain more insight in the magnitude of this practice variation in late- and post-term pregnancy 
in the Netherlands, two nationwide surveys were performed. (19) The first survey was performed in 
midwifery-led care at the end of 2011 – beginning of 2012 followed by a survey in obstetrician-led care 
in 2013. (19) In between there was no change in the national guideline on post-term pregnancy, nor 
major publications regarding management or timing of induction in late-term pregnancy which could 
have influenced local policy. In this study we report results of both surveys.
METHODS
We performed a national survey amongst all 511 independent midwifery practices in the Netherlands to 
explore management of late-term pregnancy in midwifery-led care. Respondents were representatives 
on behalf of their practice. The Midwifery organisation KNOV mailed all Dutch midwifery practices that 
were known by them with their email address with a call to fill in the on-line survey. Furthermore, a call 
was done twice by the KNOV in their two-weekly e-mail newsletter to their members. Subsequently, 
an email with a request to fill out a comparable survey was sent by the researchers to all 87 hospitals 
(42 non-teaching; 35 teaching and 10 academic hospitals) with an obstetric unit in 2013. This survey 
was based on the survey sent to midwifery practices. Both surveys included Yes/No questions, single 
answer multiple choice questions, open questions, and some clarifying questions depending on the 
answers given. Both surveys included questions concerning standard local policy in case of late-term 
pregnancy, frequency and content of antenatal consultations between 41 and 42 weeks, indications 
and timing of labour induction. A five-point Likert scale was used to evaluate level of agreement with 
six statements regarding management in late-term pregnancy (completely disagree – completely 
agree). Both surveys could be filled in anonymously, though the name of the hospital and the level of 
care were obligatory in the hospital survey. Ethical approval was deemed unnecessary according to 
Central Committee on Research Involving Human Subjects (CCMO), since it was a short survey without 
people being subjected to procedures or being required to follow rules of behaviour.(20)
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Data on timing, frequency and content of a late-term pregnancy consultation and data on management 
strategies is presented as counts (percentages) in both midwifery-led care and obstetrician led-
care, comparisons are made using Chi-square or Fisher Exact tests, when appropriate. We used the 
Mann-Whitney U test to compare agreement with the propositions between midwifery-led care and 
obstetrician-led care. A two-sided p-value of <0.05 was considered statistically significant. Statistical 
analysis was performed using SPSS version 23.0. 
The Checklist for Reporting Results of Internet ESurveys (CHERRIES) is shown in appendix 1. 
RESULTS 
In midwifery-led care, 40% (203/ 511) of the representatives of the midwifery practices responded to 
the survey in comparison to 92% (80/ 87) of the representatives of obstetric units in obstetrician-led 
care. Characteristics of respondents in both midwifery-led care and obstetrician-led care are shown 
in Table 1. Most midwifery practices (97%) are part of an MCN. Table 2 shows the origin of late-term 
pregnancy protocols used in midwifery-led care. Community midwives refer to two or more hospitals 
in late-term pregnancy in 56% (113/203) and in most cases 87% (98/113) these hospitals differ in 
their management in late-term pregnancy. In obstetrician-led care, most hospitals (93%) made their 
local late-term pregnancy protocols in cooperation with midwives from midwifery-led care, which is 
adhered to by midwives according to 76% (61/80) of respondents in obstetrician-led care (not shown 
in a table).
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Table 1 Responders in midwifery- and obstetrician-led care in comparison to national numbers
 Survey National 2012*
Level of care n % n %
Midwifery-led care practices 203 40% 511 100%
Group practice (3 midwives or more) 150 74% 313 61%
Duo practice 35 17% 114 22%
Solo practice 14 7% 84 16%
Other 4 2% 0 0%
Obstetrician-led care units 80 92% 87 100%
Non-teaching hospital 37 46% 42 48%
Teaching hospital 34 43% 35 40%
Academic teaching hospital 9 11% 10 11%
* https://www.nivel.nl
Table 2 Origin of late-term pregnancy protocols in midwifery-led care
 n %
Maternity Care Network (interdisciplinary) 97 48%
Local gynaecologists 39 19%
Obstetrical Indication List 34 17%
Own practice 11 5%
Regional agreement midwifery practices 10 5%
Other 12 6%
 203 100%
The regionally made protocols regulate the timing, frequency, content and policy of a late-term 
pregnancy consultation/surveillance in obstetrician-led care of low risk women. Table 3 shows the 
timing of the late-term pregnancy consultation in obstetrician-led care according to the respondents 
in both midwifery- and obstetrician led care which could be scheduled once, twice or ‘every other day’ 
depending on local agreements. The content of this late-term pregnancy consultation/ surveillance is 
variable, but according to the representatives of obstetrician-led care, it is standard procedure during 
hospital consultation/surveillance to perform a foetal non-stress test/ cardiotocography (87%) and a 
transabdominal ultrasound (93%), in which amniotic fluid volume is determined (96%) and/or foetal 
biometry (40%). In obstetrician-led care, 21% stated that a vaginal examination is always performed 
and 72% performs membrane sweeping ‘on indication’. Membrane sweeping (if possible) is less often 
performed in obstetrician-led care 22/72 (31%) in comparison to midwifery-led care 184/203 (91%) 
(p<0.001 RR: 0.34; 95% CI 0.24 to 0.48). 
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Table 3 Gestational age of late-term pregnancy consultation in obstetrician-led care according to respondents from 
both levels of care.
 Midwifery-led care Obstetrician-led care
 n % n %
≤41.0 22 11% 21 26%
41.1-41.3 103 51% 28 35%
41.4-41.6 51 25% 13 16%
≥42.0 12 6% 1 1%
no consultation 15 7% 0 0%
other* 0 0% 17 21%
 203 100% 80 100%
* patients request, on indication, no exact timing
Table 4 Management strategies in late-term pregnancy between 41.0 – 42.0 weeks in obstetrician-led-care for low 
risk women referred from midwifery-led-care and for women primarily in obstetrician-led care.
 
Women referred from 
midwifery-led care
Women primarily in 
obstetrician-led care
Management Strategies n % n % p-value
IOL* at GA# 41.0-41.2 2 3% 17 21% <0.001¥
IOL* at GA# 41.3-41.5 1 1% 3 4% 0.62¥
EM† with extra consultations in obstetrician-led care 45 56% 31 39% 0.03§
EM† without extra consultations in obstetrician-led care 4 5% 3 4% 1¥
Individual based 11 14% 4 5% 0.10¥
Patients request 17 21% 22 28% 0.36§
 80 100% 80 100%
# GA: Gestational age.
*IOL: Induction of labour.
†EM: Expectant management until 42.0 weeks in the absence of foetal or maternal indications for induction of 
labour before 42 weeks and subsequent induction from 42 weeks onwards.
¥ Fisher Exact
§ Chi square
In midwifery-led care, there is a strong preference (77%) to refer to a hospital that does not induce 
labour at 41.0 weeks of gestation. Table 4 shows the management strategies between 41-42 weeks 
of low risk women stratified by level of care in late-term pregnancy according to obstetrician-led care. 
In obstetrician-led care, it is less often standard care to induce the women from midwifery-led care 
at 41.0-41.2 weeks in comparison to low-risk patients originating from obstetrician-led care (3% vs 
21%; p<0.001) and it is more often standard care to adhere to a policy of expectant management 
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with consultations (56% vs 39%, p=0.04). In obstetrician-led care, labour is induced from 41.0 weeks 
onwards when there is a maternal request for induction (88% always and 10% after counselling pros 
and cons for both management strategies) and always when foetal or maternal indications arise.
Statements on management in late-term pregnancy were analysed between the professional groups. 
In both midwifery-led care and obstetrician-led care, there was no common agreement on the 
statements between the levels of care. Table 5 shows the percentage of agreement (agree and totally 
agree combined) for each proposition stratified by level of care. In midwifery-led care there was less 
agreement on the statement ‘a consultation in obstetrician-led care at 41 weeks should be standard 
practice’ (47% vs 83%) and ‘consultation in obstetrician-led care at 41 weeks reassures the midwife’ 
in comparison to obstetrician-led care (31% vs 50%). There were no significant differences in level of 
agreement on the propositions ‘consultation in obstetrician-led care at 41 weeks reassures women’ 
and ‘consultation in obstetrician-led care at 41 weeks reassures the gynaecologist’.
Table 5 Agreement (agree and strongly agree combined) on statements regarding obstetrician-led care consultations 
in late-term pregnancy according to level of care
 
Midwifery-led care 
practices (n=203)
Obstetrician-led care 
units (n=80)
 n % n % p-value*
Consultation at/ in week 41 should be standard 96 47% 66 83% <0.001
Consultation at/ in week 41 reassures pregnant women 119 59% 50 63% 0.62
Consultation at/ in week 41 reassures midwife 63 31% 40 50% <0.001
Consultation at/ in week 41 reassures gynaecologist 98 48% 48 60% 0.32
*Mann-Whitney U test based on Likert scale for agreement
DISCUSSION
Main findings
In the Netherlands, individual and local protocols are made on management of care in women reaching 
41.0 weeks of gestation because of the absence of an interdisciplinary national guideline regulating 
management of late-term pregnancy. Timing, frequency, content of antenatal monitoring in late-term 
pregnancy and timing of induction differs within and between obstetric caregivers in midwifery-led 
care and obstetrician-led care. Women in midwifery-led care receive more membrane sweeping 
in comparison to women in obstetrician-led care at 41.0 weeks. There is no consensus within and 
between midwifery-led care and obstetrician-led care regarding the optimal management in late-term 
pregnancy.
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Comparison to other studies
If a policy of expectant management until 42.0 weeks is chosen, regular antenatal checks in late-term 
pregnancy (41.0-42.0) are advised, though there is inconsistent evidence regarding the effectiveness of 
antenatal monitoring for the prevention of adverse perinatal outcome. (9, 15, 18) Studies are varying 
in timing, frequency and content of these antenatal checks. (9, 10, 15, 21-23) Some international 
guidelines advise to perform a transabdominal ultrasound measurement of amniotic fluid for timely 
detection of an oligohydramnios and to detect small-for-gestational age foetus. (9, 15) Determining 
foetal growth restriction by ultrasound at term is challenging but is regularly used in third trimester 
or prior to induction to detect foetal growth restriction(24-26). There is conflicting evidence regarding 
the detection of small for gestational age (<p10) neonates when ultrasounds are performed in routine 
or on indication at term. (27-29) The DIGITAT-trial (n=650), on induction or expectant management 
for term suspected intra uterine growth restriction, showed that most neonates in this study had a 
birth weight <p10, but still 26-34% were >p10. (29) In the late-term period, a retrospective cohort 
study (n=71,050) described the results of a comparison between a policy using a routine ultrasound 
examination (routine scan of biometry and amniotic fluid index) at 41 gestational weeks with a policy 
using ultrasound on clinical indication (e.g. suspicion on small for gestational age) at 41 weeks. A policy 
of routine screening lowered the incidence of an adverse perinatal outcome at term, probably due to 
timely detection of SGA-foetus. (28) 
According to a Cochrane systematic review on amniotic fluid assessment as screening test for 
preventing adverse pregnancy outcome, Nabhan et al. concluded that the use of the amniotic fluid 
index increases the rate of diagnosis of oligohydramnios and the rate of induction of labour without 
improvement in peripartum outcomes (NICU admissions, perinatal mortality, pH<7.10, AS5’<7, 
presence of meconium, assisted vaginal delivery or caesarean section). Therefore, the single deepest 
vertical pocket measurement in the assessment of amniotic fluid volume during foetal surveillance is 
advised to use, whereby <2cm should be defined as oligohydramnios, though there has not been a 
systematic review on diagnostic accuracy of both assessments. (27) 
In a large Dutch trial (n=742), sweeping the membranes in low risk women at 41 weeks decreased the 
risk of post-term pregnancy (23% vs 41% RR: 0.57, 95% CI 0.46-0.71) with a number needed to treat of 
6. (17) However, sweeping is not widely implemented in obstetrician-led care. According to both the 
KNOV and NVOG guidelines, sweeping the membranes is advised in late-term pregnancy in order to 
reduce the risk on a post-term pregnancy. We did not ask caregivers in obstetrician-led care why they 
do not routinely sweep the membranes in late-term pregnancy. This could be due to the usual ‘high 
risk’ population in obstetrician-led care in which termination of pregnancy is required before 41 weeks 
and cervical priming is a more certain method to start labour induction. 
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Post-term pregnancy (≥42.0 weeks of gestation) is regarded as a ‘high risk’ condition by the ‘Obstetrical 
Indication List’ (VIL). In late-term pregnancy; the Dutch NVOG recommends to grant a patients’ 
request to induce labour. The ACOG guideline recommends to consider induction of labour and the 
NICE guideline recommends to offer induction of labour between 41.0 and 42.0 weeks in accordance 
with patients’ preferences and local circumstances. (9, 12, 15) The recommendations to ‘consider’ or 
to ‘offer’ induction in late-term pregnancy may have contributed to the practice variation between 
maternity caregivers both in midwifery-led care and obstetrician-led care. Practice variation does not 
necessarily mean suboptimal care, especially when there are no high quality randomized controlled 
trials with adequate sample size or reviews available covering the required time frame of comparison. 
More results to support policy making in uncomplicated late-term pregnancies will be provided by 
two ongoing trials: the INDEX study (The Netherlands) and the SWEPIS study (Sweden), which both 
randomized low risk women at 41.0 weeks of gestation for induction of labour at 41.0 weeks or 
expectant management until 42.0 weeks. (19, 30)
We showed that policy in late term pregnancy varies between and within midwifery-led care and 
obstetrician-led care. However, on patients’ level women’s voice plays an important role in the process 
of shared decision making. In obstetrician-led care the management strategy (induction or expectant 
management) in late- term pregnancy is solely based on women’s preference in ±20% while a request 
for induction of labour is nearly always respected by the caregiver in obstetrician-led care. This 
corresponds to the international guidelines stating that the decision of women should be respected, 
whether or not she wants labour to be induced. (9, 10, 12, 15, 21, 22)
There are some differences in attitude within and between midwifery-led care and obstetrician-led care 
based on the percentage of agreement on the propositions on management in late-term pregnancy. 
In midwifery-led care, 47.5% agreed on ‘consultation at 41.0 weeks in obstetrician-led care should 
be standard’, in comparison to 82.5% in obstetrician led care. The need of a late-term pregnancy 
consultation/surveillance and its content, frequency and timing, is internationally discussed without 
supporting high levels of evidence. (9, 10, 12, 15, 22). 
Strengths and Limitations
Our study shows the results of the first two national questionnaires in maternity care on policy in 
late-term pregnancy. Because maternity care in the Netherlands is provided by both midwives and 
obstetricians, we combined the results of both questionnaires. The midwifery-led care questionnaire 
received a relatively low (203/511) response rate probably because the midwifery organisation did not 
had access to all email addresses of Dutch midwifery practices and the calls within the newsletter of 
the midwifery organisation are not very well read. However, coverage of postal codes of midwifery-
practices shows that it represents a large proportion of the practices across the country. We received 
a good (90%) response rate from the representatives in obstetrician-led care. We did not send the 
questionnaire to all individual obstetric caregivers in midwifery- and obstetrician-led care but asked 
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the views of the team because policy in the Netherlands is made within and with the teams. This leads 
to a representative overview of current practice in late-term pregnancy in the Netherlands. In the last 
5 years, the national guidelines did not change during the study period, and the incidence of induction 
of labour in week 41 remained stable (30.6% in 2013 to 29.8% in 2016). (31, 32)
Both questionnaires were based on literature, (Dutch) guidelines and daily practice. Because both 
questionnaires contained also questions for the specific professional group, a selection was made 
of those questions which were asked in both surveys. The questionnaires can be repeated after the 
implementation of a new interdisciplinary guideline, in order to compare possible differences in 
management strategy. 
CONCLUSION
In a high resource country as the Netherlands there is no consensus regarding the timing, frequency 
and content of consultations/surveillance in late-term pregnancy and on timing of labour within 
and between midwifery- and obstetrician-led care. Results of further studies are needed to develop 
an evidence based interdisciplinary guideline on management in late-term pregnancy which will 
contribute to a higher level of uniformity in the management in late- term pregnancies. 
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SUPPORTING INFORMATION
Appendix 1: SF 2 checklist for reporting result of internet ESurveys (CHERRIES).
Midwifery-led care:
Design Describe survey design Obstetrical management was explored by inviting all midwifery 
practices in the Netherlands to fill out the questionnaire by a 
representative of the practice. This study was carried out by the 
use of an electronic survey. 
IRB (Institutional Review Board) 
approval and informed consent 
process
IRB approval IRB approval was not needed for this anonymised survey 
among professionals.
Informed consent The target population was informed on the purpose of the 
study (care in late-term pregnancy) by direct mail and in a 
directly mailed newsletter of the professional organisation. 
When the link to the survey was opened, participants were 
informed that by filling out the questionnaire they will give 
approval for the anonymized use of the data.
Data protection The following commercial web survey provider was used: 
Survey Monkey. All data were hosted by Survey Monkey. An 
e-link to the survey was created; the web survey provider did 
not dispose of the email addresses used for direct mailing.
Development and pre-testing Development and testing The questions were composed by two investigators. The web 
survey was tested in a small pilot in the target population 
before the start of the study.
Recruitment process and 
description of the sample having 
access to the questionnaire
Open survey versus 
closed survey
 It was regarded as a closed survey (only for the target 
population of midwifery practices) though the survey could be 
opened without password
Contact mode The target population was informed and invited by direct mail 
and in a newsletter, which was directly mailed explaining the 
goals and purposes of the survey. This email included the link 
to the online survey. In order to enlarge the response rate, a 
second invitation was sent 2 weeks after the initial request by 
the same routes. 
Advertising the survey No advertising was used.
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Survey administration Web/E-mail The link to the survey was included in an email. Respondents 
could only get access to the web-based survey by clicking on 
the link. The data were automatically collected and stored by 
the survey provider after finishing.
Context Not applicable.
Mandatory/voluntary Responding to the survey was voluntary
Incentives None
Time/Date The survey was conducted in December 2011/January 2012.
Randomisation of items 
or questionnaires
No items or questionnaires were randomised.
Adaptive questioning Adaptive questioning was mostly used. Based on the answer, 
respondents were directed to an additional question or to the 
next question.
Number of Items The survey consisted of 19 items.
Number of screens 
(pages)
Questions were shown in the same screen.
Completeness check Most questions were multiple choice questions with the 
possibility to make a comment, though there were no 
mandatory questions. 
Review step Respondents were able to go back to change existing answers 
until the survey was finished or until they closed the survey. 
Response rates Unique site visitor Responders were determined as a unique visitor by their IP 
address. 
View rate (Ratio of 
unique survey visitors/
unique site visitors)
Not applicable. We did not build in a tracking system.
Participation rate (Ratio 
of unique visitors who 
agreed to participate/
unique first survey page 
visitors)
Not applicable. We did not build in a tracking system.
Completion rate (Ratio 
of users who finished the 
survey/users who agreed 
to participate)
The completion rate was 100% for 16 of the 19 questions. 
Three questions were skipped by 2 or 3 users.
Preventing multiple entries from 
the same individual
Cookies used Cookies were used by the survey provider to recognize repeat 
users in order to prevent multiple answering
IP check 
 
 
The IP address of the client computer was used to identify 
potential duplicate entries from the same user, the period of 
time that no two entries of the same IP address was allowed 
was 90 days. 
Log file analysis No log file analysis was performed.
Registration Not applicable.
Analysis Handling of incomplete 
questionnaires
A selection was made of relevant questions for the purpose of 
this article that were asked in both MLC and OLC survey. These 
questions had a 100% completion rate. 
Questionnaires 
submitted with an 
atypical timestamp
Not applicable
Statistical correction Not applicable.
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Obstetrician-led care:
Design Describe survey design This study was carried out by the use of an electronic 
survey. A link to the survey was sent in an e-mail by the 
researchers to the contact persons of obstetric units who 
are connected to the Dutch Consortium for Healthcare 
Evaluation and Research in Obstetrics and Gynecology or to 
the representatives of obstetric units in obstetrician-led care. 
IRB (Institutional Review Board) 
approval and informed consent 
process
IRB approval IRB approval was not needed. It was obligatory to enter the 
name of the hospital. Entering the name was voluntarily and 
and the survey was handled anonymised.
Informed consent The participants were informed about the purpose of the 
study (exploration of care in late-term pregnancy) by direct 
mail. When the link to the survey was opened, participants 
were informed that by filling out the questionnaire they will 
give approval for the anonymised use of the data.
Data protection The following commercial web survey provider was used: 
google.docs/forms. All data were hosted by google.docs. An 
e-link to the survey was created; the web survey provider did 
not dispose of email addresses. 
Development and pre-testing Development and testing The questions were composed by three investigators. The 
web survey was tested in a small pilot study before the start 
of the study.
Recruitment process and 
description of the sample having 
access to the questionnaire
Open survey versus closed 
survey
It was regarded as a closed survey (only for the target 
population of obstetrician-led care) though the survey could 
be opened without password.
Contact mode The target population received an email explaining the goals 
and purposes of the survey and asked for their participation. 
This email included the link to the online survey. In order to 
enlarge the response rate, a second and third invitation was 
sent and non-responding hospitals were called. 
Advertising the survey No advertising was used.
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Survey administration Web/E-mail The link to the survey was provided in an email. Respondents 
could only get access to the web-based survey by clicking on 
the link. The data were collected automatically after their 
submission.
Context Not applicable.
Mandatory/voluntary Responding to the survey was voluntary
Incentives None
Time/Date The survey was conducted in 2013 (May - October)
Randomisation of items or 
questionnaires
No items or questionnaires were randomised.
Adaptive questioning Adaptive questioning was mostly used. Based on the answer, 
respondents were directed to an additional question or to 
the next question.
Number of Items The survey consisted of 27 items.
Number of screens (pages) Questions on the same topic were combined on the same 
screen. All questions were preceded by an introducing text. 
After answering the questions, new questions were displayed 
on a new screen.
Completeness check Most questions were multiple choice questions with the 
possibility to make a comment. Some questions contained an 
option to quantify a certain answer (e.g. Amniotic fluid index 
in cm) As such, for every question an answer was needed 
from every participant.
Review step Respondents were able to go back to change existing 
answers until the survey was finished or until they closed 
the survey. 
Response rates Unique site visitor Responders were determined as a unique visitor by hospital 
and name (when provided) 
View rate (Ratio of unique 
survey visitors/unique site 
visitors)
Not applicable. 
Participation rate (Ratio of 
unique visitors who agreed 
to participate/unique first 
survey page visitors)
Not applicable
Completion rate (Ratio 
of users who finished the 
survey/users who agreed to 
participate)
All users completed the full survey.
Preventing multiple entries from 
the same individual
Cookies used Cookies were used by the survey provider (google form) 
to recognize repeat users in order to prevent multiple 
answering
IP check 
 
 
The IP address of the client computer was not used to 
identify potential duplicate entries from the same user. 
Duplicate database entries were based on name and were 
eliminated before analysis, with the most complete and, if 
more were complete, the first entry kept for analysis (n=8). 
Log file analysis No log file analysis was performed.
Registration In order to complete the survey, it was compulsory to fill in 
the name of the hospital and voluntarily to fill in the name of 
the respondent.
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Analysis Handling of incomplete 
questionnaires
Only completed surveys could be submitted. Therefore, no 
incomplete surveys were included in the analysis.
Questionnaires submitted 
with an atypical timestamp
Not applicable.
Statistical correction Not applicable.
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Effects of induction of labour versus expectant management 
in women with impending post-term pregnancies: 
the 41 week – 42 week dilemma
J.C. Kortekaas, A. Bruinsma, J.K.J. Keulen, J. van Dillen, M.A. Oudijk, J.J. Zwart, J.J.H. Bakker, 
D. de Bont, M. Nieuwenhuijze, P.M. Offerhaus, A.H. van Kaam, F.P.H.A. Vandenbussche, B.M.J. Mol, 
E.R. de Miranda
BMC Pregnancy and Childbirth 2014, 14:350
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ABSTRACT
Background
Post-term pregnancy, a pregnancy exceeding 294 days or 42 completed weeks, is associated with
increased perinatal morbidity and mortality and is considered a high-risk condition which requires 
specialist surveillance and induction of labour. However, there is uncertainty on the policy concerning 
the timing of induction for post-term pregnancy or impending post-term pregnancy, leading to practice 
variation between caregivers. Previous studies on induction at or beyond 41 weeks versus expectant 
management showed different results on perinatal outcome though conclusions in meta-analyses 
show a preference for induction at 41 weeks. However, interpretation of the results is hampered by 
the limited sample size of most trials and the heterogeneity in design. Most control groups had a policy 
of awaiting spontaneous onset of labour that went far beyond 42 weeks, which does not reflect usual 
care in The Netherlands where induction of labour at 42 weeks is the regular policy. Thus, leaving the 
question unanswered if induction at 41 weeks results in better perinatal outcomes than expectant 
management until 42 weeks.
Methods/design
In this study we compare a policy of labour induction at 41.0/40.1 weeks with a policy of expectant
management until 42 weeks in obstetrical low risk women without contra-indications for expectant 
management until 42 weeks and a singleton pregnancy in cephalic position. We will perform a 
multicentre randomised controlled clinical trial. Our primary outcome will be a composite outcome of 
perinatal mortality and neonatal morbidity. Secondary outcomes will be maternal outcomes as mode 
of delivery (operative vaginal delivery and caesarean section), need for analgesia and postpartum 
haemorrhage (≥1000 ml). Maternal preferences, satisfaction, wellbeing, pain and anxiety will be 
assessed alongside the trial.
Discussion
This study will provide evidence for the management of pregnant women reaching a gestational age 
of 41 weeks.
Trial registration
Dutch Trial Register (Nederlands Trial Register): NTR3431. Registered: 14 May 2012.
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BACKGROUND
Post-term or prolonged pregnancy, defined as a pregnancy extended to or beyond 42.0 weeks or ≥ 294 
days after the first day of last menstrual period, is associated with increased perinatal morbidity and 
mortality. (1-10) Therefore post-term pregnancy is considered as a high-risk condition which requires 
specialist surveillance and induction of labour at some stage, mainly because of a relatively small 
group of undetected growth-restricted foetuses that is at risk for adverse perinatal outcome. (11, 12)
In this era, with gestational age based on first trimester ultrasound, the incidence of post-term 
pregnancy is reduced to 3-5% or even less. (13-15) The risk on adverse perinatal outcome is considered 
to increase gradually rather than a steep increase from 42 weeks onwards, though the literature on 
this subject is ambiguous. (16-18) The Cochrane review on induction of labour for improving birth 
outcomes showed that a policy of labour induction at or beyond 41 completed weeks is associated 
with significant fewer perinatal deaths (22 trials, 9,383 participants, RR 0.31, 95% CI 0.12-0.88) 
although the absolute risk of perinatal death is small. (18) According to this review, labour induction 
doesn’t increase the risk of caesarean section in women with a gestational age of 41 or 42 completed 
weeks. (18) However, only a few of the included studies had a policy of labour induction at 41 weeks in 
the intervention group. In other studies, it is unclear whether labour was always induced at 41 weeks. 
Furthermore, in most trials expectant management in the control groups continued far beyond 42 
weeks. (17-20) In addition, recent observational studies showed that elective induction leads to similar 
increased maternal and foetal risks as induction on medical indication, in comparison to spontaneous 
onset of labour. (21) Recent meta-analysis showed that induction of labour on maternal or foetal 
indication in women with intact membranes reduces the risk of caesarean section, thus leaving the 
question unanswered if induction at 41 weeks in obstetrical low risk women gives better perinatal 
outcomes and maternal outcomes than expectant management until 42 weeks. (19, 22) 
Because of the uncertainty regarding the management of (impending) post-term pregnancy, there 
is no consensus on the optimal timing of induction, leading to practice variation. Policy concerning 
low risk pregnancies at or beyond 41 weeks in the Netherlands varies from expectant management 
until 42 weeks, without extra surveillance, to once or twice a week cardiotocography (CTG) and 
ultrasound surveillance in secondary care from 41 weeks onwards and labour induction at 42 weeks, 
or labour induction starting at 41 weeks. (23) Until now, the interdisciplinary agreement between the 
Royal Dutch Organisation of Midwives (KNOV) and the Dutch Society for Obstetrics and Gynaecology 
(NVOG) concerning post-term pregnancy in the Netherlands, indicates secondary care and labour 
induction from 42 weeks onwards. (8, 24) However, more and more hospitals are converting their 
policy to induction of labour at 41 weeks, though there is no consensus concerning this change of 
policy. Opponents argue that hospitalised labour will diminish physiological birth, with increased 
rates of pain treatment, and operative delivery (vacuum/forceps or caesarean section) resulting in 
more negative birth experiences and an increase in costs with doubtful perinatal benefits. (20, 25-28) 
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Unfortunately, data reflecting the Dutch situation, comparing induction of labour at 41 weeks with 
expectant management until 42 weeks, are lacking. 
Observational data of the Dutch Perinatal Registry (PRN 2000 - 2006) show very small, but increasing 
rates of adverse perinatal outcomes such as Apgar score <7 (40.0-40.6 weeks 0.9%, 41.0-41.6 weeks 
1.1% and ≥ 42 weeks 1.4%), meconium aspiration syndrome (40.0-40.6 weeks 0.12%, 41.0-41.6 weeks 
0.21% and ≥ 42 weeks 0.25%) and NICU admission (40.0-40.6 weeks 0.49%, 41.0-41.6 weeks 0.62% 
and ≥ 42 weeks 0.91%), among births from singleton pregnancies. (29) However, perinatal mortality 
(up to 28 days) of singletons born between 41.0 – 41.6 weeks (0.16%) was comparable to perinatal 
mortality between 40.0 – 40.6 weeks (0.13%) and between 39.0 – 39.6 weeks (0.16%). (30) PRN 
data also showed an increase in operative vaginal delivery when labour is induced beyond 41 weeks 
compared to induction at term (37.0-39.6 9.8%, 40.0-40.6 weeks 12.4%, 41.0-41.6 weeks 14.6% and 
≥ 42 weeks 17.1%). (31)
Previous studies comparing expectant management and induction of labour in high risk pregnancies 
showed a discrepancy between observational PRN data and data from randomised trials (Digitat trial 
(growth retardation) and Hypitat trial (hypertension at term)). (32, 33) The PRN database indicated 
an increased risk of operative vaginal delivery after induction of labour, whereas the subsequent 
randomised clinical trials showed that such an effect was absent. (32-34) Also, PRN data showed a 
significant increase in caesarean section after labour induction at or beyond 41 completed weeks 
compared to spontaneous onset of labour. However, caesarean section rates in the Netherlands 
between 2000-2006 are much lower than in many other western countries (for singletons overall 9.4% 
between 41.0-41.6 weeks and 16.6% beyond 42 weeks) thus hampering the extrapolation of results 
from international studies, and emphasising the importance of this trial. (29, 30)
Ethnic differences are likely to play an important role in post-term pregnancy. The mean duration 
of pregnancy is shorter in women from African origin and Indian origin as compared to Caucasian 
women. (35) Indeed, the incidence of stillbirth is higher from 41 weeks onwards among women from 
African and Surinam-Hindustan (Indian) origin as compared to Caucasian women. (35, 36) Though 
guidelines are not adjusted yet to ethnic origin, we will register ethnicity in our study. 
We are not aware of other ongoing studies that are similar to the present study proposal or related to 
the problem discussed here (national or international). The issue of the timing of induction of labour 
in post-term pregnancy has been addressed in many studies showing that labour induction should 
be offered in case of post-term pregnancy because of the increased risk of perinatal mortality and 
morbidity. (8, 19) 
The 41-42 weeks dilemma considers a large proportion of pregnant women, as with a policy of labour 
induction at 41 weeks 18% (31,166/173,099) of all pregnant women in The Netherlands would be 
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induced, compared to 1.5% (2,525/173,099) at 42 weeks. (37) With a policy of expectant management 
68.7% will have spontaneous onset of labour between 41.0 – 41.6 weeks. (37) Before the introduction 
of the most recent guideline on management of post-term pregnancy in 2007, there were less 
inductions of labour between 41.0 and 41.6 weeks (2006 18.2% (30,903), 2007 18.0% (30,151) and 
more deliveries after 42 weeks (2006 4.9% (8,312), 2007 4.5% (7,550)). (24, 38) 
Because of the controversy on this issue between caregivers, and the fact that the policy in surrounding 
countries is different, we feel that a nationwide randomised clinical trial is the obvious and necessary 
step to come to a multidisciplinary guideline regarding (impending) post-term pregnancy. We will 
conduct a randomised controlled trial to evaluate the effectiveness of a policy of labour induction at 
41 weeks compared to expectant management until 42 weeks in women without contra-indications 
for expectant management.
METHODS/DESIGN
The study is set in the Dutch Obstetric Consortium: a collaboration of obstetric centres in the 
Netherlands in cooperation with the Midwifery Research Network of the Netherlands (MRNN). (39) 
Approximately 200 centres, including university hospitals, teaching hospitals, nonteaching hospitals 
and midwifery practices will participate in this trial. (24)
We will ask obstetrical low risk women ≥ 18 years with a singleton pregnancy in stable cephalic 
position and a certain gestational age of 40.5 - 41.0, based on first trimester ultrasound and without 
contra-indications for expectant management until 42 weeks for consent to participate in our study 
and to be allocated to induction of labour at 41.0/41.1 weeks or at 42.0 weeks. Exclusion criteria are 
age <18 years, uncertain gestational age, obstetrical indications for secondary care (e.g. hypertension 
(systolic 140 mmHg and/or diastolic 90 mmHg or more), proteinuria (≥3 g/L), pre-existent maternal 
heart or kidney diseases, gestational diabetes, previous caesarean section, multiple pregnancy, intra-
uterine growth retardation) and non-reassuring foetal status (no foetal movements, abnormal foetal 
heart rate, known foetal abnormalities which could influence perinatal outcome, including abnormal 
karyotype, ruptured membranes at time of randomisation and a non-reassuring foetal status at time of 
randomisation). The results of the randomised clinical trial will be analysed according to the intention 
to treat principle.
Intervention group: induction of labour at 41.0 or 41.1 weeks
Women randomised to induction of labour will be referred to the cooperating hospital for induction of 
labour according to local protocol. Induction of labour will be started at 41.0 to 41.1 weeks. Women 
with a cervix that is judged to be ‘ripe’ at vaginal examination (Bishop Score of 6 or more), will have 
labour induced with amniotomy followed by intravenous oxytocin according to local protocol. In case 
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rupturing of membranes is not possible, cervical ripening will be accomplished in accordance with our 
national guidelines. In case the cervix is judged to be still unripe the day after priming, cervical ripening 
will be repeated. All patients in the intervention group will be monitored until after delivery. 
Control group: expectant management until 42 weeks 
Women allocated to expectant management await spontaneous onset of labour until 42 weeks. If 
labour has not started, monitoring is according to local protocol. This reflects current care in The 
Netherlands. Monitoring can consist of consultations, electronic foetal heart rate monitoring and 
ultrasound assessment of amniotic fluid. An increase of the frequency of these checks as well as 
admission to the hospital is based on the judgment of the midwife or clinician in charge as usual. In 
the expectant management group, intervention will occur in case the foetal condition does not justify 
expectant management, such as reduced foetal movements reported by the mother, non-optimal 
foetal heart rate on CTG or oligohydramnios. (12) If an indication for induction of labour occurs, such 
as prelabour rupture of membranes for >24 hours or meconium stained amniotic fluid, referral to 
secondary care for labour induction is indicated according to the management strategies which are 
recorded in the national Obstetrical Indication List. (40) All diagnostic tests and interventions between 
randomisation and birth are registered in the case report form. Protocol violation is noted in the case 
report form with the reason of switch of policy to induction of labour. Women with uncomplicated 
pregnancies who are still in primary care will be referred to secondary care at 42.0 weeks for induction 
of labour following the procedure as stated for the intervention group. 
OUTCOME MEASURES
Primary
Primary outcome will be a composite of perinatal mortality and neonatal morbidity. Adverse 
perinatal outcome is defined as a composite of perinatal mortality, a 5-minute Apgar score below 
7 and/or an arterial pH below 7.05 (as in other Consortium studies (32, 33)), meconium aspiration 
syndrome, plexus brachialis injury (with and without association with shoulder dystocia (additional 
manoeuvres to deliver shoulders)) and/or NICU admission (level of care and duration). Meconium 
aspiration syndrome is defined as respiratory distress in the first four hours after birth in presence of 
meconium stained amniotic fluid and categorised as severe (requiring assisted mechanical ventilation) 
or moderate (requiring oxygen for at least 48 hours or at a concentration of 40 percent or greater but 
without mechanical ventilation).
Secondary
Secondary outcomes will be maternal outcomes such as operative delivery (operative vaginal delivery, 
caesarean section), need for analgesia (epidural, remifentanil, pethidine), post-partum haemorrhage 
≥ 1000 ml and severe perineal injury (third- or fourth-degree perineal tear). Maternal preferences, 
satisfaction, wellbeing and anxiety will be assessed alongside the trial. (41, 42)
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Measurements
When a patient fulfils the study criteria and written informed consent is obtained, clinical data such as 
age, height, weight before pregnancy, ethnicity, highest finished education and social economic status 
based on postal code are collected at study-entry. (43) Obstetric history and level of care in current 
pregnancy are registered. Cervical ripeness will be assessed by digital examination of the cervix. The 
acquired Bishop score (based on dilatation, effacement, consistency, position and engagement) will 
be noted and foetal condition will be checked according to local protocol. Eligible women will be 
randomised subsequently. After randomisation, number and lengths of admissions is noted. In the 
expectant management group, level of care and number of (outpatient clinic) visits is reported. At 
each visit, maternal and foetal assessments are recorded. At the onset of labour all relevant data will 
be collected including start of labour. Data on first, second and third stage of labour are collected, 
including treatment for pain relief, mode of delivery and adverse perinatal and maternal outcomes. 
Perinatal and maternal mortality and morbidity will be specified. Data will be collected until women 
and child are discharged home for the first time or when deceased. If a participant withdraws from 
the study, the reason (lost to follow up, withdrawal of consent, prematurely stop of study) will be 
registered. We will use standardised case report forms that have been established in previous studies. 
Apart from the collection of clinical data, a sub-cohort of women will complete questionnaires 
addressing health related quality of life and wellbeing (EQ 6D (44), state anxiety (STAI(45), preferences 
and satisfaction (SSQ (46, 47), LADY-X (48), as well as questionnaires containing information on pain 
(PCS (49), NPRS/VAS) (50, 51). Questionnaires will be completed at baseline after randomisation, and 
6 weeks after delivery. Women can fill out the questionnaires online or on paper. Women who do not 
give consent for randomisation will be treated according to the local protocol and they will be followed 
in a prospective cohort study. 
Follow up of women and infants
The last questionnaires will be filled out at 6 weeks post-partum. Informed consent will be asked for 
future follow up studies.
Procedures, recruitment, randomisation and collection of baseline data
Randomisation will be performed through ALEA, a web-based software program for randomisation in 
clinical trials. The database is located in the central data collection unit in the Academic Medical Centre 
in Amsterdam. Randomisation procedure is by individual randomisation. Women will be randomly 
allocated to either induction of labour or expectant management. We will collect data from women 
who refuse randomisation due to a strong preference for one of the treatment options or because 
they want to follow local policy. The study will be an open label study, as it is impossible to blind the 
health care workers and patients for the strategy to which the woman is allocated.
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Data safety
This nationwide trial will be carried out by midwives (primary care) and gynaecologists (secondary 
care). To ensure the quality of this study and to minimize the protocol violations, a website is launched 
with all study information. All sites will be informed by the researchers on the procedures. All sites 
have the possibility to consult (in person or by phone) the researchers of the study group and an email 
address is available for non-urgent questions. All data are entered by research midwives or research 
nurses or trained medical students. After 900 inclusions, an interim analysis will be performed on 
safety. The operating procedures of the study are discussed with a data safety monitoring board, an 
independent group of experts who gave their approval to the design of the study safety. 
Serious adverse events 
The following serious adverse events (SAE) will be identified: Perinatal death, maternal death, severe 
neonatal morbidity (NICU admission), severe maternal morbidity (IC/CCU admission), event related 
to induction of labour and uterine rupture, asphyxia and meconium aspiration with admission of the 
neonate on the NICU/High Care department. The Data Safety Monitoring Board will be informed if 
three SAE of the neonate will occur or one maternal SAE. All SAE are reported to the main investigators 
within 24 hours. They will report to the data safety monitoring board.
Ethical consideration and trial registration
This study has been approved by the national central committee on research involving Human Subjects 
(CCMO- NL 38455.018.11), by the Medical Ethical Committee, Academic Medical Centre, Amsterdam 
the Netherlands (METC: 2011/ 361). The study will be a multicentre randomised controlled trial. The 
participating hospitals got approval of their local boards. The trial was registered at the Dutch Trial 
Register (Nederlands Trial Register): NTR3431. 
STATISTICAL ISSUES
Sample size calculation
Sample size was calculated for non-inferiority testing using software Query Advisor 7.0. Based on the 
incidence of the composite adverse perinatal outcome, the sample size is calculated at 900 women 
per group (1800 women in total). (52) With this sample size, a two-group large-sample normal 
approximation test of proportions with a one-sided 0.050 significance level will have 80% power to 
reject the null hypothesis that labour induction and expectant monitoring are not equivalent (the 
difference in proportions, is 0.020 or further from zero in the same direction) in favour of the alternative 
hypothesis that the proportions in the two groups are equivalent, assuming that the expected 
difference in proportions on composite adverse perinatal outcome is 0.000 and the proportion in 
the standard group is 0.030. When there is no equivalence this sample size (900 patients per group) 
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will allow us to have 85% statistical power to detect 2% reduction in the risk of composite perinatal 
mortality and neonatal morbidity from 3% to 1%. 
Data analysis
The results of the randomised clinical trial will be analysed according to the intention to treat principle. 
The effectiveness of labour induction at 41 weeks versus expectant management until 42 weeks will be 
assessed by calculating relative risks and 95% confidence intervals. Time to delivery will be compared 
using Kaplan-Meier curves and log-rank tests.
DISCUSSION
The policy regarding the timing of labour induction for (impending) post-term pregnancy is still under 
debate because of the inconclusiveness of the literature whether or not labour should be induced 
at 41 weeks or at 42 weeks for the prevention of adverse perinatal outcome. Most studies on labour 
induction or expectant management for (impending) post-term pregnancy started intervention 
beyond 41 weeks and continued expectant management far beyond 42 weeks. Until now, the Dutch 
guideline on post-term pregnancy indicates labour induction at 42 weeks. However, policy is moving 
towards labour induction at 41 weeks, though there is no consensus on this policy. This study will 
provide sufficiently precise and unbiased evidence on the difference between both strategies in 
perinatal and maternal outcome and patient preferences. When our study shows that the incidence of 
poor neonatal and maternal outcome is very low and comparable with both strategies, this will in itself 
be an argument against intervention. Maternal preferences will then be leading in the choice between 
induction or expectant management. This study will help to achieve an evidence-based management 
strategy concerning impending post-term pregnancy. We will adhere to the CONSORT guidelines for 
reporting the trial. 
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ABSTRACT
Objective 
To compare induction of labour at 41 weeks with expectant management until 42 weeks in low risk 
women.
Design 
Open label, randomised controlled non-inferiority trial.
Setting
123 primary care midwifery practices and 45 hospitals (secondary care) in the Netherlands, 2012-16.
Participants 
1801 low risk women with an uncomplicated singleton pregnancy: randomised to induction (n=900) or 
to expectant management until 42 weeks (n=901).
Interventions
Induction at 41 weeks or expectant management until 42 weeks with induction if necessary.
Primary outcome measures 
Primary outcome was a composite of perinatal mortality and neonatal morbidity (Apgar score <7 at 
five minutes, arterial pH <7.05, meconium aspiration syndrome, plexus brachialis injury, intracranial 
haemorrhage, and admission to a neonatal intensive care unit (NICU). Secondary outcomes included 
maternal outcomes and mode of delivery. The null hypothesis that expectant management is inferior 
to induction was tested with a non-inferiority margin of 2%.
Results
Median gestational age at delivery was 41.0 weeks (interquartile range 41.0 weeks to 41.1 weeks) for 
the induction group and 41.2 weeks (41.0 weeks to 41.5 weeks) for the expectant management group. 
The primary outcome was analysed for both the intention-to-treat population and the per protocol 
population. In the induction group, 15/900 (1.7%) women had an adverse perinatal outcome versus 
28/901 (3.1%) in the expectant management group (absolute risk difference −1.4%, 95% confidence 
interval (CI) −2.9% to 0.0%, P=0.22 for non-inferiority). 11 (1.2%) infants in the induction group and 23 
(2.6%) in the expectant management group had an Apgar score <7 at five minutes (relative risk (RR) 
0.48, CI 0.23 to 0.98). No infants in the induction group and three (0.3%) in the expectant management 
group had an Apgar score <4 at five minutes. One foetal death (0.1%) occurred in the induction group 
and two (0.2%) in the expectant management group. No neonatal deaths occurred. 3 (0.3%) neonates 
in the induction group versus 8 (0.9%) in the expectant management group were admitted to an 
NICU (RR 0.38, CI 0.10 to 1.41). No significant difference was found in composite adverse maternal 
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outcomes (induction n=122 (13.6%) v expectant management n=102 (11.3%)) or in caesarean section 
rate (both groups n=97 (10.8%)).
Conclusions 
This study could not show non-inferiority of expectant management compared with induction of 
labour in women with uncomplicated pregnancies at 41 weeks; instead a significant difference of 1.4% 
was found for risk of adverse perinatal outcomes in favour of induction, although the chances of a 
good perinatal outcome were high with both strategies and the incidence of perinatal mortality, Apgar 
score <4 at five minutes, and NICU admission was low.
Trial registration Netherlands Trial Register NTR3431.
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What is already known on this topic
A policy of labour induction at or beyond term compared with expectant management is associated 
with fewer perinatal deaths and fewer caesarean sections; but more operative vaginal births 
(Cochrane review)
Aggregated results of trials need to be interpreted with caution because of trials heterogeneity 
caused by different outcome measures, protocols, and time frames of comparison
Evidence is lacking for the recommendation to induce labour at 41 weeks instead of 42 weeks for 
the improvement of perinatal outcome
What this study adds
Induction of labour at 41 weeks resulted in less overall adverse perinatal outcome than a policy of 
expectant management until 42 weeks, although the absolute risk of severe adverse outcome 
(perinatal mortality, NICU admission, Apgar score <4 at five minutes) was low in both groups
RESEARCH
2 doi: 10.1136/bmj.l344 | BMJ 2019;364:l344 | the bmj
and this has been confirmed in a meta-analysis.16 17 19 20 
These results need to be interpreted with caution, 
however, because of heterogeneity between trials as 
a result of different outcome measures, protocols, 
and time frames of comparison because several trials 
compared induction beyond 41 weeks or starting 
induction at 42 weeks with a policy of expectant 
management far beyond 42 weeks.21
The obstetric management of women with a 
pregnancy exceeding 41 weeks varies considerably 
between and within countries. Although induction 
at 41 weeks has now become an accepted policy in 
many countries, in some others no consensus exists 
on the timing of induction in late term pregnancy. In 
Sweden and the Netherlands, for example, expectant 
management until 42 weeks is considered standard of 
care in women with an uncomplicated pregnancy.15 22 
In No w y, induction is started no later th n 42 weeks, 
and in Denmark delivery takes place before 42 weeks. 
Guidelines from the Royal College of Obstetricians and 
Gynaecologists/National Institute for Health and Care 
Excellence recommend that women should be offered 
induction betwe n 41 and 42 weeks.23
We compared two strategies: induction of labour at 
41 weeks (+0 days/+1 day) and expectant management 
until 42 weeks (+0 days) with subsequent induction if 
necessary. We anticipated that a policy of expectant 
management at 42 weeks, be g the simpl r strategy, 
would be acceptable for a low risk population if it did 
not lead to a substantially higher proportion of women 
with adverse perinatal outcomes compared with 
induction at 41 weeks.
Methods
Study design
Because induction of labour at 41 weeks as well as 
expectant management until 42 weeks are practised 
in the Netherlands, our study was designed to 
investigate non-inferiority of expectant management. 
We conducted a multicentre, open label, randomised 
controlled non-inferiority trial to investigate the effect 
of INDuction of labour at 41 weeks with a policy of 
EXpectant management until 42 weeks (INDEX trial) on 
adverse perinatal outcomes. Women were recruited at 
123 primary care midwifery practices and 45 hospitals 
(secondary care) equally distributed across the 
Netherlands. Twenty six of these 45 hospitals actively 
recruited participants, and 19 supported the study by 
inducing labour in women who had been recruited in a 
primary care setting and were allocated to induction. In 
t e Netherlands obstetric care is provided by primary 
care (midwives) for low risk women and secondary 
care (clinical midwives, residents, and obstetricians) 
for women with an increased risk of adverse maternal 
or perinatal outcome, or both. Low risk women in 
primary care can give birth at home or in an outpatient 
setting (birth centre or hospital), whereas women in 
secondary care give birth in hospital. For most low 
risk women, independent primary care midwives 
provide obstetric care. If risk factors are present 
during pregnancy, labour, or the postpartum period, 
women are referred to secondary care (obstetrician or 
gynaecologist). Secondary care may also be provided 
by clinical midwives or trainee obstetricians under the 
responsibility of an obstetrician.24-30
Our protocol has been published previously.31 The 
study was performed within the Dutch Consortium 
for Healthcare Evaluation and Research in Obstetrics 
and Gynaecology in cooperation with the Midwifery 
Research Network Netherlands.
Participants
Women were eligible for the study if they had a 
low risk, uncomplicated singleton pregnancy with 
the child in a stable cephalic position at a certain 
gestational age of 40 weeks+5 days to 41 weeks+0 days 
and no contraindications to expectant management 
until 42 weeks. Gestational age had to be determined 
by ultrasonography before a gestational age of 16 
weeks. Exclusion criteria for the study were age 
younger than 18 years, ruptured membranes or in 
labour, or both, non-reassuring fetal status (eg, no 
fetal movements, or abnormal fetal heart rate and/or 
expected intrauterine growth restriction), known fetal 
abnormalities (including abnormal karyotype) that 
could influence perinatal outcome, contraindications 
to induction (including previous caesarean section), 
or contraindications to expectant management (eg, 
pregnancy induced hypertension).
Randomisation and masking
Eligible women were informed about the study at the 40 
week antenatal check. At their next visit (40 weeks+5 
days to 41 weeks+0 days) the women were counselled 
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INTRODUCTION
Post-term pregnancy, defined as a pregnancy extended to or beyond 42 weeks, or 294 days or more, 
is associated with increased perinatal morbidity and mortality. (1-10) The World Health Organisation 
and various guidelines throughout the world therefore recommend induction of labour after 42 
weeks. (10-15) Although the overall probability of favourable perinatal outcomes between 40 and 42 
weeks is good in high resource settings, the risk of adverse perinatal outcome increases gradually after 
40 weeks. (16-19)
Several studies concluded that induction of labour from 41 weeks onwards improves perinatal 
outcomes, and this has been confirmed in a meta-analysis. (16, 17, 19, 20) These results need to be 
interpreted with caution, however, because of heterogeneity between trials as a result of different 
outcome measures, protocols, and time frames of comparison because several trials compared 
induction beyond 41 weeks or starting induction at 42 weeks with a policy of expectant management 
far beyond 42 weeks. (21) 
The obstetric management of women with a pregnancy exceeding 41 weeks varies considerably 
between and within countries. Although induction at 41 weeks has now become an accepted policy in 
many countries, in some others no consensus exists on the timing of induction in late term pregnancy. 
In Sweden and the Netherlands, for example, expectant management until 42 weeks is considered 
standard of care in women with an uncomplicated pregnancy.(15, 22) In Norway, induction is started 
no later than 42 weeks, and in Denmark delivery takes place before 42 weeks. Guidelines from the 
Royal College of Obstetricians and Gynaecologists/National Institute for Health and Care Excellence 
recommend that women should be offered induction between 41 and 42 weeks. (23)
We compared two strategies: induction of labour at 41.0 or 41.1 weeks and expectant management 
until 42.0 weeks with subsequent induction if necessary. We anticipated that a policy of expectant 
management at 42 weeks, being the simpler strategy, would be acceptable for a low risk population 
if it did not lead to a substantially higher proportion of women with adverse perinatal outcomes 
compared with induction at 41 weeks.
METHODS
Study design
Because induction of labour at 41 weeks as well as expectant management until 42 weeks are practised 
in the Netherlands, our study was designed to investigate non-inferiority of expectant management. 
We conducted a multicentre, open label, randomised controlled non-inferiority trial to investigate 
the effect of INDuction of labour at 41 weeks with a policy of EXpectant management until 42 weeks 
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(INDEX trial) on adverse perinatal outcomes. Women were recruited at 123 primary care midwifery 
practices and 45 hospitals (secondary care) equally distributed across the Netherlands. Twenty six 
of these 45 hospitals actively recruited participants, and 19 supported the study by inducing labour 
in women who had been recruited in a primary care setting and were allocated to induction. In the 
Netherlands obstetric care is provided by primary care (midwives) for low risk women and secondary 
care (clinical midwives, residents, and obstetricians) for women with an increased risk of adverse 
maternal or perinatal outcome, or both. Low risk women in primary care can give birth at home or in an 
outpatient setting (birth centre or hospital), whereas women in secondary care give birth in hospital. 
For most low risk women, independent primary care midwives provide obstetric care. If risk factors are 
present during pregnancy, labour, or the postpartum period, women are referred to secondary care 
(obstetrician or gynaecologist). Secondary care may also be provided by clinical midwives or trainee 
obstetricians under the responsibility of an obstetrician. (24-30)
Our protocol has been published previously. (31) The study was performed within the Dutch 
Consortium for Healthcare Evaluation and Research in Obstetrics and Gynaecology in cooperation 
with the Midwifery Research Network Netherlands.
Participants
Women were eligible for the study if they had a low risk, uncomplicated singleton pregnancy with 
the child in a stable cephalic position at a certain gestational age of 40.5 weeks to 41.0 weeks and no 
contraindications to expectant management until 42 weeks. Gestational age had to be determined 
by ultrasonography before a gestational age of 16 weeks. Exclusion criteria for the study were age 
younger than 18 years, ruptured membranes or in labour, or both, non-reassuring foetal status (e.g., 
no foetal movements, or abnormal foetal heart rate and/or expected intrauterine growth restriction), 
known foetal abnormalities (including abnormal karyotype) that could influence perinatal outcome, 
contraindications to induction (including previous caesarean section), or contraindications to expectant 
management (e.g., pregnancy induced hypertension).
Randomisation and masking
Eligible women were informed about the study at the 40-week antenatal check. At their next visit 
(40.5 weeks to 41.0 weeks) the women were counselled by the community midwife, secondary 
obstetric caregiver, or research-nurse or research-midwife of the participating centres collaborating 
in the Dutch Obstetric Research Consortium. After written informed consent had been obtained, 
the study participants underwent digital vaginal examination to determine the Bishop score which 
is used to assess the ripeness of the cervix before planning of induction of labour. It rates position, 
consistency, and dilation of the cervix and engagement of the foetal head (station) in a single score. 
Sweeping of the membranes was optional. Participants were randomly allocated by a web-based 
program (ALEA) using randomly permuted block sizes of 4 and 2, stratified by centre to induction of 
labour at 41.0 or 41.1 weeks or to expectant management with subsequent induction if necessary, 
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at 42.0 weeks. Owing to the nature of the intervention it was not possible to blind the women or 
caregivers to treatment allocation.
Procedures
Women allocated to induction were scheduled for the procedure at 41.0 or 41.1 weeks. All women 
were primed or induced, or both according to local protocols. Women with a Bishop score of less 
than 6 received cervical priming with prostaglandin E1 (misoprostol, oral or vaginal), prostaglandin E2 
(dinoprostone), Foley catheter or double balloon catheter, or a combination of these until amniotomy 
could be performed. Amniotomy was followed by intravenous oxytocin if required.
Women in primary and secondary care who were allocated to expectant management awaited 
spontaneous onset of labour until 42.0 weeks in their initial care setting, with monitoring according 
to local protocol. Monitoring typically involved a combination of cardiotocography, and sonographic 
assessment of amniotic fluid in secondary care at 41-42 weeks. Women in the expectant management 
group with ongoing pregnancies were scheduled for induction at 42.0 weeks in secondary care, 
following a similar induction protocol to the intervention group.
In both groups, labour was induced if the maternal or foetal condition was no longer reassuring—for 
example, reduced foetal movements, non-optimal cardiotocography findings, or oligohydramnios. 
Labour was also induced if prelabour rupture of membranes had occurred more than 24 hours 
previously or meconium stained amniotic fluid was present.
The caregivers systematically collected information on perinatal and maternal condition, as well as 
protocol deviations and the reasons for these. Every case report form was checked on completion 
and inconsistency. Trained staff entered data in an online digital case report form (Oracle Clinical, 
version 4.6.6.4.1). Anonymised source documents were collected at the midwifery practice or hospital 
to check adverse perinatal and maternal outcomes. Serious adverse events were reported on a case 
by case basis to an independent Data Safety and Monitoring Board and to the Dutch national internet 
portal for the submission, review, and disclosure of medical-scientific research with participants 
(www.toetsingonline.nl).
Outcomes
The primary outcome was a composite of perinatal mortality and neonatal morbidity. 
Perinatal mortality was defined as foetal death, intrapartum death, and neonatal death until 28 
days. Neonatal morbidity was defined as having an Apgar score <7 at five minutes and/or an arterial 
umbilical cord pH <7.05 and/or meconium aspiration syndrome and/or plexus brachialis injury and/or 
intracranial haemorrhage and/or or being admitted to a neonatal intensive care unit (NICU). Though 
a neonate could suffer from more than one adverse event, it is counted as one composite adverse 
perinatal outcome (neonatal level). 
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We defined meconium aspiration syndrome as respiratory distress after birth in the presence of 
meconium stained amniotic fluid. NICU admissions were reviewed to reveal final diagnosis and 
presence of congenital anomalies.
The cut-off for Apgar score <7 at five minutes was based on the committee opinion of the American 
College of Obstetricians and Gynecologists and American Academy of Pediatrics (ACOG/AAP), 2006. 
October 2015, after trial registration and during inclusion for this study, the ACOG/AAP committee 
released an update, which stated that the inappropriate use of the Apgar score in outcome studies 
had led to an erroneous definition of asphyxia. (32) Although it is incorrect to use Apgar score alone to 
diagnose birth asphyxia, an Apgar score <4 at five minutes ‘can be considered as a non-specific sign of 
illness’. Because of this mid-trial change of cut-off value, we also planned an additional analysis of the 
primary outcome including Apgar scores <4 instead of <7 at five minutes.
Secondary perinatal outcomes consisted of maternal outcomes: instrumental delivery (instrumental 
vaginal delivery, caesarean section), pain treatment (epidural, remifentanil, pethidine), postpartum 
haemorrhage, and severe perineal injury (third- or fourth-degree perineal tear (obstetrical anal 
sphincter injuries (OASIS)). Other neonatal outcomes included admission to medium care, congenital 
abnormality, hypoglycaemia, neonatal infection or sepsis, and small for gestational age (<10th centile) 
or large for gestational age (>90th centile). We also added a composite of adverse maternal outcome 
and other delivery outcomes.
The composite adverse maternal outcome included postpartum haemorrhage (≥1000 mL), manual 
removal of the placenta, third- or fourth-degree perineal tear (obstetrical anal sphincter injuries), 
and admission to an intensive care unit (ICU). Other delivery outcomes concerned onset of labour, 
pain treatment during labour, use of tocolytics, maternal intrapartum infection, meconium stained 
amniotic fluid, gestational age at delivery, mode of delivery, episiotomy, total postpartum blood loss, 
and blood transfusion. Though a woman could experience more than one adverse event, it is counted 
as one composite adverse maternal outcome.
For both the perinatal and the maternal composite outcomes, we also compared the individual 
components.
Statistical analysis
Before the start of the trial, we formed an expert panel, consisting of midwives, gynaecologists, and 
paediatricians, and methodologists to conceive the design, content, and execution of the trial. Using 
data on adverse perinatal outcomes in the Netherlands from the Perined registry (www.perined.nl/), 
we expected an incidence of 3% for the primary composite adverse perinatal outcome with both 
strategies. The panel made a reasoned choice about the acceptable difference in adverse perinatal 
outcome and feasibility of the trial. As a result, the non-inferiority margin (∆) was defined as a 2% risk 
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difference in incidence of the composite outcome favouring induction to justify a possible change in 
management strategy of pregnancies reaching a gestational age of 41.0 weeks.
With a one-sided α of 0.05, the study could achieve a power (β) of more than 0.80 if 900 women were 
recruited in each trial arm (1800 women in total). Non-inferiority would be concluded if the lower 
limit of the 95% confidence interval of the risk difference excluded a 2% higher proportion of women 
with an adverse perinatal outcome in the group allocated to expectant management. We established 
a Data Safety Monitoring Board to review the accumulating data of the trial. Interim analyses were 
conducted on safety after 517 and 1088 women had been recruited.
The statistician who performed the analyses was blinded to the allocation of the participants and 
performed the analysis according to a predefined analysis plan. The analysis of the primary outcome 
was done for both the intention-to-treat groups and the per protocol groups. For the per protocol 
analysis, we selected all randomised women with start of cervical ripening or spontaneous onset of 
labour at 41.0 weeks or more. Subsequently we defined the per protocol induction group as women 
allocated to induction who received induction before 41.2 weeks or who had a spontaneous onset 
of labour before induction could be started (<41.2 weeks). The per protocol expectant management 
group included women allocated to expectant management with spontaneous onset of labour 
until 42.0 weeks, women with a medical reason for induction before 42.0 weeks during expectant 
management, and women with induction at 42.0 weeks or more.
For all outcomes we estimated relative risks (RR) or median or mean differences, with 95% confidence 
intervals (CI). As appropriate, we investigated significance using χ2 test, Fisher’s exact test, t test, or 
Mann-Whitney U test statistics. We plotted Kaplan-Meier curves for the time between randomisation 
and birth. The log-rank test statistic was used to evaluate the difference in time to birth. Birth centiles 
were determined using national reference data for the Netherlands on birthweight, ethnicity, parity, 
and gestational age by week and day. Analyses were performed using SAS software for Windows, 
version 9.4 (SAS Institute, Cary, NC).
Patient and public involvement
No patients were asked for input in the creation of this article. Patient representatives will be asked 
to join a multidisciplinary working group consisting of (representatives of) obstetric caregivers 
(primary and secondary care) and neonatologists to create a new nationwide guideline addressing 
the management of late term pregnancy. Patients will also be involved in writing patient information 
brochures and a patient decision aid on this topic.
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RESULTS
Between 14 May 2012 and 17 March 2016, 6088 eligible women were invited to participate in 
the INDEX trial, of whom 4273 declined owing to a maternal preference for induction of labour or 
expectant management, or refusal to let randomisation determine the management strategy. After 
randomisation but before analysis, one woman (induction group) withdrew her consent, and 13 
women did not to meet the eligibility criteria (n=6 induction and n=7 expectant management). Of 
the remaining 1801 participants, 900 were randomly allocated to the induction group and 901 to 
the expectant management group (figure 1). Baseline characteristics were comparable between the 
groups, except for nulliparity: induction 50.8% (457/900) and expectant management 56.7% (511/901) 
(table 1).
Figure 1 Flow of women through study
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of labour before the planned induction. Of these 
women, 11.1% (67/611) had a spontaneous onset 
of labour at 41 weeks+0 days and 4.1% (25/611) at 
41 weeks+1 day. In the per protocol induction group, 
84.9% (519/611) of the women were induced: 62.5% 
(382/611) at 41 weeks+0 days and 22.4% (137/611) 
at 41 weeks+1 day. In the per protocol expectant 
management group, 80.9% (524/647) of the women 
had a spontaneous onset of labour at 41 weeks+0 days 
or later and 19.0% (123/647) were induced: 5.4% 
(35/647) because of concerns about fetal condition 
at 41 weeks+0 days or later, 3.4% (22/647) because 
of maternal condition 41 weeks+0 days or later, 0.6% 
(4/647) because of rupture of the membranes more 
than 24 hours previously at 41 weeks+0 days or later, 
and 9.6% (62/647) because of post-term pregnancy 
(≥42 weeks+0 days).
Primary outcome
Table 3 presents the perinatal outcomes in the 
intention-to-treat analysis. Fifteen women in the 
induction group (1.7%) and 28 in the expectant 
management group (3.1%) had a composite adverse 
perinatal outcome (absolute risk difference −1.4%, 
95% CI −2.9% to 0.0%; number needed to treat (NNT) 
69, 95% CI 35 to 3059). The P value for non-inferiority 
was 0.22, indicating that we could not exclude that 
expectant management leads to 2% or more adverse 
perinatal outcomes compared with induction. All 
neonates in the expectant management group with 
a composite adverse perinatal outcome were born 
in secondary care. In these cases, women either had 
labour started in secondary care or were transferred 
during labour from primary to secondary care.
The per protocol analysis showed a 1.6% risk of an 
adverse perinatal outcome (10/611) in the induction 
group compared with 2.9% (19/647) in the expectant 
management group (risk difference −1.3%, 95% 
CI −3.0% to 0.4%, P=0.21 for non-inferiority; see 
supplementary appendix).
Additional analysis of the composite primary 
outcome including Apgar score <4 at five minutes 
instead of <7 resulted in 0.4% (4/900) adverse 
perinatal outcomes in the induction group and 
1.3% (12/901) in the expectant management group 
(absolute risk difference −0.9%, −1.9% to 0.2%; NNT 
113, 57 to 4624, P=0.02 for non-inferiority).
The additional per protocol analysis of the composite 
primary outcome including Apgar score <4 at five 
minutes showed a 0.5% risk (3/611) of an adverse 
perinatal outcome in the induction group versus 1.2% 
(8/647) in the expectant management group (risk 
difference −0.7%, −2.0% to 0.5%, P=0.02 for non-
inferiority; see supplementary appendix).
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Fig 1 | Flow of women through study
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Table 1  Baseline characteristics of study participants by intervention group. Values are numbers (percentages) 
unless stated otherwise
Characteristics
Induction of labour 
(n=900)
Expectant management  
(n=901)
Mean (SD) maternal age (years): 30.6 (4.8) 30.2 (4.6)
 18-34 728 (80.9) 758 (84.2)
 35-39 148 (16.4) 132 (14.7)
 ≥40 24 (2.7) 11 (1.2)
Ethnicity:   
 White 779 (86.6) 767 (85.1)
 Other 121 (13.4) 134 (14.9)
Body mass index at start of pregnancy:   
 <18.5 26 (2.9) 19 (2.1)
 18.5-<25 532 (59.1) 523 (58.1)
 25-<30 230 (25.6) 229 (25.4)
 ≥30 89 (9.9) 117 (13.0)
 Missing 23 (2.6) 13 (1.4)
Highest level of education:
 Primary school 7 (0.8) 4 (0.4)
 Secondary school 37 (4.1) 15 (1.7)
 Lower/medium professional education 358 (39.8) 350 (38.8)
 Higher professional education/university 286 (31.8) 322 (35.7)
 Other/unknown 212 (23.4) 210 (23.3)
Social economic status:   
 Low 219 (24.3) 251 (27.9)
 Medium 401 (44.6) 365 (40.5)
 High 225 (25.0) 233 (25.9)
 Unknown 55 (6.1) 52 (5.8)
Parity:   
 Nulliparous 457 (50.8) 511 (56.7)
 Multiparous 443 (49.2) 390 (43.3)
Previous post-term pregnancy (³294 days) * 51/443 (11.5) 34/390 (8.7)
Level of care at recruitment:   
 Primary 851 (94.6) 850 (94.3)
 Secondary 49 (5.4) 51 (5.7)
Bishop score at study entry   
Nulliparous women:   
 ≥6 47/457 (10.3) 71/511 (13.9)
 <6 360/457 (78.8) 365/511 (71.4)
 Missing 50/457 (10.9) 75/511 (14.7)
Multiparous women:   
 ≥6 71/443 (16.0) 46/390 (11.8)
 <6 310/443 (70.0) 294/390 (75.4)
 Missing 62/443 (14.0) 50/390 (12.8)
Membrane sweeping before randomisation 286/900 (31.8) 343/901 (38.1)
*Numerator: multiparous women.
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In the induction group, 28.9% (260/900) of the women had a spontaneous onset of labour before the 
planned induction, and 71.1% (640/900) underwent induction (42.2% (382/900) underwent cervical 
ripening) (figure 2). In the induction group, 4.8% (43/900) of the women were not induced at 41.0 
weeks–41.1 weeks but at 41.2 weeks or later.
Figure 2 Cervical ripening during study
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perinatal outcome in the induction group and 4.1% 
(21/511) in the expectant management group (RR 
0.59, 95% CI 0.29 to 1.20). In multiparous women the 
incidence of adverse perinatal outcome was lower in 
both groups compared with nulliparous women: 0.9% 
(4/443) in the induction group and 1.8% (7/390) in the 
expectant management group (RR 0.50, 95% CI 0.15 
to 1.71). In logistic regression analysis, no interaction 
was found between parity and induction or expectant 
management.
Secondary outcomes
Table 3 shows the secondary perinatal outcomes in the 
intention-to-treat groups. No difference was found in 
medium care admissions, 6.6% and 6.7% (induction 
59/899 v expectant management 60/899). Small for 
gestational age (<10th centile), according to Dutch 
birthweight centiles, was similar between the groups: 
6.8% (61/900) in the induction group versus 6.9% 
(62/901) in the expectant management group. Overall, 
9.6% (86/900) of infants in the induction group were large 
for gestation age (>90th centile) versus 11.0% (99/901) 
in the expectant management group. The incidence of 
congenital abnormalities was similar between groups: 
1.8% in the induction group (16/900) versus 2.1% in the 
expectant management group (19/901).
Table 2 summarises the characteristics of labour 
and mode of delivery. Oxytocin was given significantly 
more often in the induction group than in the expectant 
management group (59.2% (533/900) and 39.4% 
(355/901) (RR 1.50, 95% CI 1.36 to 1.66)). Meconium 
stained amniotic fluid occurred significantly less often 
in the induction group compared with expectant 
management group (16.3% (147/900) and 22.8% 
(205/901) (RR 0.72, 95% CI 0.59 to 0.87). Ninety 
seven women in each group (10.8%) had a caesarean 
section (RR 1.00, 95% CI 0.77 to 1.31), mainly for non-
progressive labour at the first stage of labour (table 2).
Table 5 shows the results of adverse maternal 
outcomes in the intention-to-treat groups. The 
composite adverse maternal outcome occurred in 
13.6% (122/900) of the women in the induction group 
versus 11.3% (102/901) in the expectant management 
group (RR 1.20, 95% CI 0.94 to 1.53). Postpartum 
haemorrhage ≥1000 mL was the main contributor to 
the composite adverse maternal outcome and occurred 
in 9.1% (82/900) of women in the induction group 
versus 8.0% (72/901) in the expectant management 
group (RR 1.14, 95% CI 0.84 to 1.54). Manual removal 
of the placenta occurred in 5.1% (41/803) in the 
induction group versus 4.1% (33/804) in the expectant 
management group (RR 1.24, 95% CI 0.79 to 1.95). 
Obstetrical anal sphincter injuries were diagnosed 
in 3.5% (28/803) of women in the induction group 
versus 3.9% (31/804) in the expectant management 
group (RR 0.90, 95% CI 0.55 to 1.49). Three mothers 
(0.3%) in the induction group and two (0.2%) in the 
expectant management group were admitted to an ICU 
post partum (RR 1.50, 95% CI 0.25 to 8.97), all after 
postpartum haemorrhage. Blood loss in these women 
was 3000 mL, 5100 mL, and 7000 mL in the induction 
group and 3390 mL and 5000 mL in the expectant 
management group. No maternal deaths occurred. 
During labour, 29.4% (265/900) of the women in 
the induction group received epidural anaesthesia 
compared with 25.6% (231/901) in the expectant 
management group (RR 1.15, 95% CI 0.99 to 1.33).
Discussion
This randomised controlled trial compared the effect 
of induction of labour at 41 weeks with expectant 
management until 42 weeks with subsequent induction 
if necessary on perinatal and maternal outcomes in 
women with an uncomplicated pregnancy. A policy of 
induction resulted in a median reduction in gestational 
age at delivery of two days. We found a 1.4% difference 
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Fig 2 | Cervical ripening during study
In the expectant management group, 73.7% (664/901) of the women had a spontaneous onset of 
labour and 26.3% (237/901) were induced (14.7% (132/901) underwent cervical ripening). In the 
expectant management group, 35.9% (85/237) underwent induction at 42 weeks for post-term 
pr gnancy, and 27.4% (65/237) underwent induction before 42 weeks due to medical reaso s (e.g., 
foetal condition in 15.6% (37/237), maternal condition in 9.7% (23/237)), whereas 36.7% (87/237) 
in the expectant management group underwent induction on request. The median gestational age 
at time of delivery was 287 days (interquartile range 287-288 days) corresponding with 41.0 weeks 
(interquartile range 41.0 weeks t  41.1 weeks) for the induction group and 289 days (interquartile 
range 287-292 days), corresponding with 41.2 weeks (41.0 weeks to 41.5 weeks) in the expectant 
management group (table2). In both groups three quarters of the women had a Bishop score <6 at 
study entry. Figure 3 shows the time to delivery for both groups.
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Table 2  Delivery outcomes in intention-to-treat population. Values are numbers (percentages) unless stated 
otherwise
Outcomes
Induction of 
labour 
(n=900)
Expectant 
management 
(n=901)
Relative risk  
(95% CI)
p-value
Median (interquartile range) gestational 
age delivery (days)
287 (287-288) 289 (287-292) −2.1 (−2.3 to −1.9) * <0.001†
Mean (SD) time from randomisation to 
delivery (days)
2.1 (1.6) 4.2 (3.0) −2.2 (−2.5 to −2.0) * <0.001†
Level of care at onset of labour:     
 Primary 255 (28.3) 619 (68.7) NC -
 Secondary 645 (71.7) 282 (31.3) NC -
Onset of labour:     
 Spontaneous (reference) 260 (28.9) 664 (73.7) 1.00 -
 Induction 640 (71.1) 237 (26.3) 2.70 (2.41 to 3.04) <0.001
 Mode of induction: n=640 n=237   
    Cervical ripening (catheter/
prostaglandins)
382 (59.7) 132 (55.7) 1.07 (0.94 to 1.22) 0.30
   Amniotomy without oxytocin 87 (13.6) 34 (14.8) 0.95 (0.66 to 1.37) 0.77
   Amniotomy with oxytocin 156 (24.4) 59 (24.9) 0.98 (0.76 to 1.27) 0.87
 Indication for induction:   
   Randomisation 634 (99.1) 0 (0.0) NC -
   Post-term pregnancy 0 (0.0) 85 (35.9) NC -
   Foetal condition 5 (0.8) 37 (15.6) NC -
   Maternal condition 0 (0.0) 23 (9.7) NC -
   Elective or maternal request 1 (0.2) 87 (36.7) NC -
   Membranes ruptured >24 h 0 (0.0) 4 (1.7) NC -
   Other 0 (0.0) 1 (0.4) NC -
Use of oxytocin 533 (59.2) 355 (39.4) 1.50 (1.36 to 1.66) <0.001
Use of tocolytics 28 (3.1) 16 (1.8) 1.75 (0.95 to 3.22) 0.07
Maternal intrapartum infection: n=900 n=901   
 Fever during labour (≥38°C) 50 (5.6) 46 (5.1) 1.09 (0.74 to 1.61) 0.67
 Use of antibiotics 48 (5.3) 35 (3.9) 1.37 (0.90 to 2.10) 0.14
Meconium stained amniotic fluid 147 (16.3) 205 (22.8) 0.72 (0.59 to 0.87) 0.001
Level of care at time of birth:     
 Primary 129 (14.3) 309 (34.3) NC -
 Secondary 771 (85.7) 592 (65.7) NC -
Mode of delivery:     
 Spontaneous vaginal 710 (78.9) 696 (77.2) 1.02 (0.97 to 1.07) 0.40
 Operative vaginal 93 (10.3) 108 (12.0) 0.86 (0.66 to 1.12) 0.27
 (Secondary) caesarean section 97 (10.8) 97 (10.8) 1.00 (0.77 to 1.31) 0.99
Indication successful operative vaginal 
delivery:
n=93 n=108   
 Failure to progress at second stage 39 (41.9) 49 (45.4) 0.92 (0.67 to 1.27) 0.63
 Suspected foetal distress 43 (46.2) 37 (34.3) 1.35 (0.96 to 1.90) 0.08
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  Suspected foetal distress and failure 
to progress
10 (10.8) 22 (20.4) 0.53 (0.26 to 1.06) 0.07
 Maternal complication or other 1 (1.1) 0 (0.0) NA -
Indication for secondary caesarean 
section:
n=97 n=97   
 Failure to progress at first stage 29 (29.9) 21 (21.6) 1.38 (0.85 to 2.25) 0.19
 Failure to progress at second stage 12 (12.4) 18 (18.6) 0.67 (0.34 to 1.31) 0.24
 Failed operative vaginal delivery 6 (6.2) 12 (12.4) 0.50 (0.20 to 1.28) 0.22‡
 Suspected foetal distress 24 (24.7) 21 (21.6) 1.14 (0.68 to 1.91) 0.61
  Suspected foetal distress and failure 
to progress at first stage
7 (7.2) 8 (8.3) 0.75 (0.17 to 3.26) 1.00‡
  Suspected foetal distress and failure 
to progress at second stage
4 (4.1) 3 (3.1) 1.00 (0.26 to 3.88) 1.00‡
 Maternal complication or other 15 (15.5) 14 (14.4) 0.93 (0.48 to 1.83) 0.84
NC=not calculable; NA=not applicable.
*Mean (95% CI) difference between groups.
†Mann-Whitney U test.
‡Fisher’s exact test.
In the per protocol induction group, 15.1% (92/611) of the women had spontaneous onset of labour 
before the planned induction. Of these women, 11.1% (67/611) had a spontaneous onset of labour 
at 41.0 weeks and 4.1% (25/611) at 41.1 weeks. In the per protocol induction group, 84.9% (519/611) 
of the women were induced: 62.5% (382/611) at 41.0 weeks and 22.4% (137/611) at 41.1 weeks. In 
the per protocol expectant management group, 80.9% (524/647) of the women had a spontaneous 
onset of labour at 41.0 weeks or later and 19.0% (123/647) were induced: 5.4% (35/647) because of 
concerns about foetal condition at 41.0 weeks or later, 3.4% (22/647) because of maternal condition 
41.0 weeks or later, 0.6% (4/647) because of rupture of the membranes more than 24 hours previously 
at 41.0 weeks or later, and 9.6% (62/647) because of post-term pregnancy (≥42.0 weeks).
Primary outcome
Table 3 presents the perinatal outcomes in the intention-to-treat analysis. Fifteen women in the 
induction group (1.7%) and 28 in the expectant management group (3.1%) had a composite adverse 
perinatal outcome (absolute risk difference −1.4%, 95% CI −2.9% to 0.0%; number needed to treat 
(NNT) 69, CI 35 to 3059). The p-value for non-inferiority was 0.22, indicating that we could not 
exclude that expectant management leads to 2% or more adverse perinatal outcomes compared 
with induction. All neonates in the expectant management group with a composite adverse perinatal 
outcome were born in secondary care. In these cases, women either had labour started in secondary 
care or were transferred during labour from primary to secondary care.
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Figure 3 Time to delivery
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management. The corresponding risk ratio for perinatal 
death (RR 0.50, 95% CI 0.05 to 5.51) is comparable 
with that of the four studies (n=998) starting induction 
at 41 weeks (n=501) versus expectant management 
with varying upper limits of gestational age (n=497) 
included in a Cochrane systematic review (RR 0.33, 
95% CI 0.03 to 3.17).19 21 33
Congenital anomaly accounted for a substantial part 
of the NICU admissions in our trial, although it was 
an exclusion criterion at study entry. It is unknown 
if the outcome for these children would have been 
better if they had been born earlier, although it is 
unlikely (table 4). For these reasons we also analysed 
the primary composite outcome using an Apgar score 
<4 at five minutes and NICU admission without severe 
congenital anomalies. With these adapted adverse 
outcomes (perinatal mortality, Apgar score <4 instead 
of <7 at five minutes, and NICU admission without 
severe congenital anomalies), the absolute risk on the 
composite adverse perinatal outcome was substantially 
lower in both groups, with a still significant difference 
in favour of induction (0.1% (1/897)) versus expectant 
management (1.0% (9/898)): absolute risk difference 
−0.9%, 95% CI −1.6% to 0.2%; P=0.01 for non-
inferiority; P=0.02 for Fisher’s exact test; and NNT of 
112 (95% CI 63 to 491)).
Since in our trial all women in the 41 week 
induction group received obstetrician led intrapartum 
secondary care whereas in the expectant management 
group until 42 weeks 68.7% of the women received 
midwifery led primary care at start of labour and 
34.3% at time of birth, it could be suggested that our 
study is prone to performance bias (different care) and 
measurement bias (different assessment of neonates). 
Several studies, however, showed that Apgar scoring 
does not differ significantly between midwives and 
obstetricians.34 35 36 Furthermore, in our trial all 
neonates in the expectant management group with 
an adverse outcome were born in secondary care—the 
women had started labour in secondary care or were 
referred from primary to secondary care during labour. 
Various studies have shown that it is safe for low risk 
women in the Netherlands to deliver in midwifery led 
care, and the level of care does not seem to influence 
delivery outcome for these women.24-28 Although this 
study could be considered as a comparison between 
obstetrician led care with labour induction and midwife 
led care with a policy of expectant management, 
we cannot adjudicate whether the difference in the 
composite adverse perinatal outcome is due to the level 
of care (performance bias) or to a possible difference 
in Apgar scoring (measurement bias). We do not, 
however, expect bias to be a major factor.
In our study, meconium aspiration syndrome occurred 
in two neonates in the expectant management group. 
In a randomised controlled trial with a comparable 
time frame, Gelisen et al reported meconium 
aspiration syndrome in 16/600 neonates of whom 
12/300 were in the expectant management group. 
We found a 10 and 20 times lower rate of meconium 
aspiration syndrome (0.0% and 0.2% versus 1.3 and 
4%) in the induction and expectant management 
groups compared with the study by Gelisen et al. Since 
these authors did not specify meconium aspiration 
syndrome, the difference in magnitude could be 
attributed to a difference in definition. Despite this, 
Gelisen et al found no difference in NICU admissions 
(4.3% induction v 5.0% expectant management), 
which is expected to be associated with meconium 
aspiration syndrome. We found a lower rate of NICU 
admissions compared with the Cochrane systematic 
review on induction of labour at more than 41 weeks: 
0.3% induction and 0.9% expectant management 
(INDEX trial) v 11% induction and 12% expectant 
management (systematic review). The systematic 
review lacked details on NICU admission, such as 
diagnosis, potential association with gestational age, 
or presence of congenital anomalies, which hampers a 
clear comparison.16 33
We did not find differences in caesarean section or 
operative vaginal delivery rates, which is consistent 
with other large studies on induction of labour.37 38 
In the only study that compared the same timeframes 
as our study, the risk ratio for caesarean section was 
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The per protocol analysis showed a 1.6% risk of an adverse perinatal outcome (10/611) in the induction 
group compared with 2.9% (19/647) in the expectant management group (risk difference −1.3%, 95% 
CI −3.0% to 0.4%, P=0.21 for non-inferiority; see supplementary appendix).
Additional analysis of the composite primary outcome including Apgar score <4 at five minutes instead 
of <7 resulted in 0.4% (4/900) adverse perinatal outcomes in the induction group and 1.3% (12/901) 
in the expectant management group (absolute risk difference −0.9%, −1.9% to 0.2%; NNT 113, 57 to 
4624, P=0.02 for non-inferiority).
The additional per protocol analysis of the composite primary outcome including Apgar score <4 at 
five minutes showed a 0.5% risk (3/611) of an adverse perinatal outcome in the induction group versus 
1.2% (8/647) in the expectant management group (risk difference −0.7%, −2.0% to 0.5%, P=0.02 for 
non-inferiority; see supplementary appendix).
Three perinatal deaths (stillbirths) occurred: one in the induction group and two in the expectant 
management group. There were no neonatal deaths. The stillbirth in the induction group was 
in a 30 year old multiparous woman who was randomised at 40 weeks+5 days and scheduled for 
induction at 41 weeks+1 day. She had reduced foetal movements at 40 weeks+6 days, and foetal 
death was diagnosed at consultation. She delivered a neonate weighing 3595 g (20th to 50th centiles). 
Investigations, including a post-mortem examination, did not explain the stillbirth. In the expectant 
management group, stillbirth was diagnosed in a 36-year-old nulliparous woman at 41 weeks+3 days, 
when she was admitted to hospital in labour. She delivered a neonate weighing 2945 g (5th to 10th 
centiles). Investigations, including placental examination, did not explain the stillbirth, and the parents 
declined a post-mortem examination. The second stillbirth in the expectant management group was 
diagnosed in a 32-year-old multiparous woman at 41 weeks+4 days during a regular consultation in 
secondary care for impending post-term pregnancy. She delivered a neonate weighing 3715 g (20th 
to 50th centiles). No post-mortem examination was performed, but the placenta showed signs of 
chorioamnionitis.
The main contributor to the composite adverse outcome was an Apgar score <7 at five minutes: 1.2% 
(11/900) of neonates in the induction group and 2.6% (23/901) in the expectant management group 
(RR 0.48, CI 0.23 to 0.98). Three of these neonates, all in the expectant management group, had an 
Apgar score <4 at five minutes. The first neonate was born at 41.6 weeks after spontaneous onset of 
labour and an operative vaginal delivery (vacuum), because of foetal distress and failure to progress 
in second stage. The diagnosis was meconium aspiration syndrome, and the neonate was admitted to 
the NICU (table 4). Sepsis after spontaneous onset of labour at 40.6 weeks and rupture of membranes 
of more than 24 hours was diagnosed in the second neonate. The third neonate, weighing 4320 g, was 
born after cervical ripening that started at 41.6 weeks and failure to progress of second stage followed 
by a caesarean section at 42.2 weeks. The diagnosis in this neonate was airway obstruction caused by
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Table 3 Perinatal outcomes in intention-to-treat groups
Outcomes
Induction 
 of labour  
(n=900)
Expectant 
management 
(n=901)
Relative risk  
(95% CI)
p-value
Composite adverse perinatal outcome* 15 (1.7) 28 (3.1) 0.54 (0.29 to 1.00) 0.045†
 with 5 min Apgar score <4 instead of <7 4 (0.4) 12 (1.3) 0.33 (0.11 to 1.03) 0.06†
 including arterial pH <7.05 27 (3.0) 37 (4.1) 0.72 (0.44 to 1.20) 0.16†
Stillbirth 1 (0.1) 2 (0.2) 0.50 (0.05 to 5.51) 1.00†
Neonatal death post-partum 0 (0.0) 0 (0.0) NA -
Apgar score 5 mins post-partum: ¤     
 <7 11 (1.2) 23 (2.6) 0.48 (0.23 to 0.98) 0.038
 <4 0 (0.0) 3 (0.3) NA -
Neonate admitted to:     
 NICU 3/899 (0.3) 8/899 (0.9) 0.38 (0.10 to 1.41) 0.23†
 Medium care 59 (6.6) 60 (6.7) 0.98 (0.69 to 1.39) 0.90
Meconium aspiration syndrome‡ 0 (0.0) 2 (0.2) NA -
Plexus brachialis injury 0 (0.0) 0 (0.0) NA -
Intracranial haemorrhage§ 0 (0.0) 0 (0.0) NA -
Umbilical cord pH (arterial):     
 <7.05 16 (1.8) 12 (1.3) 1.06 (0.51 to 2.20) 0.88
 Missing 557 (62.0) 629 (70.0) NA -
Congenital abnormality 16 (1.8) 19 (2.1) 0.84 (0.44 to 1.63) 0.61
Hypoglycaemia¶ 3 (0.3) 6 (0.7) 0.50 (0.13 to 2.00) 0.51†
Neonatal infection/sepsis** 37 (4.1) 37 (4.1) 1.00 (0.64 to 1.56) 1.00
Female 453 (50.3) 463 (51.4) 0.98 (0.89 to 1.07) 0.65
Mean (SD) birthweight (g) 3685 (417.4) 3741 (430.0) −56.6 (−95.8 to −17.4) †† 0.005
Small for gestational age:    
 <2.3rd centile 13 (1.4) 11 (1.2) 1.18 (0.53 to 2.62) 0.68
 <10th centile 61 (6.8) 62 (6.9) 0.99 (0.70 to 1.39) 0.93
Large for gestational age:     
 >90th centile 86 (9.6) 99 (11.0) 0.87 (0.66 to 1.14) 0.32
 >97th centile 15 (1.7) 27 (3.0) 0.56 (0.30 to 1.04) 0.07
NA=not applicable; NICU=neonatal intensive care unit.
*Composite outcome defined as perinatal mortality (foetal death, intrapartum death, and neonatal death until 28 
days) or perinatal morbidity (a 5-minute Apgar score <7, and/or meconium aspiration syndrome, and/or plexus 
brachialis injury, and/or intracranial haemorrhage, and/or NICU admission).
In the IOL group all livebirths with a CAPO had either a 5-minute Apgar score <7 or a NICU admission. In the 
EM group livebirths with a CAPO: two neonates had MAS, 5-minute Apgar score <7 and NICU admission; three 
neonates were admitted to NICU, and also had a 5-minute Apgar score <7; three neonates were admitted to NICU, 
but had no 5-minute Apgar score <7; 18 neonates had a 5-minute Apgar score <7, but no NICU admission.
†Fisher’s exact test. 
¤Apgar score of live births.
‡Defined as respiratory distress after birth in presence of meconium stained amniotic fluid.
§Defined as clinical signs of intracranial haemorrhage.
¶Defined as glucose concentration <1.9 mmol/L and need for intravenous glucose.
**Defined as clinical suspected findings or proved positive blood culture result.
††Mean (95% confidence interval) difference between groups.
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vernix caseosa. Both these neonates were admitted to a medium care unit for observation. All three 
neonates recovered without complications. Admission to an NICU was reported in 0.3% (3/899) of 
neonates in the induction group versus 0.9% (8/899) in the expectant management group (RR 0.38, 
CI 0.10 to 1.41). Of the 11 children admitted to the NICU, six (three in each group) had a diagnosis 
of severe congenital disorder. Meconium aspiration syndrome was diagnosed twice, but only in the 
expectant management group, and both neonates recovered fully. No plexus brachialis lesions and 
no intracranial haemorrhage were diagnosed in the study population. In two admissions because of 
a (suspected) infection, one neonate had group B streptococcus and the other had a negative culture 
result. One neonate was admitted because of a pneumothorax.
Table 4 Admission to neonatal intensive care unit (NICU) by intervention
Allocation NICU admission: diagnosis
Congenital 
anomaly
Gestational 
age at birth
Induction Long QT syndrome Yes 40.6 weeks
Induction Mild mitral valve insufficiency, persistent ductus arteriosus Yes 41.0 weeks
Induction Interstitial lung disorder Yes 41.1 weeks
Expectant 
management
Diaphragm herniation, atrial septal defect, ventricular septal 
defect Yes 40.6 weeks
Expectant 
management Muscular ventricular septal defect Yes 41.5 weeks
Expectant 
management Vocal cord paresis, dysmorphic features Yes 41.5 weeks
Expectant 
management Infection (suspected, but culture was sterile) No 41.2 weeks
Expectant 
management Infection, Group B Streptococcus positive No 41.3 weeks
Expectant 
management Pneumothorax No 41.4 weeks
Expectant 
management Meconium aspiration syndrome No 41.2 weeks
Expectant 
management Meconium aspiration syndrome No 41.6 weeks
Arterial pH measurements were not recorded systematically and therefore could not be included 
in the analysis. Imputing was not possible owing to many missing data (62.0% induction v 70.0% 
expectant management). However, when we analysed data including the available pH measurements, 
the composite adverse perinatal outcome was 27/900 (3.0%) in the induction group versus 37/901 
(4.1%) in the expectant management group (risk difference −1.11%, CI −2.84% to 0.63%, P=0.16 for 
non-inferiority). For the per protocol analysis, the composite adverse perinatal outcome including 
the available pH measurement was 3.1% (19/611) in the induction group versus 4.0% (26/647) in the 
expectant management group (risk difference −0.91%, −2.98 to 0.01%, P=0.15 for non-inferiority).
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When stratifying by parity, we observed 2.4% (11/457) nulliparous women with a composite adverse 
perinatal outcome in the induction group and 4.1% (21/511) in the expectant management group (RR 
0.59, CI 0.29 to 1.20). In multiparous women the incidence of adverse perinatal outcome was lower 
in both groups compared with nulliparous women: 0.9% (4/443) in the induction group and 1.8% 
(7/390) in the expectant management group (RR 0.50, CI 0.15 to 1.71). In logistic regression analysis, 
no interaction was found between parity and induction or expectant management.
Secondary outcomes
Table 3 shows the secondary perinatal outcomes in the intention-to-treat groups. No difference was 
found in medium care admissions, 6.6% (59/899) in the induction group versus 6.7% (60/899) in the 
expectant management group. Small for gestational age (<10th centile), according to Dutch birthweight 
centiles, was similar between the groups: 6.8% (61/900) in the induction group versus 6.9% (62/901) 
in the expectant management group. Overall, 9.6% (86/900) of infants in the induction group were 
large for gestation age (>90th centile) versus 11.0% (99/901) in the expectant management group. 
The incidence of congenital abnormalities was similar between groups: 1.8% in the induction group 
(16/900) versus 2.1% in the expectant management group (19/901).
Table 2 summarises the characteristics of labour and mode of delivery. Oxytocin was given significantly 
more often in the induction group than in the expectant management group (59.2% (533/900) and 
39.4% (355/901) (RR 1.50, CI 1.36 to 1.66)). Meconium stained amniotic fluid occurred significantly less 
often in the induction group compared with expectant management group (16.3% (147/900) and 22.8% 
(205/901) (RR 0.72, CI 0.59 to 0.87). Ninety-seven women in each group (10.8%) had a caesarean section 
(RR 1.00, CI 0.77 to 1.31), mainly for non-progressive labour at the first stage of labour (table 2).
Table 5 shows the results of adverse maternal outcomes in the intention-to-treat groups. The composite 
adverse maternal outcome occurred in 13.6% (122/900) of the women in the induction group 
versus 11.3% (102/901) in the expectant management group (RR 1.20, CI 0.94 to 1.53). Postpartum 
haemorrhage ≥1000 mL was the main contributor to the composite adverse maternal outcome and 
occurred in 9.1% (82/900) of women in the induction group versus 8.0% (72/901) in the expectant 
management group (RR 1.14, CI 0.84 to 1.54). Manual removal of the placenta occurred in 5.1% 
(41/803) in the induction group versus 4.1% (33/804) in the expectant management group (RR 1.24, 
CI 0.79 to 1.95). Obstetrical anal sphincter injuries were diagnosed in 3.5% (28/803) of women in the 
induction group versus 3.9% (31/804) in the expectant management group (RR 0.90, CI 0.55 to 1.49). 
Three mothers (0.3%) in the induction group and two (0.2%) in the expectant management group 
were admitted to an ICU post-partum (RR 1.50, CI 0.25 to 8.97), all after postpartum haemorrhage. 
Blood loss in these women was 3000 mL, 5100 mL, and 7000 mL in the induction group and 3390 mL 
and 5000 mL in the expectant management group. No maternal deaths occurred. During labour, 29.4% 
(265/900) of the women in the induction group received epidural anaesthesia compared with 25.6% 
(231/901) in the expectant management group (RR 1.15, CI 0.99 to 1.33).
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Table 5 Adverse maternal outcomes in intention-to-treat population. Values are numbers (percentages) unless 
stated otherwise
Adverse outcomes
Induction  
of labour  
(n=900)
Expectant 
management 
(n=901)
Relative risk  
(95% CI)
p-value
Composite adverse maternal outcome* 122 (13.6) 102 (11.3) 1.20 (0.94 to 1.53) 0.15
Maternal death 0 (0.0) 0 (0.0) NA -
Postpartum blood loss:     
 <1000 mL (reference) 818 (90.9) 829 (92.0) 1.00 -
 ≥1000 mL 82 (9.1) 72 (8.0) 1.14 (0.84 to 1.54) 0.40
   1000-1499 mL 34 (3.8) 35 (3.9) 0.97 (0.61 to 1.54) 0.91
   1500-1999 mL 21 (2.3) 14 (1.6) 1.50 (0.77 to 2.93) 0.23
  ≥2000 mL 27 (3.0) 23 (2.6) 1.18 (0.68 to 2.04) 0.56
Median (interquartile range) postpartum 
blood loss (mL)
300 (200-500) 300 (250-500) - 0.18†
Transfusion (packed cells or plasma) 23 (2.6) 17 (1.9) 1.35 (0.73 to 2.52) 0.34
Manual removal placenta 41/803 (5.1) 33/804 (4.1) 1.24 (0.79 to 1.95) 0.34
Perineal tear: n=803 n=804   
 Episiotomy (without tear) 234 (29.3) 246 (30.6) 0.95 (0.82 to 1.11) 0.52
 Obstetrical anal sphincter injuries 28 (3.5) 31 (3.9) 0.90 (0.55 to 1.49) 0.69
 Third degree tear 15 (1.9) 19 (2.4) 0.79 (0.40 to 1.54) 0.49
 Fourth degree tear 8 (1.0) 7 (0.9) 1.14 (0.41 to 3.14) 0.80‡
 Episiotomy and third-degree tear 4 (0.5) 2 (0.3) 2.00 (0.37 to 10.90) 0.45‡
 Episiotomy and fourth degree tear 1 (0.1) 3 (0.4) 0.33 (0.03 to 3.20) 0.62‡
Maternal admission (highest level of care):     
 Intensive care 3 (0.3) 2 (0.2) 1.50 (0.25 to 8.97) 0.66‡
 Medium care 5 (0.6) 5 (0. 6) 1.00 (0.29 to 3.45) 1.00‡
 Ward 271 (30.1) 277 (30.7) 0.98 (0.85 to 1.13) 0.77
Indications for maternal admission:     
 Thromboembolic complications 0 (0.0) 0 (0.0) NA -
 Hypertensive disorders§ 5 (0.6) 14 (1.6) 0.36 (0.13 to 0.99) 0.06‡
 Postpartum blood loss 49 (5.5) 52 (5.8) 1.06 (0.72 to 1.54) 0.78
 Post-caesarean section  97 (10.8)  97 (10.8) 1.00 (0.77 to 1.31) 0.99
Pain treatment during labour: 420 (46.7) 386 (42.8) 1.09 (0.98 to 1.20) 0.10
 Remifentanil 128 (14.2) 129 (14.3) 0.99 (0.79 to 1.25) 0.95
 Pethidine/promethazine/other opiates 60 (6.7) 51 (5.7) 1.18 (0.82 to 1.69) 0.38
 Epidural anaesthesia 265 (29.4) 231 (25.6) 1.15 (0.99 to 1.33) 0.07
 Other 1 (0.1) 5 (0.6) 0.20 (0.02 to 1.71) 0.22‡
NA=not applicable.
*Defined as postpartum haemorrhage ≥1000 mL, and/or manual removal of placenta, and/or third- or fourth-
degree tears (obstetrical anal sphincter injuries), and/or intensive care admission, and/or maternal death. 
Denominator for perineal tear are vaginal deliveries only.
†Mann-Whitney U test
‡Fisher’s exact test.
§Including pre-eclampsia, and HELLP syndrome.
DISCUSSION
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This randomised controlled trial compared the effect of induction of labour at 41 weeks with 
expectant management until 42 weeks with subsequent induction if necessary, on perinatal and 
maternal outcomes in women with an uncomplicated pregnancy. A policy of induction resulted in a 
median reduction in gestational age at delivery of two days. We found a 1.4% difference in composite 
adverse perinatal outcome favouring induction, although the absolute risk of severe adverse perinatal 
outcome (perinatal mortality, Apgar score <4 at five minutes, admission to a neonatal intensive care 
unit (NICU) without severe congenital anomalies) was low in both groups.
Most of our primary composite outcomes can be attributed solely to the component Apgar score <7 
at five minutes 73.3% (11/15) in the induction group v 64.3% (18/28) in the expectant management 
group), which means that these neonates did not have any other adverse outcome besides the Apgar 
score being <7 at five minutes. We performed a post hoc analysis of the composite outcome including 
Apgar scores <4 instead of <7 at five minutes owing to the American College of Obstetricians and 
Gynecologists/American Academy of Pediatrics (ACOG/AAP) mid-trial change in recommended cut-
off value for Apgar score at five minutes indicating a non-specific sign of illness. A considerably lower 
incidence of adverse perinatal outcome was found in both groups (0.4% induction and 1.3% expectant 
management), with an absolute risk difference of −0.9% (CI −1.9% to 0.2%) favouring induction, 
showing non-inferiority of expectant management with respect to the predefined margin of 2% 
(P=0.02 for non-inferiority).
Comparison with other studies
The incidence of perinatal death in our study was one after induction v two after expectant management. 
The corresponding risk ratio for perinatal death (RR 0.50, CI 0.05 to 5.51) is comparable with that of 
the four studies (n=998) starting induction at 41 weeks (n=501) versus expectant management with 
varying upper limits of gestational age (n=497) included in a Cochrane systematic review (RR 0.33, CI 
0.03 to 3.17). (16, 19, 21)
Congenital anomaly accounted for a substantial part of the NICU admissions in our trial, although it was 
an exclusion criterion at study entry. It is unknown if the outcome for these children would have been 
better if they had been born earlier, although it is unlikely (table 4). For these reasons we also analysed 
the primary composite outcome using an Apgar score <4 at five minutes and NICU admission without 
severe congenital anomalies. With these adapted adverse outcomes (perinatal mortality, Apgar score 
<4 instead of <7 at five minutes, and NICU admission without severe congenital anomalies), the 
absolute risk on the composite adverse perinatal outcome was substantially lower in both groups, 
with a still significant difference in favour of induction (0.1% (1/897)) versus expectant management 
(1.0% (9/898)): absolute risk difference −0.9%, CI −1.6% to 0.2%; P=0.01 for non-inferiority; P=0.02 for 
Fisher’s exact test; and NNT of 112 (CI 63 to 491)).
531977-L-sub01-bw-Kortekaas
Processed on: 6-6-2019 PDF page: 122
Chapter 7
122
Since in our trial all women in the 41-week induction group received obstetrician led intrapartum 
secondary care whereas in the expectant management group until 42 weeks 68.7% of the women 
received midwifery led primary care at start of labour and 34.3% at time of birth, it could be 
suggested that our study is prone to performance bias (different care) and measurement bias 
(different assessment of neonates). Several studies, however, showed that Apgar scoring does not 
differ significantly between midwives and obstetricians. (33-35) Furthermore, in our trial all neonates 
in the expectant management group with an adverse outcome were born in secondary care—the 
women had started labour in secondary care or were referred from primary to secondary care during 
labour. Various studies have shown that it is safe for low risk women in the Netherlands to deliver 
in midwifery led care, and the level of care does not seem to influence delivery outcome for these 
women. (24-28) Although this study could be considered as a comparison between obstetrician led 
care with labour induction and midwife led care with a policy of expectant management, we cannot 
adjudicate whether the difference in the composite adverse perinatal outcome is due to the level of 
care (performance bias) or to a possible difference in Apgar scoring (measurement bias). We do not, 
however, expect bias to be a major factor.
In our study, meconium aspiration syndrome occurred in two neonates in the expectant management 
group. In a randomised controlled trial with a comparable time frame, Gelisen et al reported meconium 
aspiration syndrome in 16/600 neonates of whom 12/300 were in the expectant management group. 
We found a 10- and 20-times lower rate of meconium aspiration syndrome (0.0% and 0.2% versus 1.3 
and 4%) in the induction and expectant management groups compared with the study by Gelisen et 
al. Since these authors did not specify meconium aspiration syndrome, the difference in magnitude 
could be attributed to a difference in definition. Despite this, Gelisen et al found no difference in 
NICU admissions (4.3% induction v 5.0% expectant management), which is expected to be associated 
with meconium aspiration syndrome. We found a lower rate of NICU admissions compared with the 
Cochrane systematic review on induction of labour at more than 41 weeks: 0.3% induction and 0.9% 
expectant management (INDEX trial) v 11% induction and 12% expectant management (systematic 
review). The systematic review lacked details on NICU admission, such as diagnosis, potential 
association with gestational age, or presence of congenital anomalies, which hampers a clear 
comparison. (16)
We did not find differences in caesarean section or operative vaginal delivery rates, which is consistent 
with other large studies on induction of labour. (36, 37) In the only study that compared the same 
timeframes as our study, the risk ratio for caesarean section was comparable for both groups, 
although the absolute risk was twice as high compared with that of our study. This could be due 
to other inclusion criteria (Gelisen et al, Bishop score <5) or differences in policy during labour, as 
reflected by differences in national overall caesarean rates in Turkey (53% v 16% in the Netherlands). 
(34, 38) The Cochrane systematic review concluded that induction at or beyond 41 weeks is associated 
with lower caesarean section rates. The largest contribution to this outcome was from a randomised 
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controlled trial in which women in the control group were induced only with oxytocin according to 
study protocol, whereas prostaglandin use was allowed in women with low Bishop scores in the 
induction group. (16) Two other systematic reviews including the same trial concluded that the 
difference in caesarean section rate is possibly due to the influence of this study with incomparable 
study arms. (17, 20, 39) Population based cohort studies showed conflicting results on the effect of 
induction on caesarean section rates. (40-42) In the recently published ARRIVE (A Randomized Trial of 
Induction Versus Expectant Management) trial, low risk nulliparous women were randomised in the 
39th week of pregnancy to be induced at 39.0 weeks to 39.4 weeks or to expectant management until 
41 weeks. No statistically significant difference was found in perinatal outcome (RR 0.80, CI 0.64 to 
1.00), although fewer caesarean sections took place in the induction group (18.6% v 22.2%; RR 0.84, CI 
0.76 to 0.93). Our study comprised more white women (86% v 44%), with a higher median age (30 v 24 
years) and a lower percentage of body mass index ≥30 (12% v 53%), whereas 46% of the participants 
in our study were multiparous women and ARRIVE included only nulliparous woman. Caesarean 
section rates in our nulliparous low risk women were comparable between the groups: 18.6% in the 
induction group and 18.0% in the expectant group. This could be due to the differences in gestational 
age, baseline characteristics, indication for induction of labour, or indication for a caesarean section 
(suspected foetal distress or failure to progress). (43)
Our trial had some notable results besides those for the main outcomes. Around 85% of participating 
women were of white ethnicity. The risk of perinatal mortality beyond term has been shown to be 
higher in women of South Asian, African, and Mediterranean origin compared with white women. (44) 
In our study, we were not able to assess the effect of induction in women of non-white ethnicity owing 
to the low number of women of other ethnic origin. Also, we were unable to assess the effect of age 
on adverse perinatal outcome because of the low number of participating older mothers (>35 years).
As in other studies on pregnancies at or beyond 41 weeks, most women in our study had an 
unfavourable cervix, with a Bishop score of <6 at randomisation. Although induction was planned 
one or two days after randomisation, 28.9% of the women in the induction group had a spontaneous 
onset of labour before induction started, compared with 73.7% in the expectant management group. 
Despite women with suspected or established intrauterine growth restriction being ineligible for 
inclusion in the study, the birthweight for 7% of the children was less than the 10th Dutch centile 
(61/900 induction and 62/901 expectant management), confirming the difficulty in diagnosing growth 
restricted babies at term. In the induction group, 2/61 infants had a birthweight less than the 10th 
centile and an adverse perinatal outcome: one neonate, weighing 3100 g (<10th centile), had an Apgar 
score of 6 at five minutes after operative vaginal delivery by forceps because of foetal distress. The 
other neonate, weighing 2595 g (<2.3rd centile), had an Apgar score of 6 at five minutes after caesarean 
section because of foetal distress, with an umbilical cord pH of 6.87, possibly due to hypotension of 
the mother after epidural analgesia for pain relief or multiple entanglement of the umbilical cord. In 
the expectant management group, 3/62 infants weighed less than the 10th centile at birth and had an 
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adverse perinatal outcome: one (birthweight 2945 g) was a stillbirth, one (2980 g) was admitted to the 
NICU because of a pneumothorax, and one (3040 g) had an Apgar score of 6 at five minutes that was 
attributed to pethidine use in the mother.
Strengths and limitations of this study
A major strength of our study is that it concerns a nationwide multicentre randomised controlled trial 
of a well-defined obstetrical population at low risk; the largest trial to date to compare induction of 
labour at 41 weeks with expectant management until 42 weeks.(45) No cases were lost to follow-up.
In the Netherlands, expectant management until 42 weeks is the standard of care in the low risk 
obstetrical population at 41-42 weeks according to the Dutch Obstetrical Indication List, although 
there is wide variation in practice because of women and caregiver preferences, which complicated 
inclusion.15 Not all eligible women were invited, and not all women who were asked participated, 
because of a preference for induction or expectant management. Despite this selective participation, 
our trial offers the best possible representation of pregnant women reaching 41.0 weeks in the 
Netherlands.
We are aware of some potential limitations of our trial. We chose to use a composite adverse perinatal 
outcome instead of a single outcome like perinatal mortality. We considered any major adverse 
perinatal outcome in an otherwise uncomplicated pregnancy as undesirable. It is debatable if all the 
included adverse perinatal outcomes in our composite outcome measure are relevant to identify real 
severe adverse perinatal outcome with an effect on an infant’s short term or long-term health status. 
However, if we included an Apgar score of <4 instead of <7 at five minutes, according to the ACOG/AAP 
criteria, and excluded severe congenital abnormalities, induction of labour resulted in a statistically 
significant risk reduction of 0.9%, although with a substantially lower incidence of the composite 
adverse outcome in both groups.
We chose the non-inferiority design because we did not expect the Dutch standard policy of expectant 
management in our low risk obstetrical population to be inferior to a policy of induction of labour 
but acceptable or preferable if leading to comparable outcomes. (46) It is good practice to use a 
per protocol analysis in non-inferiority trials, as an intention-to-treat analysis carries a risk of falsely 
rejecting the null hypothesis of inferiority. Because we did not reject the null hypothesis and do not 
conclude non-inferiority, we presented the intention-to-treat analyses first, since such analyses are 
more common in reports of clinical trials. We also reported the per protocol outcome of the primary 
outcome (see supplementary appendix for the other per protocol analyses).
We did not stratify randomisation by parity, because we expected a balanced allocation in both groups 
owing to the large study population. However, it did result in an imbalance between groups: 50.8% of 
nulliparous women in the induction group compared with 56.7% in the expectant management group. 
After stratifying by parity in an additional analysis, we observed similar results. A higher incidence 
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of the composite adverse perinatal outcome was seen in the nulliparity group in both the induction 
group (nulliparous 2.4% v multiparous 0.9%) and the expectant management group (nulliparous 
4.1% v multiparous 1.8%), which is in concordance with other studies. (47) Furthermore, we saw no 
interaction between parity and induction of labour or expectant management in logistic regression 
analysis.
The measurement of arterial pH is not possible in primary care, and pH measurement is no standard 
policy for uncomplicated birth in most hospitals in the Netherlands. Because of the high number of 
missing pH measurements (60-70%) and the impossibility to impute, we could not include umbilical 
artery pH in the composite outcome, which could have led to selection bias. Including the available 
data on umbilical arterial pH in the analyses, however, did not alter the results.
The results of our study can be interpreted in different ways, which might have implications for 
standard practice. If the composite outcome is interpreted straightforwardly, there is a small benefit of 
induction at 41 weeks that could justify standard induction at 41 weeks. It could be argued, however, 
that a change of policy to earlier induction, concerning roughly one fifth of all women with a singleton 
pregnancy, is too rigorous in light of the relatively low incidence of perinatal mortality, gestational 
age associated NICU admission, and Apgar score <4 at five minutes as indicator for encephalopathy. 
This could justify expectant management if women want to avoid induction. On both sides of the 
spectrum, caregivers are challenged to provide neutral, evidence-based counselling of low risk women 
in late term pregnancy on the pros and cons of induction. In a recent report by Walsh et al, women felt 
they were not offered a real choice when it came to management of their prolonged pregnancy, and 
this is confirmed by other studies; induction of labour is often presented as an inevitable next step to 
women, without information provided on alternative management strategies. (48-50)
Conclusions and policy implications
Our large trial compared induction of labour at 41 weeks with expectant management until 42 weeks 
and subsequent induction if necessary. Substantial larger trials are needed to evaluate differences 
in rare outcomes, such as perinatal mortality and NICU admission. A systematic review or individual 
participant meta-analysis on the comparison between 41 weeks and 42 weeks could then be 
performed including findings from those studies as well as those of our own study. Future research 
could also focus on long term adverse perinatal outcome of both strategies, although this requires 
long term follow-up of children. (45) In addition, a more tailored approach will need identification 
of women who could maintain pregnancy until 42 weeks or are at increased risk of adverse perinatal 
outcomes (e.g., relational model).
The incidence of late term pregnancy varies between countries because of different management 
strategies. (51) Women need to be counselled on the desired policy in late term pregnancy. In this 
trial, induction of labour at 41 weeks resulted in less overall adverse perinatal outcome than a policy 
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of expectant management until 42 weeks, although the absolute risk of severe adverse outcome 
(perinatal mortality, NICU admission, Apgar score <4 at five minutes) was low in both groups. As with 
every intervention in the natural birth process, the decision to induce labour must be made with 
caution, as the expected benefits should outweigh possible adverse effects for both mother and child. 
(52) The results of our study should be used to inform women approaching a gestational age of 41 
weeks, so they can weigh the respective outcomes and decide whether to be induced at 41 weeks or 
to continue pregnancy until 42 weeks.
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APPENDIX
Per-protocol population
Perinatal outcomes 
Induction of 
labour 
Expectant 
management
Relative risk
(95% CI)
p-value
(n=611) (n=647)
Composite adverse perinatal outcome* 10 (1.6%) 19 (2.9%) 0.56 (0.26 to 1.19) 0.13†
with Apgar score 5’ <4 instead of <7 3 (0.5%) 8 (1.2%) 0.40 (0.11 to 1.49) 0.23†
including arterial pH <7.05 19 (3.1%) 26 (4.0%) 0.40 (0.11 to 1.49) 0.15†
Stillbirth 1 (0.2%) 2 (0.3%) 0.53 (0.05 to 5.82) 1.00†
Neonatal death, post-partum 0 (0.0%) 0 (0.0%) n/a -
Apgar score 5 min. post-partum¤
<7 7 (1.1%) 16 (2.5%) 0.46 (0.19 to 1.12) 0.08
<4 0 (0.0%) 1 (0.2%) n/a -
Admission neonate to
intensive care (NICU) 2 (0.3%) 6 (0.9%) 0.35 (0.07 to 1.74) 0.51†
medium care 39 (6.4%) 48 (7.4%) 0.86 (0.57 to 1.29) 0.45
Meconium aspiration syndrome‡ 0 (0.0%) 2 (0.2%) n/a -
Plexus brachialis injury 0 (0.0%) 0 (0.0%) n/a -
Intracranial haemorrhage 0 (0.0%) 0 (0.0%) n/a -
Umbilical cord pH (arterial)
pH <7.05 11 (1.8%) 10 (1.6%) 1.12 (0.49 to 2.58) 0.79
missing 366 (59.9%) 447 (69.6%) n/c -
Congenital abnormality 11 (1.8%) 12 (1.9%) 0.97 (0.42 to 2.18) 0.94
Hypoglycaemia§ 1 (0.2%) 5 (0.8%) 0.21 (0.02 to 1.81) 0.22†
Neonatal infection / sepsis 23 (3.8%) 29 (4.5%) 0.84 (0.49 to 1.44) 0.52
Sex, female 305 (49.9%) 337 (52.1%) 0.96 (0.86 to 1.07) 0.44
Birth weight (g; mean, sd) 3,697 (414.4) 3,747 (433.5) -50.2 (-97.2 to -3.2) ** 0.04 
Small of gestational age
<2.3rd percentile 11 (1.8%) 8 (1.2%) 1.46 (0.59 to 3.60) 0.42
<10th percentile 40 (6.6%) 46 (7.1%) 0.92 (0.61 to 1.39) 0.69
Large for gestational age
>90th percentile 54 (8.8%) 74 (11.4%) 0.77 (0.55 to 1.08) 0.13
>97.7th percentile 12 (2.0%) 22 (3.4%) 0.58 (0.29 to 1.16) 0.12
Perinatal outcomes (per-protocol). Data are n (%) or mean (standard deviation). Confidence intervals are 95%. 
NICU: Neonatal Intensive Care Unit * Composite outcome defined as: perinatal mortality, and/or a 5-minute 
Apgar-score below 7, and/or meconium aspiration syndrome, and/or plexus brachialis injury, and/or intracranial 
haemorrhage, and/or NICU admission. ¤ Apgar score of the live births. † Fisher’s exact test. ‡ Defined as respiratory 
distress after birth in presence of meconium stained amniotic fluid). § Defined as glucose concentration <1.9 
mmol/L and need for intravenous glucose. ¶ Defined as clinical suspected findings, or proved positive culture. ** 
Mean difference between groups with 95% confidence interval.
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Delivery outcomes
Induction of 
labour 
Expectant 
management
Relative risk
(95% CI)
p-value
(n=611) (n=647)
Gestational age at delivery (days; 
median, IQR)
288 (287 - 288) 290 (288 - 292) -2.3 (-2.5 to -2.1) * <0.001 †
Time randomisation to delivery (days; 
mean, sd)
2.2 (1.5) 4.5 (2.9) -2.2 (-2.5 to -2.0) * <0.001 †
Level of care at onset of labour
Primary care 96 (15.7%) 474 (73.3%) n/c -
Secondary care 515 (84.3%) 173 (26.7%) n/c -
Onset of labour
Spontaneous (reference) 92 (15.1%) 524 (81.0%) 1.00 -
Induction 519 (84.9%) 123 (19.0%) 4.47 (3.80 to 5.26) <0.001
Mode of induction
cervical ripening (catheter /
prostaglandins)
304 / 519 (58.6%) 71 / 123 (57.7%) 1.01 (0.86 to 1.20) 0.86
amniotomy, without oxytocin 72 / 519 (13.9%) 12 / 123 (9.8%) 1.42 (0.80 to 2.54) 0.23
amniotomy, with oxytocin 135 / 519 (26.0%) 33 / 123 (26.8%) 0.97 (0.70 to 1.34) 0.85
Indication for induction
randomisation 519 / 519 (100%) 0 / 123 (0.0%) n/c -
post-term pregnancy 0 / 519 (0.0%) 62 / 123 (50.4%) n/c -
foetal condition 0 / 519 (0.0%) 35 / 123 (28.5%) n/c -
maternal condition 0 / 519 (0.0%) 22 / 123 (17.9%) n/c -
elective / maternal wish 0 / 519 (0.0%) 0 / 123 (0.0%) n/c -
>24 h of ruptured membranes 0 / 519 (0.0%) 4 / 123 (3.3%) n/c -
other 0 / 519 (0.0%) 0 / 123 (0.0%) n/c -
Use of oxytocin 402 (65.8%) 255 (39.4%) 1.69 (1.49 to 1.87) <0.001
Use of tocolytics 20 (3.3%) 13 (2.0%) 1.63 (0.82 to 3.25) 0.17
Maternal intrapartum infection
fever during labour (≥38 °C) 33 (5.4%) 35 (5.4%) 0.99 (0.63 to 1.59) 0.99
use of antibiotics 34 (5.6%) 22 (3.4%) 1.64 (0.97 to 2.77) 0.07
Meconium stained amniotic fluid 82 (13.4%) 163 (25.2%) 0.53 (0.42 to 0.68) 0.001
Level of care at time of birth
Primary care 44 (7.2%) 221 (34.2%) n/c -
Secondary care 567 (92.8%) 426 (65.8%) n/c -
Mode of delivery
spontaneous vaginal delivery 484 (79.2%) 493 (76.2%) 1.04 (0.98 to 1.10) 0.20
operative vaginal delivery 56 (9.2%) 80 (12.4%) 0.74 (0.54 to 1.02) 0.07
(secondary) caesarean section 71 (11.6%) 74 (11.4%) 1.02 (0.75 to 1.38) 0.92
Indication successful operative vaginal 
delivery
failure to progress at second stage 27 / 56 (48.2%) 37 / 80 (46.3%) 1.04 (0.73 to 1.49) 0.82
suspected foetal distress 24 / 56 (42.9%) 29 / 80 (36.3%) 1.18 (0.78 to 1.80) 0.43
suspected foetal distress and failure 
to progress 5 / 56 (8.9%) 14 / 80 (17.5%) 0.51 (0.19 to 1.34) 0.21‡
maternal complication or other 0 / 56 (0.0%) 0 / 80 (0.0%) n/a -
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Indication secondary caesarean section
failure to progress at first stage 27 / 71 (38.0%) 16 / 74 (21.6%) 1.76 (1.04 to 2.98) 0.04
failure to progress at second stage 8 / 71 (11.3%) 12 / 74 (16.2%) 0.69 (0.30 to 1.60) 0.39
failed OVD 3 / 71 (4.2%) 9 / 74 (12.2%) 0.35 (0.10 to 1.23) 0.13‡
suspected foetal distress 14 / 71 (19.7%) 18 / 74 (24.3%) 0.81 (0.44 to 1.50) 0.51
suspected foetal distress and failure 
to progress at first stage
3 / 71 (4.2%) 7 / 74 (9.5%) 0.45 (0.12 to 1.66) 0.33‡
suspected foetal distress and failure 
to progress at second stage 3 / 71 (4.2%) 3 / 74 (4.1%) 0.96 (0.22 to 4.99) 1.00‡
maternal complication or other 13 / 71 (18.3%) 9 / 74 (12.2%) 1.51 (0.69 to 3.30) 0.31
Delivery outcomes (per-protocol). Data are n (%), mean and standard deviation, or median (IQR). OVD: Operative 
Vaginal Delivery. * Mean difference between groups with 95% confidence interval. †Mann-Whitney U test. ‡Fisher’s 
exact test.
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(Adverse) maternal outcomes
Induction of 
labour
Expectant 
management
Relative risk
(95% CI)
p-value
(n=611) (n=647)
Composite adverse maternal outcome* 84 (13.7%) 75 (11.6%) 1.19 (0.89 to 1.59) 0.25
Maternal death 0 (0.0%) 0 (0.0%) n/a -
Post-partum blood loss
< 1000 mL (reference) 552 (90.3%) 592 (91.5%) 1.00 -
≥ 1000 mL 59 (9.7%) 55 (8.5%) 1.14 (0.80 to 1.61) 0.48
1000-1500 mL 23 (3.8%) 27 (4.2%) 0.92 (0.53 to 1.58) 0.76
>1500-2000 mL 15 (2.5%) 10 (1.6%) 1.59 (0.72 to 3.52) 0.25
> 2000 mL 21 (3.4%) 18 (2.8%) 1.24 (0.67 to 2.31) 0.49
Post-partum blood loss (mL; median, 
IQR)
300 (200 – 500) 300 (250 – 500) - 0.18†
Transfusion (packed cells or plasma) 18 (2.9%) 13 (2.0%) 1.47 (0.72 to 2.97) 0.29
Manual removal placenta 29 (5.4%) 26 (4.5 %) 1.18 (0.71 to 1.98) 0.52
Perineal tear
episiotomy (without tear) 150 / 540 (27.8%) 181 / 573 (31.6%) 0.88 (0.73 to 1.05) 0.17
OASIS 16 / 540 (3.0%) 21 / 573 (3.7%) 0.81 (0.43 to 1.53) 0.51
third degree tear 10 / 540 (1.9%) 14 / 573 (2.4%) 0.79 (0.40 to 1.55) 0.49
fourth degree tear 5 / 540 (0.9%) 5 / 573 (0.9%) 1.06 (0.31 to 3.64) 1.00‡
episiotomy and third-degree tear 0 / 540 (0.0%) 1 / 573 (0.2%) - -
episiotomy and fourth degree tear 1 / 540 (0.2%) 1 / 573 (0.2%) 1.06 (0.07 to 16.92) 1.00‡
Maternal admission (highest level of 
care)
intensive care 3 (0.5%) 2 (0.3%) 1.59 (0.27 to 9.47) 0.61‡
medium care 4 (0.7%) 4 (0.6%) 1.06 (0.27 to 4.22) 1.00‡
ward 196 (32.1%) 209 (32.3%) 0.99 (0.85 to 1.17) 0.93
Indications for maternal admission
Thromboembolic complications 0 (0.0%) 0 (0.0%) n/a -
Hypertensive disorders§ 3 (0.5%) 13 (2.0%) 0.24 (0.07 to 0.85) 0.02‡
Post-partum blood loss 34 (5.6%) 40 (6.2%) 0.90 (0.58 to 1.40) 0.64
Post-caesarean 71 (11.6%) 74 (11.4%) 1.02 (0.75 to 1.38) 0.92
Pain treatment during labour 309 (50.6%) 278 (43.0%) 1.18 (1.05 to 1.33) 0.007
Remifentanil 93 (15.2%) 89 (13.8%) 1.11 (0.85 to 1.45) 0.46
Pethidine / promethazine / other 
opiates 47 (7.7%) 33 (5.1%) 1.51 (0.98 to 2.32) 0.06
Epidural / spinal 194 (31.4%) 173 (26.6%) 1.19 (1.00 to 1.41) 0.05
Others 1 (0.2%) 4 (0.6%) 0.26 (0.03 to 2.36) 0.38‡
(Adverse) maternal outcomes (per-protocol). *Defined as post-partum haemorrhage ≥ 1000 mL, and/or manual 
removal of placenta, and/or third- or fourth-degree tears (Obstetrical Anal Sphincter Injuries, OASIS), and/or 
intensive care admission, and/or maternal death. Denominator for perineal tear are vaginal deliveries only. †Mann 
Whitney U test. ‡Fisher’s exact test. §Including (pre-)eclampsia, and HELLP syndrome.
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This thesis describes the foetal and maternal risks in late-term and post-term pregnancy and provides 
evidence for obstetric caregivers in midwifery- and obstetrician-led care to design guidelines on 
management in late- and post-term pregnancies in collaboration with patients. Preferably, the 
described risks in our studies are incorporated in national guidelines and local protocols first, before 
they are used clinically in the counselling of the individual woman with a late-term pregnancy.
CURRENT PROBLEM
Existing international guidelines on management of late-term pregnancy are predominantly based on 
the Cochrane review on ‘induction of labour for improving birth outcomes for women at or beyond 
term’ by Gülmezoglu (2012) and updated by Middleton (2018). (1, 2) The authors of this systematic 
review conclude that an induction at 41.0 weeks improves perinatal and maternal outcomes, though 
the absolute risk on perinatal death is small and the optimal timing of offering induction of women at 
or beyond term needs further investigation, including exploration of risk profiles and preferences. (1) 
However, the results of this review should be interpreted with caution as the conclusion is based on 
heterogenous studies, including studies with a comparison outside the 41/42 timeframe. (3) The risks 
in late- and post-term pregnancy and the recommendation in the Cochrane review are interpreted 
differently by caregivers between and within countries, resulting in different national guidelines. This 
reflects the differences in risk perception of the professionals in charge with guideline development. 
(4-10) All international guidelines state that induction of labour between 41 and 42 weeks should be 
offered to women. Some countries define categories of women with increased risk of adverse perinatal 
outcomes from 41 weeks onwards, such as obesity (BMI>25), gestational diabetes, or maternal age >38 
years, in which case induction of labour should be advised. (7, 9) Midwives from midwifery-led care 
refer annually around 25,000 women to obstetrician-led care for an antenatal late- term pregnancy 
consultation. (11) All guidelines imply but do not explicitly describe that maternal and foetal wellbeing 
should be assessed in late-term pregnancy. Most guidelines advise to provide a foetal non-stress test 
(e.g. CTG) and assessment of foetal weight and/ or amniotic fluid. Some guidelines advise to induce 
labour when the estimated foetal weight is <2.5th percentile or the single deepest pocket of amniotic 
fluid is <2cm. (7) Despite all these guidelines, there has been a shift in policy towards earlier induction 
of labour. A recent trial performed in the United States showed that induction of labour at 39 weeks 
in low-risk nulliparous women did not result in less composite adverse perinatal outcomes, but in a 
significantly lower frequency of caesarean section (18.6% versus 22.2%). (12) However, the included 
pregnant women in this study do not reflect the Dutch population as they were nulliparous, around 
45% were of white ethnicity and had median BMI of 30.5. The risk of caesarean section in nulliparous 
women in the Netherlands is substantially lower (15.8%) than in the United States (30.8%). (13, 14) 
Despite the mentioned differences, the results of this trial could also lead to a change in policy in the 
Netherlands for women with a request of being induced before 41 weeks of gestation.
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Caregivers also perceive risks differently. In the Netherlands, obstetric care is provided by midwives 
in midwifery-led care and by obstetricians and clinically working midwives in obstetrician-led care as 
stated before, and is considered as safe when adequate risk selection is performed. (15-19) Midwifery-
led care is also practised in countries like Australia, Canada, Ireland and the United Kingdom. Previous 
studies have shown that women in midwifery-led care are less likely to experience an intervention 
during childbirth and are more likely to be satisfied with their care. (20) There are no differences in 
adverse outcomes in comparison to women who received other models of care. (20) By performing 
late-term pregnancy consultations, caregivers try to differentiate between physiological and 
pathological post-term pregnancies. A late-term pregnancy consultation consists of history taking, 
blood pressure measurement, foetal ultrasound and CTG monitoring to assess maternal and foetal 
wellbeing. Before counselling on the management strategy to follow, caregivers should make an 
individualised risk assessment based on factors like ethnicity, maternal age, social background and 
presence of substandard factors in these late-term women. (21-23) Women reaching 41.0 weeks can 
decide whether or not they would like to undergo induction of labour. Their decision is based on 
the assessment of maternal and foetal wellbeing during the late-term pregnancy consultation, on 
information in factsheets or choice models based on (international) research, on her own preferences 
on giving birth and on their way of life. (8, 10)
INTERPRETATION OF THE RESULTS 
Multiparous women who delivered post-term in their first pregnancy, have a higher risk on a recurrent 
post-term delivery (15% vs. 4%). Multiparous women who have a de novo post-term delivery do not 
have an increased risk on adverse pregnancy outcomes in comparison to multiparous women who 
have a recurrent post-term pregnancy (chapter 2). (24) Women aged ≥35 years have an increased risk 
on adverse perinatal and maternal outcomes in comparison to women aged 18-34. The influence of 
gestational age on an adverse perinatal outcome is higher than increasing maternal age. Women aged 
≥40 years could therefore possibly benefit from induction of labour before 41.0 weeks, though more 
studies need to be performed to confirm this. (25) The absolute risk on foetal death in women aged ≥35 
years remains low (chapter 3). When women ≥41.0 weeks experience a decrease in foetal movement, 
adequate action (e.g. induction) should be taken. When a CTG is performed, the CTG interpretation 
and documentation should be performed according to the guideline ‘foetal monitoring’, to identify 
possible signs of asphyxia in time (chapter 4). (22) When women with uncomplicated pregnancies 
reach 41.0 weeks of gestation, they should be informed that there are different management 
strategies between obstetric caregivers in timing, frequency and content of late-term pregnancy 
consultations and on timing of induction of labour in the Netherlands (chapter 5). (26) When an 
intervention is intended, like induction of labour, women should be counselled on the possible risks 
and benefits. Benefits of inducing labour at 41.0 weeks in our trial were the significant decrease in 
risk of the composite adverse perinatal outcome (stillbirth, 5-minute Apgar Score <7, NICU admission 
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and meconium aspiration syndrome) from 3.1% in the expectant management (EM) group to 1.7% in 
the induction of labour (IOL) group. Also, a significant decrease in the risk of serious adverse perinatal 
outcome (stillbirth, 5-minute Apgar Score<4 and NICU without congenital anomalies) was found (1.0% 
versus 0.1%). (27) The risks on caesarean section or post-partum haemorrhage (≥1000ml) were not 
increased in our trial nor in more recent trials as previously described. (1, 12, 21, 28, 29) The benefits 
of expectant management are less usage of oxytocin (39.4% vs 59.2%) and more often a birth without 
medical intervention in midwifery-led care (14.3% versus 34.3%). In our low risk women, the risk of a 
good pregnancy outcome is high in both groups (chapter 6 and 7). (27) 
IMPLICATIONS FOR CLINICAL PRACTICE
 
While awaiting all other INDEX project studies (cohort, patient preferences, cost effectiveness) and in 
the absence of a new multidisciplinary guideline on late- and post-term pregnancy, women will need 
to be informed about two possible strategies. 
1)  Induction of labour at 41.0 weeks.
When women are induced at 41.0 weeks, there is an absolute lower risk on adverse perinatal outcome 
(1.7%), without an increase in adverse maternal outcomes or risk of caesarean section. On the other 
hand, women are not able to deliver with their own midwife (at home). Midwives will therefore not 
be able to guide women through their whole pregnancy, and they would not receive payment for 
performing a delivery. 
2 ) Expectant management until 42.0 weeks.
When following expectant management until 42.0 weeks, there is an absolute higher risk on an adverse 
perinatal outcome (3.1%) without an increase in adverse maternal outcomes or risk of caesarean 
section with a high chance on a spontaneous onset of labour. To stimulate a spontaneous onset of 
labour, membranes can be swept in midwifery- and obstetrician-led care, in order to significantly 
reduce the number of post-term pregnancies.(30) Most women start labour with their own midwife in 
their own home. Women should be counselled during the late-term pregnancy consultation whether 
or not extra consultations are needed. Since there is no high level of supporting evidence on the 
content and effect of monitoring during the 41-42-week period, further (prospective) research is 
needed on the effects of different monitoring strategies in late term pregnancy. 
In the meantime, practice variation will continue to exist with regional differences in management 
strategies. Developers of a new multidisciplinary guideline for management of late-term pregnancy 
should take the results of our studies into account. (8, 10) Historically, both levels of care approach 
pregnancy in a different way. In midwifery-led care, midwives consider themselves as specialist in the 
physiological birth process and refer when pathology arises. (31) In obstetrician-led care, residents 
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are also educated on the physiology of pregnancy and birth, but they are trained to detect and treat 
pathology during pregnancy, delivery and the puerperium. (32) Another challenge could be the 
implementation of integrative care in low-risk women receiving an induction. Induction of labour is 
performed in obstetrician-led care. If a late-term, low-risk woman makes her well-informed decision 
to receive induction of labour at 41.0 weeks, she would possibly benefit by being supported during 
induction by her own midwife (from midwifery-led care) in an obstetrician-led care setting. If an 
increase of induction of labour at 41.0 weeks is occurs, obstetric caregivers in obstetrician-led care 
will possibly have to change their capacity and induction policy on the labour wards, to handle the 
extra inductions. In some regions in the Netherlands there is already a capacity problem on the labour 
wards. These extra inductions should be implemented without compromising the women’s safety 
because of a lack of capacity (labour wards/ obstetric caregivers (obstetric nurses/ clinical midwives/ 
gynaecologists)) for high risk women in need of specialist care. One of the other challenges in the 
Netherlands will be to let the cooperation of midwives, obstetricians and paediatricians work together 
to create a new guideline on which all levels of care agree on the information provided to women and 
on management of late-term pregnancy. (33) Their challenge is to deal with possible differences in risk 
perception on caregiver-level and to provide neutral information for women and their partners to be 
able to take the decision that fits best with their risk perception, preferences and way of life. 
FUTURE RESEARCH
Secondary analyses will be performed on data derived from the INDEXtrial. A prospective cohort was 
formed from women who did not give informed consent (n=4,273). Information on these women 
has been collected alongside the trial and will be analysed separately. In addition to the cohort, 
questionnaires on women’s preferences and experiences, as well as pain and anxiety scores were 
collected alongside the trial. A secondary analysis on the data from the INDEX RCT will be performed 
on care level, parity and advanced maternal age. Also, an assessment will be made of baseline 
characteristics as possible risk factors for an adverse event. In addition, a cost-effectiveness analysis 
will be performed as has been performed in previous consortium studies. (34)
During the execution of the INDEX trial in the Netherlands, the SWEPIS trial started in Sweden. This 
randomised controlled trial also compares induction of labour at 41 weeks vs expectant management 
and induction at 42 weeks. They plan to include 10,038 healthy women, with a singleton pregnancy in 
cephalic position at 41 weeks for induction at 41 weeks (early induction) versus induction at 42 weeks 
(late induction) with a primary outcome containing a composite of stillbirth, neonatal mortality and 
severe neonatal morbidity defined as AS5’<7, umbilical cord pH<7.05 and base deficit >12mmol/L 
or pH<7.00 to detect metabolic acidosis, HIE 1-3, intracranial haemorrhage, neonatal convulsion, 
meconium aspiration syndrome, mechanical ventilation, obstetric plexus brachialis injury to detect 
a 0.9% reduction (from 2.74% to 1.84%) in primary outcome. (35) The results of this trial can be 
used to supplement the results from our trial, though they used a slightly different primary outcome. 
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Individual patient data can be combined to perform an IPD analysis and possibly detect a difference 
in more rare outcomes.
CONCLUSION
A national multi-disciplinary guideline concerning late- and post-term pregnancy should be made 
based on outcomes, preferences, risk factors and costs, containing understandable information for 
women and caregivers to individualise the management strategy in late- and post-term pregnancy. In 
the end, women will make their own choice, based on neutral information and their risk perception 
and preferences. 
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SUMMARY 
In this thesis, we describe the research that we have performed in the INDEX project. The focus of this 
thesis is on risks and management in late-term pregnancy.
In chapter 1 we address the background of pregnancy dating, using definitions of term (37.0-40.6 
weeks), late-term (41.0-41.6 weeks) and post-term (≥42.0 weeks) pregnancy and describe the recording 
of all pregnancy outcomes in the Perined database. We explain the Dutch obstetric care situation with 
its division into midwifery-led care and obstetrician-led care. Women with a low-risk pregnancy and/
or delivery receive midwifery-led care. Women with a high-risk pregnancy and/or delivery receive 
obstetrician-led care. Most late- and post-term pregnancies occur because of biological variation. In 
only a small number of these pregnancies, there is a reduced placental function, which can lead to an 
increased risk on an adverse pregnancy outcome. However, it is still difficult to assess which women 
are at risk on these adverse outcomes. We make clear that there is uncertainty regarding management 
of low- risk women reaching late-term pregnancy. Finally, we provide the aim and outline of this thesis.
In chapter 2 and chapter 3, we used data from the Perined database. In chapter 2 we assessed the 
recurrence rate of post-term delivery and determined perinatal outcomes in women with a recurrent 
post-term delivery and a de novo post-term delivery. In the first pregnancy, 7.7% delivered post-term. 
In the second pregnancy, 15% had a recurrent post-term delivery in comparison to 4% with a de novo 
post-term delivery. There were no differences in composite adverse perinatal and maternal outcomes 
and the absolute risk of antenatal death was low. In chapter 3 we assessed the influence of maternal 
age on adverse perinatal and maternal outcomes in late- and post-term pregnancies. Low-risk women 
aged 35-39 and aged ≥40 had a higher risk on adverse perinatal outcomes and adverse maternal 
outcomes in comparison to women aged 18-34. Increasing gestational age contributes more to the 
risk of an adverse perinatal or maternal outcome than maternal age. Women aged ≥40 years could 
possibly benefit from induction before 41 weeks of gestation.
In chapter 4, we evaluated causes of death and substandard factors in term and post-term perinatal 
death. In order to perform this study, we used data of a three year time period from the Perinatal 
Audit Registry of the Netherlands (PARS). 598 women suffered from an early-/full-term perinatal 
death (37.0-40.6) and 109 from a late-/post-term death (≥41.0). In early-/ full-term pregnancy, more 
antepartum death occurred in comparison to late-/post-term pregnancy (55.2% vs 42.2%). In late-/
post-term pregnancy more intrapartum death occurred in comparison to early-/full-term pregnancy 
(19.3% vs 7.2%). Also cause of death and substandard factors (SSFs) as determined by the local 
perinatal audit group in pregnancies ≥41.0 weeks were explored. The most relevant cause of perinatal 
death in pregnancies ≥41.0 are asphyxia (antepartum 7.3%, intrapartum 9.2% and neonatal 10.1%) 
and placental insufficiency in 10.1%. Most frequent reported SSFs are inadequate cardiotocography 
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(CTG) evaluation and/or classification (10.1%), incomplete CTG registration or documentation in 
medical files (4.6%) or inadequate action on decreased foetal movements (4.6%).
In chapter 5, we explored current management in Dutch obstetric caregivers in late-term pregnancy 
by performing two nationwide surveys in both levels of care. Nearly all midwifery practices (93%) 
refer low-risk women for a consultation to obstetrician-led care. Frequency, content and timing of 
these late-term pregnancy consultations vary between hospitals. Timing of induction of labour varies 
between hospitals. Women in obstetrician-led care are more often offered to be induced at 41.00 
weeks than women in midwifery-led care (21% vs 3%). Women in midwifery-led care are more often 
offered to have their membranes swept in comparison to women in obstetrician-led care (90 vs 31%). 
In chapter 6, we wrote the outline of the INDEX trial: INDuction of labour at 41 weeks versus EXpectant 
management until 42 weeks in low-risk women. Our trial was an open label, randomised controlled 
non-inferiority trial. Women were counselled in participating midwifery practices or hospitals to be 
randomised between induction of labour at 41 weeks (IOL) or expectant management until 42 weeks 
(EM). Primary outcome was a composite of perinatal mortality and neonatal morbidity (Apgar score <7 
at five minutes, arterial pH <7.05, meconium aspiration syndrome, plexus brachialis injury, intracranial 
haemorrhage, and admission to a neonatal intensive care unit (NICU). Secondary outcomes included 
maternal outcomes and mode of delivery. Based on a non-inferiority margin of 2% risk difference 
(from an expected 3% occurrence of the primary outcome in the expectant management group), an 
α of 0.05 and a β ≥ 0.80 we calculated that we had to include 900 women in each trial arm. The first 
randomisation was done at 14th may 2012. The last randomisation was done at 12th March 2016.
In chapter 7 we present the results of the INDEX trial. In total 1801 women were analysed in the trial, 
most of them (94%) were randomised in midwifery-led care. Median gestational age at delivery was 
41.0 (interquartile range 41.0 - 41.1) for the induction group and 41.2 (41.0 – 41.5) for the expectant 
management group. In the IOL group, 28.9% (260/900) and in the EM group 73.7% (664/901) of the 
women had a spontaneous onset of labour before the planned induction. The primary outcome was 
according to the intention-to-treat principle. In the induction group, 1.7% (15/900) women had an 
adverse perinatal outcome versus 3.1% (28/901) in the expectant management group (absolute risk 
difference −1.4%, 95% confidence interval −2.9% to 0.0%, P=0.22 for non-inferiority). When the Fisher 
exact test is performed on the primary outcome, a significant difference was found, favouring the 
IOL group (relative risk 0.54, 95% confidence interval 0.29-1.00, p=0.045). One foetal death (0.1%) 
occurred in the IOL group and two (0.2%) in the EM group. No neonatal deaths occurred. Most 
contributable factor to the CAPO is the 5-minute Apgar Score<7. During the trial, the American College 
of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP) released a new 
statement on perinatal asphyxia, stating that the 5-minute Apgar Score <4 indicates a non-specific 
sign of illness and that 5-minute Apgar Score <7 should not be used (anymore) in research as a proxy 
for perinatal asphyxia. When we change our 5-minute Apgar Score <7 into 5-minute Apgar Score <4 
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in the primary outcome, we found 0.4% (4/900) in IOL group and 1.3% (12/901) in the EM group 
(absolute risk difference −0.9%, −1.9% to 0.2%; number needed to treat 113, 57 to 4624, P=0.02 for 
non-inferiority). NICU admittance was reported in 0.3% (3/899) of neonates in the IOL group versus 
0.9% (8/899) in the EM group (relative risk 0.38, 95% confidence interval 0.10 to 1.41). From the 
children admitted to the NICU, 6 children had a congenital disorder that would have resulted in an 
admittance, despite the gestational age. When we excluded these 6 children with a congenital disorder 
and then recalculate the CAPO with 5-minute Apgar Score <4, we found 0.1% (1/897) in the IOL group 
versus 1.0% (9/898) in the EM group (absolute risk difference −0.9%, 95% confidence interval −1.6% to 
0.2%; P=0.01 for non-inferiority; P=0.02 for Fisher’s exact test; and number needed to treat 112 (95% 
confidence interval 63 to 491)). There were no significant differences found in any maternal outcome: 
The composite adverse maternal outcome occurred in 13.6% (122/900) of the women in the induction 
group versus 11.3% (102/901) in the expectant management group (Relative Risk 1.20, confidence 
interval 0.94 to 1.53). Rate of caesarean section (10.8% IOL vs 10.8% EM) or postpartum haemorrhage 
≥1000ml (9.1% IOL vs 8.0% EM) did not differ significantly. The results of our trial should be used to 
inform women approaching a gestational age of 41 weeks, so they can weigh the respective outcomes 
and decide whether to be induced at 41 weeks or to continue pregnancy until 42 weeks.
In Chapter 8, we discuss the main outcomes of our studies. We describe the importance of creating 
a new multidisciplinary guideline on management of late-term pregnancy in low-risk women based 
on our completed and future studies and we describe possible risks in late-term pregnancy and the 
interpretation of these risks by caregivers and women. 
Rate of caesarean section (10.8% IOL vs 10.8% EM) or postpartum haemorrhage ≥1000ml (9.1% 
IOL vs 8.0% EM) did not differ significantly. The results of our trial should be used to inform women 
approaching a gestational age of 41 weeks, so they can weigh the respective outcomes and decide 
whether to be induced at 41 weeks or to continue pregnancy until 42 weeks.
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SAMENVATTING
In dit proefschrift worden de risico’s en het beleid beschreven in de laat-terme periode (e.g. 
zwangerschapsduur tussen 41-42 weken). Het proefschrift bevat de beschrijving van een aantal 
onderzoeken die verricht zijn binnen het kader van het INDEX-project. 
In hoofdstuk 1 wordt de termijnindeling van zwangerschappen besproken met bijbehorende definities 
van de begrippen ‘a terme’ (37.0-40.6 weken), ‘laat- terme’ (41.0-41.6 weken) en ‘serotiene’ (≥42.0 
weken) zwangerschappen en wordt beschreven hoe gegevens van zwangerschappen worden verzameld 
in de Perined database. Er wordt een toelichting gegeven op het Nederlandse verloskundige systeem, 
waarin de zorg voor de laagrisico zwangerschap en baring is ondergebracht bij de ‘eerstelijn’ en bij 
de ‘tweedelijn’ indien er sprake is van een zwangerschap en/of baring met een verhoogd risico op 
een slechte uitkomst bij moeder en/of kind. Bij de meeste zwangerschappen die ‘over tijd’ lopen is er 
sprake van biologische variatie, een klein aantal vrouwen heeft een verslechterende placentafunctie 
in de laat-terme periode waardoor ze at risk zijn voor een slechte uitkomst van de zwangerschap. Het 
is echter momenteel nog niet goed mogelijk om te voorspellen welke vrouwen dit verhoogde risico 
hebben. Er is geen eenduidig bewijs voor het te voeren beleid bij laat-terme zwangere vrouwen. Het 
hoofdstuk wordt afgesloten met het doel en de opbouw van dit proefschrift. 
In hoofdstuk 2 en hoofdstuk 3 wordt onderzoek beschreven met data uit de Perined database. 
In hoofdstuk 2 is de kans op een herhaalde serotiene zwangerschap bepaald en zijn de 
zwangerschapsuitkomsten geanalyseerd van vrouwen met een herhaalde serotiene zwangerschap 
of een ‘de novo’ serotiene zwangerschap. In de eerste zwangerschap, beviel 7.7% van de vrouwen 
serotien. In de tweede zwangerschap beviel 15% van dezelfde groep opnieuw serotien. Slechts 4% 
van de vrouwen die in de eerste zwangerschap ‘a terme’ was bevallen, beviel nu serotien. Er werden 
geen verschillen gevonden in ongunstige perinatale- en maternale uitkomsten en het absolute 
risico op sterfte was klein. In hoofdstuk 3 wordt de invloed van de maternale leeftijd beschreven op 
ongunstige perinatale- en maternale uitkomsten in laat-terme en serotiene zwangerschappen. Laag 
risico vrouwen met een leeftijd van 35-39 en ≥40 jaar hadden een hoger risico op deze ongunstige 
zwangerschapsuitkomsten (zoals sterfte van het kind of lage Apgar Score) in vergelijking met vrouwen 
in de leeftijd van 18-34 jaar. Het toenemen van de zwangerschapsduur draagt meer bij aan het 
totale risico op een ongunstige perinatale- of maternale uitkomst dan een toenemende maternale 
leeftijd. Zwangere vrouwen ≥40 jaar hebben mogelijk voordeel van een inleiding voor 41 weken 
zwangerschapsduur. 
In hoofdstuk 4 worden de oorzaken van perinatale sterfte en bijbehorende substandaard zorgfactoren 
besproken in casus met een a terme en serotiene perinatale sterfte. Data van drie jaar Perinatale Audit 
Registratie (PARS) werd gebruikt om de studie uit te voeren. Er waren 598 casus van een terme (37.0-
40.6 weken) perinatale sterfte en 109 casus met een laat-terme of serotiene (≥41.0 weken) perinatale 
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sterfte. Antepartum sterfte kwam vaker voor in zwangerschappen met een a-terme sterfte dan in 
zwangerschappen met een laat-terme of serotiene sterfte (55.2% vs 42.2%). Intrapartum sterfte kwam 
vaker voor in zwangerschappen met een laat-terme of serotiene sterfte dan in zwangerschappen 
met een a-terme sterfte (19.3% vs 7.2%). De oorzaken van sterfte in zwangerschappen ≥41.0 weken 
en bijbehorende substandaard factoren zoals aangegeven door de lokale perinatale audit teams, 
zijn nader bekeken en gecategoriseerd. Antepartum, intrapartum en neonatale asfyxie waren de 
meest relevante oorzaak voor perinatale sterfte ≥41.0 weken (7.3%, 9.2% en 10.1% respectievelijk). 
Placentaire insufficiëntie werd in 10.1% benoemd als meest relevante oorzaak van de perinatale sterfte 
≥41.0 weken. De meest gerapporteerde substandaard factoren zijn ‘inadequate cardiotocografie 
(CTG) evaluatie en/ of classificatie’ (10.1%), ‘incomplete CTG registratie of documentatie in medische 
dossiers’ (4.6%) of ‘inadequate actie op het ‘minder leven’ voelen’ (4.6%).
In hoofdstuk 5 wordt het huidige gevoerde beleid door Nederlandse verloskundig hulpverleners in 
de laat-terme zwangerschappen besproken. De data werd verkregen uit twee nationale enquêtes 
in zowel de eerste- als tweedelijn. Van alle responderende verloskundige praktijken (eerstelijn) 
verwijst 93% laag-risico zwangere vrouwen voor een consult naar de tweedelijn in de laat-terme 
periode. De frequentie, inhoud en zwangerschapsduur waarop dit consult plaatsvindt, varieert tussen 
ziekenhuizen. Er zijn zowel verschillen in beleid binnen de beroepsgroepen van gynaecologen en 
verloskundigen als tussen de beroepsgroepen. Zo varieert de zwangerschapsduur waarbij de inleiding 
vanwege (naderende) ‘serotiniteit’ wordt afgesproken tussen ziekenhuizen. Zwangere vrouwen die 
reeds tijdens hun zwangerschap in de tweedelijn worden begeleid, worden vaker ingeleid bij 41.0 
weken dan vrouwen die tijdens hun zwangerschap in de eerstelijn worden begeleid (21% vs 3%). Bij 
vrouwen in de eerstelijnszorg worden vaker de vliezen gestript dan bij vrouwen in de tweedelijns zorg 
(90% vs 31%). 
In hoofdstuk 6 wordt het studieprotocol van de INDEX-trial besproken. INDEX is een acroniem voor 
‘INDuction‘ (inleiding) en ‘EXpectant management’ (afwachtend beleid). Het betreft een onderzoek naar 
het ‘Inleiden van de bevalling bij 41 weken zwangerschap versus een expectatief beleid tot 42 weken 
in laag- risico zwangere vrouwen’. Deze trial was opgezet als een open-label, gerandomiseerde, non-
inferority trial waarvoor laag-risico vrouwen die voldeden aan de inclusiecriteria in de deelnemende 
verloskundigenpraktijken of ziekenhuizen gecounseld zouden worden. Randomisatie tussen inleiding 
bij 41 weken (inleidgroep) of een expectatief beleid tot 42 weken zou plaatsvinden na het geven van 
toestemming. De primaire uitkomst was samengesteld uit perinatale sterfte en neonatale morbiditeit 
(Apgar score <7 na vijf minuten, arteriële pH<7.05, meconium aspiratiesyndroom, plexus brachialis 
laesie, intracraniële bloeding en opname op een neonatale intensive care unit (NICU). De secundaire 
uitkomst bestond onder andere uit maternale uitkomsten en de modus partus. Op basis van een 
non-inferiority grens van 2% risicoverschil (ten opzichte van de te verwachten 3% voorkomen van 
de primaire uitkomst in de afwachtgroep), een α van 0.05 en een β ≥ 0.80 werd berekend dat er 900 
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vrouwen in elke trial arm geïncludeerd dienden te worden. De eerste randomisatie werd gedaan op 14 
mei 2012. De laatste randomisatie werd gedaan op 12 maart 2016. 
In hoofdstuk 7 worden de resultaten van de INDEX trial besproken. In totaal werden er 1815 vrouwen 
gerandomiseerd en 1801 vrouwen geanalyseerd. Het grootste deel van de vrouwen (94%) werd 
door de eerstelijn gerandomiseerd. De mediane zwangerschapsduur bij de partus was 41.0 weken 
(interkwartielafstand 41.0-41.1 weken) in de inleidgroep en 41.2 weken (interkwartielafstand 41.0-
41.5 weken) in de afwachtgroep. In de inleidgroep raakte 28.9% (260/900) spontaan in partu voor 
de geplande datum van inleiding versus 73.7% (664/901) in de afwachtgroep. Analyse vond plaats 
volgens het ‘intention to treat’ principe. In de inleidgroep had 1.7% (15/900) van de vrouwen een 
ongunstige perinatale uitkomst in vergelijking met 3.1% (28/901) in de afwachtgroep (absolute 
risicoverschil −1.4%, 95% betrouwbaarheidsinterval −2.9% tot 0.0%, p=0.22 voor non-inferiority). Er 
werd er een significant verschil gevonden in het voordeel van de inleidgroep (relatieve risico 0.54, 95% 
betrouwbaarheidsinterval 0.29-1.00, p=0.045). Er vond een foetale sterfte (0.1%) plaats in de inleidgroep 
en twee (0.2%) in de afwachtgroep. Er was geen neonatale sterfte in beide groepen. De Apgar score 
<7 na vijf minuten draagt het meeste bij aan de primaire uitkomst. Tijdens de looptijd van de trial 
publiceerde de American College of Obstetricians and Gynecologists (ACOG) en de American Academy 
of Pediatrics (AAP) een opiniestuk over het gebruik van de Apgar score als uitkomstmaat voor perinatale 
asfyxie in wetenschappelijk onderzoek. Zij stellen dat een Apgar score <4 na vijf minuten een betere 
maat is voor een klinisch relevante perinatale asfyxie en dat de Apgar score <7 na vijf minuten dus niet 
meer gebruikt zou mogen worden als een proxy voor perinatale asfyxie. Als we in onze primaire uitkomst 
de Apgar score <7 na vijf minuten vervangen door de Apgar score <4 dan komt de ongunstige uitkomst 
voor in 0.4% (4/900) in de inleidgroep en 1.3% (12/901) in de afwachtgroep (absolute risico verschil 
−0.9%, −1.9% tot 0.2%; number needed to treat 113, 57 tot 4624, p=0.02 voor non-inferiority). NICU 
opname werd gerapporteerd in 0.3% (3/899) van de kinderen in de inleidgroep versus 0.9% (8/899) in de 
afwachtgroep (relatieve risico 0.38, 95% betrouwbaarheidsinterval 0.10 tot 1.41). Van de 11 kinderen die 
opgenomen werden op de NICU hadden 6 kinderen een congenitale afwijking die, los van de termijn, zou 
resulteren in een opname op een NICU. Als we deze 6 kinderen met een congenitale afwijking excluderen 
en de primaire uitkomst berekenen met ook de Apgar score <4 na 5 minuten zien we deze ‘zeer slechte’ 
uitkomst nog in 0.1% (1/897) in de inleidgroep en 1.0% (9/898) in de afwachtgroep (absolute risico 
verschil −0.9%, 95% betrouwbaarheidsinterval −1.6% tot 0.2%; p=0.01 voor non-inferiority; p=0.02 
voor Fisher’s exact test; en number needed to treat 112 (95% betrouwbaarheidsinterval 63 tot 491)). 
Er werden geen significante verschillen gevonden in maternale uitkomsten. De ongunstige maternale 
uitkomst gebeurde in 13.6% (122/900) van de vrouwen in de inleidgroep versus 11.3% (102/901) in de 
afwachtgroep (Relatief Risico 1.20, betrouwbaarheidsinterval 0.94 tot 1.53). Er waren geen significante 
verschillen in het aantal sectio’s (10.8% inleidgroep vs 10.8% afwachtgroep) of postpartum bloedverlies 
≥1000ml (9.1% inleidgroep vs 8.0% afwachtgroep) tussen beide groepen. De resultaten van onze studie 
zouden gebruikt moeten worden om vrouwen te informeren over de uitkomsten, waarna zij hun eigen, 
weloverwogen beslissing kunnen nemen over het te volgen beleid.
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In hoofdstuk 8 worden de hoofduitkomsten van alle studies nogmaals besproken. Daarnaast wordt 
het belang besproken van een nieuwe multidisciplinaire richtlijn over het beleid bij laat-terme 
zwangerschappen in laag-risico zwangere vrouwen. De resultaten van onze afgeronde en toekomstige 
studies kunnen hiervoor gebruikt worden. Tenslotte worden de potentiële risico’s van laat-terme 
zwangerschappen en de interpretatie van deze risico’s door hulpverleners en zwangere vrouwen 
besproken.
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ABBREVIATIONS
AMA   Advanced Maternal Age
AS   Apgar Score
CAMO  Composite Adverse Maternal Outcome
CAPO  Composite Adverse Perinatal Outcome
CS   Caesarean Section
CTG   Cardiotocography or foetal non-stress test
EDD   Estimated Due Date
EM   Expectant management
INDEX  INDuction vs EXpectant management
IOL   Induction of Labour
KNOV  Koninklijke Nederlandse Organisatie van Verloskundigen
MAS   Meconium Aspiration Syndrome
NICU   Neonatal Intensive Care Unit
NVOG  Nederlandse Vereniging voor Obstetrie en Gynaecologie
OASIS  Obstetric Anal Sphincter Injuries
OVD   Operative Vaginal Delivery
PAN   the Perinatal Audit Netherlands
PARS   Perinatal Audit Registry System
PPH   Postpartum haemorrhage
PRN   the Perinatal Registry Netherlands (now: Perined)
PRN-audit the Perinatal Audit Registry Netherlands
RCT   Randomised Controlled Trial
ReCoDe  Relevant Condition of Death
SOL   Spontaneous Onset of Labour
SSF   Substandard Factor
VIL   Verloskundigen Indicatie Lijst
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Department   Obstetrics & Gynaecology
Graduate School   Radboud Institute for Health Sciences
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Promotors   Prof. dr. F.P.H.A. Vandenbussche, Prof. dr. B.W.J. Mol
Co-promotors   Dr. J. van Dillen, Dr. E.R. de Miranda
Courses, workshops, study group & journal clubs Year ECTS*
Castle course/ ‘consortiumdagen’ 2012 1
Good Clinical Practice (GCP) course 2012 1.5
Statistics course 2014 1
Basiscursus Regelgeving en Organisatie Klinisch onderzoek (BROK) course 2015 1.5
Introduction day Radboudumc 2016 0.5
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price session 2017 0.5
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DANKWOORD
Het zit erop! Dit proefschrift heeft wat mij betreft een serotiene status gekregen. Of dat ook een 
betere kwaliteit heeft opgeleverd, laat ik aan de lezer over.
Uiteraard was dit proefschrift nooit tot stand gekomen zonder de hulp en steun van vele lieve mensen 
die mij elk op hun eigen manier hebben geïnspireerd. Voordat ik de mensen wil bedanken die voor 
mij een extra speciale betekenis hebben gehad tijdens mijn promotietraject, wil ik graag een moment 
stilstaan hoe bijzonder het is dat 1801 vrouwen hebben deelgenomen aan onze trial: omdat zij zich 
op zo’n persoonlijk en belangrijk moment in hun leven wilden laten randomiseren om zich te laten 
inleiden dan wel om  af te wachten, hebben wij dit onderzoek kunnen afronden. Ik wil graag extra 
stilstaan bij de vrouwen die tijdens deelname aan de trial een ‘ongunstige uitkomst’ hebben gehad, in 
het bijzonder de vrouwen waarvan hun kindje is overleden. 
Beste Frank, dank voor de begeleiding ‘op maat’ tijdens de afgelopen jaren en de bijsturing waar 
nodig. Het was fijn om met jou en Jeroen de vordering van het proefschrift te bespreken en dit ook als 
‘stok achter de deur’ te hebben om de deadlines te halen. 
Beste Ben Willem, fijn dat je me in 2012 als arts-onderzoeker hebt aangenomen voor de INDEX-studie. 
Ondanks de fysieke afstand bleef je wel betrokken bij de INDEX-studie en had je altijd zeer bruikbare 
tips, al dan niet in CAPSLOCK.  
Jeroen, de afgelopen jaren heb ik heel veel waardering gekregen voor jou als begeleider, zowel op 
klinisch- als op onderzoeksgebied. Als ik weer eens mijzelf ergens druk om maakte, dingen niet gingen 
zoals ik had bedacht of ik gewoon even wilde klagen: ik kon altijd bij jou terecht om zaken te relativeren 
en een plan te bedenken. Heel veel dank voor jouw bijdrage aan de voltooiing van dit proefschrift!
Lieve Esteriek, ik heb diep ontzag voor de manier waarop jij elke keer weer alle stukken minutieus 
nakeek en voorzag van feedback. Terwijl ik vaak dacht ‘het is goed zo’, had jij suggesties waardoor 
de stukken altijd beter werden. Jouw betrokkenheid, inzet en passie voor de verloskundige zorg in 
Nederland is groot en ik ben blij dat ik deel heb uitgemaakt van ‘jouw’ INDEX-studie!
Lieve Aafke en Judit, lieve paranimfen: In de afgelopen jaren hebben wij een hele fijne en sterke band 
met elkaar opgebouwd, lief en leed gedeeld, successen gevierd, vele uren monnikenwerk verricht 
en vele, vele, vele versies van protocollen, presentaties, artikelen et cetera voorbij zien komen. Jullie 
aandeel in mijn promotie zal ik nooit vergeten, maar nog minder snel vergeet ik alle leuke momenten 
die wij hebben mogen delen. Ik ben blij dat ik jullie tijdens dit promotietraject naast mij heb gehad en 
ik blijf ook naast jullie staan in jullie traject! 
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Lieve Sanne, dankzij jou is dit avontuur begonnen. Waarschijnlijk ga ik aan het einde van de dag tegen 
jou zeggen dat ik blij ben dat ik heb gesolliciteerd voor dit promotietraject. 
Beste verloskundig hulpverleners in de eerste- en tweedelijn, beste researchmedewerkers. Al was in 
het begin niet iedereen gewend aan het verrichten van onderzoek (dan tel ik mezelf daarbij mee), 
dankzij eenieders inspanningen en medewerking hebben we dit grote onderzoek door heel Nederland 
in de eerste- en tweedelijn op een kwalitatief hoog niveau kunnen afronden! Nogmaals dank voor de 
prettige samenwerking!
Beste mede-auteurs van de artikelen, dank voor de input om de inhoud van de artikelen naar een 
wetenschappelijk hoger niveau te tillen.
Lieve collega-assistenten, poli-medewerkers, verloskundigen, verpleegkundigen, operatie-assistentes 
en gynaecologen van het Rijnstate, Radboudumc en Catharina Ziekenhuis. Een promotietraject doen 
naast de opleiding tot gynaecoloog is niet altijd even makkelijk, maar dankzij jullie gezelligheid, humor, 
luisterend oor en samenwerking, heb ik beide trajecten fijn kunnen combineren. 
Lieve Saskia, Bart, Jan, Marike, Kim, Elli en Jeroen. Mede dankzij alle mooie momenten die ik met jullie 
afgelopen jaren heb gehad, ben ik niet omgevallen tijdens de soms erg drukke periodes. Het gaf altijd 
nieuwe energie als ik met jullie weer eens een spellenavond of filmavond had, naar het theater ging, 
vakantie vierde, of een nieuw record zette in een escape room! Jan, (bijna) al mijn advanced Excel 
vaardigheden heb ik aan jou te danken. Dank voor het indirect zeer veel bijdragen aan de kwaliteit van 
de data en het makkelijker maken van mijn onderzoeksleven. Saskia, ik kan met jou hysterisch zijn en 
een diepgaand gesprek hebben. Dank voor jouw oprechtheid en steun in mindere tijden.
Lieve Ramon, Yara, Lianne, Wienke, Nienke, Maaike, Nicky, Lyvonne en Nicole. Alweer bijna 15 jaar 
geleden leerden wij elkaar kennen tijdens de studie. Ondanks dat we elkaar niet meer met grote 
regelmaat zien, is het altijd ‘als vanouds’ gezellig als we samen zijn. Fijn dat wij deze club hebben!
Lieve Martijn en Manon. Ik had me geen betere start in het theater kunnen wensen. Vanaf auditieronde 
1 was er een klik en heb ik me comfortabel gevoeld in de groep en op het podium. Samen straalden we 
in ‘Annie’ en ‘Aïda’ en natuurlijk op menig karaokeavond. Met grote dank…
Lieve Nathan. Ondanks dat wij besloten hebben om niet meer samen verder te gaan, wil ik jou heel 
erg bedanken voor jouw luisterend oor, interesse en aansporingen om soms wat meer voor mijzelf op 
te komen.
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Lieve familie, lieve opa en oma, Gerard en Marjan, Alice en Fred, Bram en Resi, Elske en Dennis: 
Eindelijk is duidelijk geworden waar dat ‘onderzoek’ waar ik steeds mee bezig was eigenlijk over gaat. 
Ik ben blij met de goede band die we met elkaar hebben en de mooie momenten die we met elkaar 
kunnen delen!
Lieve pap en mam, lieve Carel en Maryon. Jullie liefde, aandacht en warmte voor ons gezin hebben 
Bram, Elske en mij gemaakt tot wie we nu zijn. Nog steeds zijn jullie er altijd voor ons, en is niets teveel. 
Ik ben blij dat ik dit moment met jullie kan delen en laten we nog vele leuke herinneringen met zijn 
allen maken!
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